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Abstract 
 
Influenza A Virus (IAV) assembly at the plasma membrane of infected cells is a complicated 
process that is orchestrated by at least five viral components: hemagglutinin (HA), 
neuraminidase (NA), matrix (M1), the ion channel M2, and viral ribonucleoprotein complexes 
(vRNPs). While the roles of these individual viral components during IAV assembly have been 
described before, the precise nature and sequence of interactions between viral proteins during 
IAV assembly are not completely understood. In addition, very few host factors that are involved 
in IAV assembly have been identified. The goal of this thesis is to better define the role of viral 
and host factors in IAV assembly. To do so, a strategy that involves comparison between cell 
types that support IAV assembly (permissive) and cell types that do not (non-permissive) has 
been employed. This comparison allows for identification of viral-viral and viral-host 
interactions that regulate IAV assembly in host cells. 
 In this thesis, the primary human monocyte-derived macrophages (MDM) has been 
identified as a cell type that is non-permissive to IAV assembly. In comparison with a cell type 
that is permissive to IAV assembly, MDM are efficient at supporting the early steps of the IAV 
life cycle but fail to support assembly of nascent particles. A more thorough analysis of the IAV 
assembly process revealed that MDM are defective at supporting a discrete step in IAV 
assembly: association between the viral proteins HA and M2 at the plasma membrane. In 
addition, the association between HA and M2 likely precedes particle assembly in cells and 
hence, is an essential step for initiation of virus particle assembly.  
	 x	
 As for the host factors involved in IAV assembly, IAV particle assembly is restored in 
MDM upon disruption of the actin cytoskeleton. Hence, the actin cytoskeleton plays a negative 
role in IAV assembly in a cell-type-dependent manner. In addition, the actin cytoskeleton 
suppresses IAV assembly in MDM likely by restricting the association of M2 with HA. Data in 
this thesis further indicate that both linear and branched actin filaments contribute to suppression 
of HA-M2 association in MDM.  
 Overall, in this thesis, key viral and host factors that regulate assembly of nascent IAV 
particles have been identified. This information will potentially aid in development of new 
antiviral strategies that specifically target IAV assembly. 
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Chapter 1  
Introduction 
 
Influenza A Virus (IAV) belongs to the Orthomyxovirus family of viruses.  The Orthomyxovirus 
family consists of seven genera, out of which three genera: Influenza A, Influenza B and 
Influenza C cause disease in humans. Among these three genera, IAV is the most widespread 
with respect to its host range. While the natural reservoir of IAV are wild birds, the virus can 
infect pigs, horses, minks, seals, whales, dogs, cats, bats as well as humans [1]. In humans, 
seasonal outbreaks of IAV infection occur every year and affect 3-5 million people worldwide. 
Severe disease and complications leading to death occur in susceptible populations including 
children, individuals older than 65 years, individuals with chronic medical conditions as well as 
individuals with immunosuppressive conditions such as HIV/AIDS. A recent study estimated 
that 291,243-645,832 seasonal influenza-associated respiratory deaths (4·0-8·8 per 100,000 
individuals) occur annually worldwide [2]. In addition to these seasonal outbreaks, IAV has been 
the cause of disease pandemics affecting millions worldwide. These pandemics are caused by the 
introduction and adaptation of new viral strains in humans from an animal source. The deadliest 
influenza pandemic in recent history is the Spanish Flu, which began in 1918 and killed 40-50 
million people [3]. The most recent 2009 H1N1 pandemic affected about 60 million people 
worldwide but the mortality rates were relatively low because of advancements in medicine as 
well as higher infection rates in children and young and middle-aged adults than in older 
individuals [4]. The emergence of new IAV strains within the human population, via the 
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introduction of new viral strains from other animals (antigenic shift) and/or adaptation of 
existing strains (antigenic drift), continues to be a threat.  
 
Composition of IAV 
IAV is an enveloped virus with an eight-segmented negative sense RNA genome. On the surface 
of the virus are present three transmembrane proteins: hemagglutinin (HA), neuraminidase (NA) 
and the ion channel protein (M2). On the cytoplasmic side of the viral membrane, the matrix 
(M1) protein oligomerizes to coat the inside of the virus particle [5]. The viral RNA segments 
incorporated into the virus particle are present as a viral ribonucleoprotein (vRNP) complex 
between the RNA, nucleoprotein (NP) and three polymerase subunits: PA, PB1, and PB2 [6]. The 
virus also encodes for two NS proteins: NS1 and NS2, which play non-structural roles during 
virus replication. Recently, five additional proteins expressed by the PA and PB1 segment of 
IAV have been identified: PB1-F2 [7], PB1-N40 [8], PA-X [9], PA-N155 and PA-N182 [10]. With 
exception to the identification of PB1-F2 as a virulence factor inducing cell death [7], the 
functions of the remaining four proteins are not well understood.  
 
IAV life cycle 
The IAV life cycle begins with binding of IAV to the target cell via interactions between HA on 
the viral membrane and sialic acids on the host cell membrane [11,12]. Following this interaction, 
the virus is internalized via the host cell’s endocytic pathway. The acidic pH of the endosome 
causes a conformational change in HA, exposing a fusion peptide that allows for fusion of the 
endosomal membrane with the viral membrane [13], following which the vRNPs can be released 
in the cytosol and imported into the nucleus. Viral RNA replication and transcription of mRNAs 
take place in the nucleus, followed by viral protein translation in the cytoplasm. Assembly of 
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new virus particles requires trafficking of at least four viral structural proteins, HA, NA, M1, and 
M2 as well as vRNPs to the plasma membrane [14,15]. After incorporation of the viral genome 
into budding virus particles, the M2 protein mediates scission and thus, release of the nascent 
particles from the cell [16]. The IAV life cycle is depicted in Figure 1.1. 
 
 
 
Figure 1.1: An overview of IAV lifecycle. The virus lifecycle is initiated upon binding of virus-
associated HA to cell-associated sialic acid groups. The early stages of the lifecycle are: fusion, 
uncoating, nuclear import of viral genome, viral gene replication and transcription, and protein 
translation. Viral RNA (vRNA) is replicated via complementary RNA (cRNA). vRNA is also transcribed 
into messenger RNA (mRNA), which is used to produce viral proteins. The late stages of the virus 
lifecycle are: protein trafficking to plasma membrane, virus particle assembly and budding, and particle 
release.   
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IAV Assembly 
IAV is thought to assemble in cholesterol-enriched microdomains, or membrane rafts, of the 
plasma membrane of host cells [14,15,17-20]. HA and NA accumulate and co-cluster at these 
microdomains and form sites of virus assembly known as budozones [17,18,21-24], while the third 
transmembrane protein, M2, is suggested to localize at the edge of the budozone [16,18,25,26]. 
M1, which is predominantly cytosolic, associates with membranes containing HA, NA and M2, 
either at the ER-Golgi or at the plasma membrane [27-30]. Expression of HA, NA, M1 and M2 in 
cells is sufficient to drive assembly and budding of virus-like particles at the plasma membrane 
[21,31]. A subset of the M1 population is also imported into the nucleus [32-35], where it mediates 
the export of vRNPs via the Crm1 pathway along with NS2 [36,37]. After nuclear export, vRNPs 
are thought to co-opt the cellular recycling compartment to traffic to assembly sites at the plasma 
membrane [38-41]. Arrival of vRNPs at virus assembly sites further promotes assembly and 
budding of virus particles [42-44].  While HA, NA and, likely, M1 induce and stabilize membrane 
curvature [21,31,45], membrane scission and release of virus buds requires M2. M2 is enriched at 
the neck of the virus bud [16,25,26] and is thought to induce positive membrane curvature, which 
may be sufficient for membrane scission [16,46]. NA prevents retention of nascent particles that 
have undergone scission by cleaving cell-surface sialic acid moieties, which could otherwise 
bind virus-associated HA [47,48]. The different steps of IAV assembly are depicted in Figure 1.2. 
5	
 
 
Figure 1.2: Overview of IAV assembly. IAV assembly is initiated at the plasma membrane after arrival 
of three transmembrane proteins, HA, NA and M2, and the cytoplasmic protein M1 through the 
cytoplasm. Clustering of these viral proteins drives assembly of the virus particle. Assembling virus 
particles can have a spherical or filamentous morphology. For the sake of simplicity, only the spherical 
morphology is depicted in this figure. vRNPs are transported across the cytoplasm on Rab11-positive 
vesicles and are incorporated into the assembling virus particle. NA allows for release of nascent particles 
that have undergone the scission by cleaving cell-surface sialic acid moieties.  
 
Different morphologies of IAV 
IAV is pleomorphic, possessing two distinct morphologies: spherical virions that are ~100 nm in 
diameter and filamentous particles that are ~100 nm in diameter and up to 20 um in length [49-
52]. Most commonly used laboratory-adapted strains, such as A/Puerto Rico/8/1934 (H1N1) 
(PR8) and A/WSN/1933 (H1N1) (WSN), are solely spherical [53]; however, in vivo human 
infection produces both spherical and filamentous virions [49,51]. In addition, virions having 
filamentous morphology emerge after passaging of spherical viral strains in guinea pigs, 
suggesting the selective advantages of this morphology [52]. The key genetic determinant of 
virion morphology is the M1 protein, since specific mutations in the M1 protein confer the 
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ability to form filamentous virions [52,54-58], although M2 [57,59,60] and NP [44] also play some 
roles. 
 
Viral proteins important for IAV assembly and budding 
The roles of individual viral components that contribute to IAV assembly are briefly described 
below. In addition, a schematic describing the functional domains of individual viral proteins 
involved in IAV assembly is shown in Figure 1.3. 
i. HA: HA is a homotrimeric glycoprotein with a 27 residue transmembrane domain. The HA 
ectodomain, which is 529 residues long, is involved in virus binding and entry and hence, serves 
as a target for most anti-HA antibodies. The motifs that mediate association of HA with lipid 
rafts are found in the transmembrane domain and the 10 amino acid long cytoplasmic tail 
[17,22,61-63]. These motifs are also involved in the targeting of HA to the apical plasma 
membrane [23,64], indicating that lipid-raft association and apical targeting of HA are linked. The 
role of HA in particle assembly is not fully understood. In early studies using transfection 
systems, expression of HA without expression of any other viral proteins showed that HA alone 
cannot form virus-like particles [65,66]. However, it was later shown that expression of HA alone 
is sufficient for assembly and release of virus-like particles [21]. A recent study showed that 
while HA (along with NA) can induce curvature in the plasma membrane, the expression of 
additional proteins such as M1 and/or M2 is required for stabilization of this curvature and 
hence, formation of virus-like particles [31]. In terms of virus infection, viruses lacking HA are 
still able to bud from infected cells [61], suggesting that other viral proteins such as NA, M1 and 
M2 can drive virus assembly in the absence of HA. Similarly, even when HA is intentionally 
targeted to the basolateral membrane of the cell, virus assembly still takes place at the apical 
membrane [67,68]. Therefore, the current understanding in the field is that HA can initiate 
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membrane curvature at the plasma membrane; however, it is not essential for assembly or 
budding of virus particles. In addition to its role in induction of membrane curvature, HA helps 
in recruitment of other viral structural components such as M1 [27-30,45] and vRNPs [69,70] to 
virus assembly sites. 
ii. NA: NA is a type II transmembrane glycoprotein that, like HA, associates with lipid rafts in a 
manner dependent on its transmembrane (29 amino acids) and cytoplasmic (5 amino acids) 
domains [22,71-73]. Similarly to HA, the exact role of NA during virus particle assembly is not 
fully understood. While NA is thought to be able to induce membrane curvature [21], particle 
assembly relies on additional viral components such as HA, M1 and M2 [31,65,66]. The 
cytoplasmic tail of NA plays an important role in IAV assembly since mutations in this domain 
alter the shape and morphology of assembling virus particles [29,73]. Like in the case of HA, the 
cytoplasmic domain of NA is also important for recruitment of M1 to virus assembly sites [27-
30]. Apart from its role in particle assembly, NA plays a key role in cleaving sialic acid residues 
on the cell surface before the assembled virus particle can be released from the cell. This 
enzymatic activity of NA is encoded by the extracellular domain (436 amino acids) of the protein 
[47].  
iii. M1: M1 is a 252 amino acid protein that contains three domains: N-domain, Middle(M)-
domain and the C-domain. The N- and M- domains play key roles in the oligomerization [74-76], 
membrane binding [74,75], and vRNP binding [32,74,77,78] of M1. The C-domain has been 
suggested to be involved in vRNP binding [34] and M1-M1 interactions [74,76]. Nevertheless, all 
three domains of M1 protein are important for virus assembly and contribute to the morphology 
of virus particles [55,56,74]. When expressed alone, M1 is predominantly localized to the cytosol. 
However, it associates with detergent resistant membranes and is incorporated into virus-like 
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particles in the presence of HA and/or NA [27-29,69]. Even though earlier studies showed that M1 
possesses intrinsic membrane binding ability [34,79,80] and can initiate virus-like particle 
formation by itself [65,66], later studies showed that HA, NA and/or M2 and not M1 initiate 
particle assembly [21,81]. Based on these studies, the current model is that interactions between 
M1 and the cytoplasmic tails of HA, NA or M2 allow for initial targeting of M1 to the plasma 
membrane, following which interactions with negatively charged lipids stabilize membrane-
association of M1. Upon membrane binding, M1 multimerizes to provide structure to the virus 
particle [5]. The importance of M1 in IAV assembly is further evident by its role in conferring 
the ability to form filamentous virus particles [52,54-57,82,83]. 
iv. M2: M2 is a homotetrameric transmembrane protein, which is also encoded by the M segment 
of the viral genome through alternate splicing. The transmembrane domain (19 amino acids) of 
M2 forms the pore of the ion channel, the activity of which is important for uncoating of the 
virus particle core during virus entry [84,85]. The cytoplasmic tail (54 amino acids) of M2 plays 
important roles in virus assembly and budding [16,59,86-88]. While the membrane proximal 17 
amino acids of the M2 cytoplasmic tail form an amphipathic helix, which has been proposed to 
induce positive membrane curvature for scission of the virus bud [16,26,46,89], the membrane 
distal amino acids are involved in binding and recruitment of M1 and/or vRNPs to virus 
assembly sites [59,60,86-88,90,91]. Some complementarity has been observed for the roles of M1 
and M2 during particle assembly [92,93], suggesting a direct link between the two viral proteins.  
With respect to spherical IAV particle assembly, M2 is not important for initiating particle 
assembly per se but is important for membrane scission and pinching off of the assembled bud 
[16,26,59,88]. In contrast, filamentous particle assembly is highly dependent on the function(s) of 
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M2 [25,26,60,88,92,93], indicating that, in addition to M1, M2 also plays an important role in IAV 
morphogenesis. 
v. vRNP: While incorporation of vRNPs into assembling virus particles is required for generation 
of infectious virus particles, the arrival of vRNPs at virus assembly sites also promotes IAV 
assembly [42,43]. Consistent with the role of vRNP recruitment in IAV particle assembly, 
mutations in NP also confer the ability to form filamentous virus particles [44]. However, the 
exact mechanism by which vRNPs regulates particle assembly is not known. Since NP associates 
with both M1 and M2 [59,60,74,87,90], it is likely that the role of vRNPs in particle assembly is at 
least partially dependent on its association with M1 and/or M2. In addition, transport of vRNPs 
and cholesterol to the plasma membrane are linked [42] and hence, vRNP recruitment may drive 
particle assembly in a cholesterol-dependent manner.  
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Figure 1.3: Functional domains of viral proteins involved in IAV assembly. The five viral structural 
proteins (HA, NA, M1, M2, and NP) that play important roles during IAV assembly are shown. Note that 
HA and M2 are type I transmembrane proteins while NA is a type II transmembrane protein. The 
functional domains of individual viral proteins as well as the specific functions of these domains during 
IAV assembly are shown. ED, Ectodomain; TMD, Transmembrane domain; CT, Cytoplasmic tail; aa, 
amino acids.  
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Host factors regulating IAV assembly 
Genome-wide approaches have identified numerous host cellular proteins that play important 
roles during IAV infection [94-103]. However, the functional significance of many of the 
identified proteins still needs to be determined. Host cellular proteins could either serve as virus 
cofactors or restriction factors for replication of viruses. Released IAV particles incorporate 
several host cellular proteins that are known to associate with plasma membrane lipid rafts such 
as cytoskeletal proteins, annexins, glycolytic enzymes, and tetraspanins [104,105]. However, the 
exact roles (positive or negative) are understood for only a subset of these proteins. In this 
section, I provide a brief description of the host cellular proteins known to play positive or 
negative roles during different steps of IAV assembly. The roles of these individual proteins 
during IAV assembly are further summarized in Table 1.1. 
Host proteins important for trafficking of vRNPs: 
i. Rab11: Trafficking of the newly replicated genome to sites of virus assembly at the apical 
plasma membrane and its packaging into assembling virus particles is mediated by Rab11-
positive vesicles [39,40,106-112]. While these vesicles were thought to be derived from the 
endocytic recycling compartment (ERC) in earlier studies [39,40,43,107,112-114], a more recent 
study suggested that they are derived from the ER [41]. Rab11 also localizes in the Golgi and 
post-Golgi vesicles, where it may serve as a link between the endocytic and exocytic pathways 
[115]. The ubiquitous localization of Rab11 in the cell makes it difficult to understand the exact 
nature of the compartment driving vRNP transport in the cell.  While their origin is yet to be 
determined, the Rab11-positive vesicles, which are enriched in cholesterol [42], are proposed to 
promote IAV particle assembly [42,116]. Rab11-dependent transport is also important for 
bundling of vRNPs so that eight unique segments can be incorporated into assembling virus 
particles [107,108]. 
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ii. HRB: Human immunodeficiency virus (HIV) Rev-binding protein (HRB) is a cytoplasmic 
protein, which has been shown to be important for trafficking of vRNPs to the cell periphery 
[117]. In addition to its association with vRNPs, HRB also interacts with Crm1 [118] and NS2 
[37,117], which are both key drivers of vRNP nuclear export. While HRB has no obvious effect 
on nuclear export of vRNPs, the lack of functional HRB impairs vRNP transport to the plasma 
membrane [117]. The localization of HRB in the cytoplasm as well as its ability to interact with 
the nuclear export machinery may allow it to serve as a potential link between nuclear export and 
trafficking of vRNPs in the cytoplasm. However, the molecular mechanisms behind HRB-
mediated transport of vRNPs are not completely understood. 
iii. STAU1: Staufen 1 (STAU1) is an RNA-binding protein that regulates the transport and 
localization of mRNA in cells [119,120]. In terms of IAV infection, STAU1 is required for 
efficient particle assembly and release. STAU1 is important late during the IAV life cycle and 
associates with vRNPs to likely drive their trafficking and/or packaging into assembling virus 
particles [121].   
iv. YB-1: Y-box-binding protein 1 (YB-1) is a predominantly cytoplasmic RNA- and DNA-
binding protein, which translocates to the nucleus in response to IAV infection [122]. While YB-1 
likely first interacts with vRNPs in the nucleus [122], its role in vRNP trafficking has been mainly 
described in the cytoplasm [42,122]. YB-1 anchors microtubules at the microtubule organizing 
center (MTOC) and bridges the interactions between vRNPs and microtubules. However, since 
the role of microtubules in vRNP trafficking to the plasma membrane is still debatable 
[39,106,110], the exact mechanism by which YB-1 drives vRNP transport in the cytoplasm is not 
clear.  
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v. hCLE: hCLE is a human transcription factor, which was previously shown to promote the 
activity of the IAV polymerase [123-125]. However, recently, hCLE was also shown to be 
upregulated in IAV-infected cells and associate with vRNPs in the cytoplasm as well as in 
released virus particles [126]. However, the exact role(s) of hCLE during vRNP transport is not 
known. 
Host proteins important for trafficking of transmembrane proteins: 
i. COPI: The IAV transmembrane proteins HA, NA and M2 traffic from the ER to the plasma 
membrane via the anterograde transport pathway. COPI, which is expressed on vesicles 
transporting contents between the Golgi and the ER, is important for efficient membrane protein 
expression and trafficking of the transmembrane proteins M2 and NA to the plasma membrane 
[127].  
ii. Cdc42: Cdc42, a Rho GTPase that is involved in regulation of the cell cycle, is activated in 
response to IAV infection. The active form of Cdc42 promotes the transport of NA to the plasma 
membrane by increasing the efficiency of anterograde transport in cells [128]. 
iii. UBR4: Ubiquitin N-recognin domain-containing E3 ligase 4 (UBR4) is a predominantly 
nuclear protein, which translocates to the cytoplasm in response to IAV infection. It associates 
with M2 in the perinuclear ER region and promotes the trafficking of not just M2 but also HA 
and NA to the plasma membrane. While the binding of UBR4 to M2 prevents the degradation of 
M2 and thus increases its expression at the plasma membrane, it is not clear how UBR4 
promotes the trafficking of HA and NA [100]. 
iv. Rab11: In addition to its role in vRNP trafficking, Rab11 also promotes trafficking of M2 to 
the plasma membrane [16]. However, it is not known whether Rab11-dependent trafficking of 
M2 occurs by mechanisms similar to those for vRNP trafficking.  
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v. TRAPPC6AΔ: The transport protein particle (TRAPP) complex is a multisubunit tethering 
complex that is involved in protein transport between different cellular organelles. 
TRAPPC6AΔ, a subunit of TRAPP complex, interacts with M2 and slows down the trafficking 
of M2 to the plasma membrane [129]. While TRAPPC6AΔ associates with M2 in cytoplasmic 
vesicles, the exact identity of these vesicles as well as their role in regulating M2 transport are 
not known.  
vi. Cyclin D3: Cyclin D3 is a key regulator of the cell cycle that restricts IAV assembly in a 
manner independent of its regulatory role during the cell cycle. In response to IAV infection, 
Cyclin D3 redistributes from the nucleus to the cytoplasm, where it binds to M2. Binding of 
Cyclin D3 to M2 impairs binding of M1 to M2 and reduces the efficiency of M2 trafficking to 
the plasma membrane [130].  
Host proteins important for particle assembly 
i. CD81: CD81 is a tetraspanin that is expressed on the plasma membrane and endosomal 
membranes. It is incorporated into IAV particles [104] and plays important roles during both IAV 
entry and assembly [131]. With respect to IAV assembly, the efficiency of virus bud formation is 
not altered in the absence of CD81; however, the buds are elongated and have a higher 
propensity to remain attached to the host cell. With respect to the mechanism by which CD81 
promotes IAV assembly, it localizes to the growing tip as well as the neck of the assembling 
particle and is thought to promote pinching-off of the virus bud [131]. 
ii. Rack1: The scaffolding protein receptor for protein C kinase 1 (Rack1) interacts with the N-
domain of M1. In the absence of Rack1, M1 is still recruited to the plasma membrane and virus 
particle assembly can be initiated. However, the assembled virus particles are unable to pinch off 
and be released from the cell [132]. 
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iii. F1Fo ATPase: The F1Fo ATPase is an enzyme complex, which consists of a catalytic portion 
(F1) and a proton channel (Fo). It is found in the inner membrane of the mitochondria and at the 
plasma membrane. The β subunit of plasma membrane-associated F1Fo ATPase interacts with 
NS2 and this interaction allows for clustering and polymerization of the ATPase close to virus 
assembly sites. At virus assembly sites, F1Fo ATPase localizes at the bottom edge of assembling 
virus particles and promotes particle assembly [133]. 
iv. Annexin A6: Annexin A6 is a calcium-dependent membrane-binding protein that associates 
with M2 at the plasma membrane and negatively regulates IAV budding. Upon overexpression 
of Annexin A6 in IAV-infected cells, particle assembly is still initiated; however, membrane 
scission and release of virus particles are significantly reduced [134]. 
v. Viperin: Viperin is an evolutionarily conserved protein that is inducible by interferon and 
blocks the infection of many different viruses [135]. In the case of IAV, expression of Viperin 
inhibits IAV budding. While particle assembly is initiated, assembled virus particles are not able 
to pinch off and be released from the cell. Viperin interacts with a key enzyme in the isoprenoid 
biosynthesis pathway to block its activity and thereby, affects lipid raft formation. Consistent 
with its role in lipid raft disruption, expression of Viperin increases the diffusion rate of plasma 
membrane-associated HA [136]. 
vi. Actin cytoskeleton: The role of the actin cytoskeleton in IAV assembly depends on the 
morphology of the assembling virus particle. Disruption of the actin cytoskeleton has no obvious 
effects on spherical particle assembly. Interestingly, in some cases, disruption of the actin 
cytoskeleton modestly increases spherical virus release [82,137]. In contrast, filamentous particle 
assembly is highly dependent on an intact actin cytoskeleton. Both stabilization and disruption of 
F-actin impedes filamentous particle formation at the apical surface [82,137]. In chapter 2, I 
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describe a host cell-type-dependent role for the actin cytoskeleton in assembly of spherical IAV 
particles. 
 Since I focus on the role of the actin cytoskeleton during IAV assembly in later chapters, 
I provide an overview of the structure and function of the actin cytoskeleton in the following 
section(s). In addition, I provide a summary of the currently known roles of the actin 
cytoskeleton at different steps of IAV assembly.   
 
Overview of the Actin Cytoskeleton 
The actin cytoskeletal system is composed of actin monomers (G-actin) that polymerize to form 
helical filaments (F-actin) [138,139]. Actin filaments are asymmetric in nature with a barbed end 
that grows faster and a pointed end that loses actin monomers faster. Actin filaments can form 
more complex structures such as branched networks, bundled networks, and non-aligned 
networks. These different conformations of F-actin require different actin-nucleating proteins 
[140,141]. While the Arp2/3 complex nucleates branched F-actin structures, formins nucleate 
unbranched actin filaments and serve as elongation factors for the growing actin filament. In 
addition to nucleating factors, organization of F-actin is dependent on cofilin, an actin-binding 
protein that severs filaments to generate free ends for addition of G-actin [142]. Actin filaments 
do not grow outwards from an organizing center but polymerize and depolymerize locally in 
response to different stimuli. The actin cytoskeleton functions in cell migration, providing 
structure and strength to the plasma membrane, trafficking of cargo within the cell, organization 
of organelles, and regulation of cytokinesis during cell division. The cortical actin cytoskeleton, 
a network of actin filaments that underlies and interacts with the plasma membrane, plays an 
important role in maintaining the structure of the plasma membrane [143-145]. These functions of 
F-actin are carried out with the help of myosin motors, which play key roles in regulating the 
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dynamics of F-actin networks [146].  The Rho family of small GTPases also regulates actin 
assembly and disassembly. The most well characterized Rho GTPases are RhoA, Rac, and 
Cdc42. RhoA stimulates the activity of formins and promotes assembly of linear F-actin bundles. 
On the other hand, Rac and Cdc42 promote branching of the actin cytoskeleton by activating the 
Arp2/3 complex [147]. 
 
Relationships between IAV growth and actin cytoskeleton  
Various lines of evidence support multifaceted relationships between the actin cytoskeleton and 
the IAV life cycle. First, actin is incorporated into released IAV particles [104,105]. Second, viral 
components, specifically M1 and proteins comprising the vRNPs, associate with actin in host 
cells [148-151]. Third, IAV infection alters the levels, structures and functions of F-actin in host 
cells. Several studies show an enhancement in total actin [152,153] levels upon infection, with the 
exception of one study that showed no difference in cellular actin levels [154]. In addition to total 
actin levels, IAV infection can also modulate the levels or activities of proteins involved in 
regulation of F-actin dynamics. While some key proteins involved in F-actin dynamics such as 
cofilin-1 [153,155], ERM proteins [153], talin [153], and the regulatory light chain of myosin II 
motor [153] are upregulated in response to IAV infection, others such as Arp2/3 [154], formins 
[154], cortactin [156] and myosin Vb [154] are downregulated. RhoA, which regulates functions of 
the actin cytoskeleton, was downregulated in infected epithelial cells [157]. In addition, the 
activity of RhoA [153,157] and another Rho GTPase, Rac1 [158], is reduced upon IAV infection 
but the activity of a third Rho GTPase, Cdc42 [128], is enhanced upon infection. Therefore, there 
seems to be some specificity with which IAV infection modulates expression or activity of 
proteins engaged in F-actin dynamics.  
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 Fourth, disruption of actin cytoskeletal dynamics has either a negative or a positive effect 
on viral replication. Disruption of F-actin dynamics, by drugs inhibiting polymerization 
(cytochalasin D), enhancing depolymerization (latrunculin A), or stabilizing actin filaments 
(jasplakinolide), leads to increase in released viral titers in non-polarized cells [82,137]. In 
epithelial cells, the effects of these drugs on viral replication differ between different studies. In 
the Madin-Darby Canine Kidney (MDCK) cell line, disruption of F-actin dynamics has no [82], a 
positive [137], or a negative [159,160] effect on released viral titers. In polarized rhesus monkey 
kidney cells, which are inefficient in supporting infection of a laboratory adapted IAV strain, 
inhibition of F-actin polymerization [161] drastically increases released viral titers. Cofilin-1 [155] 
and cortactin [156], which can promote disassembly and assembly of F-actin, respectively, are 
both thought to play positive roles during IAV infection.  
 Among those listed above, studies that show infection-induced changes in actin 
cytoskeletal proteins or their association with viral proteins or particles are consistent with a role 
for the cytoskeleton in IAV infection. Obviously, however, studies conducted using specific 
inhibitors or genetic ablation should provide more definitive evidence on the role of specific 
actin cytoskeletal components in the virus life cycle. Nonetheless, some studies using these 
strategies show contradictory data even as to whether the actin cytoskeleton of interest plays a 
positive role or not [39,82,110,114,137,155,159,161,162]. This could partially be attributed to the use 
of viral titers as read-out for IAV infection. Measurement of viral titers may not allow for 
identification of the role(s) of the actin cytoskeleton at different stages of the IAV life cycle, 
especially if the actin cytoskeleton plays opposing roles in the early and late stages of IAV 
infection. Even with studies focusing on the late stages of the virus life cycle, disruption of F-
actin can have contradictory effects on particle assembly [82,137,159,163]. This could be because 
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F-actin can play negative and positive roles at different steps in IAV assembly. Depending on the 
conditions, such as host cell types, viral strains, and the time points at which analyses are 
performed, cumulative effects of F-actin disruption may lead to different final outcomes on virus 
production. Therefore, to advance our understanding of the roles played by cytoskeletons in virus 
growth, it is necessary to determine the effects of cytoskeleton disruption on each of single 
defined steps of the virus life cycle in addition to the overall viral titers. In the following 
sections, I describe the individual steps of the IAV assembly process as well as the role of actin 
cytoskeleton during these steps.  
 
Roles played by the actin cytoskeleton at specific steps of IAV assembly 
F-actin could regulate at least the following steps in the IAV assembly process: trafficking of 
viral transmembrane proteins to the plasma membrane, trafficking of cytoplasmic viral 
components to the assembly sites, association between viral components at the plasma 
membrane, and morphogenesis of nascent particles. The different steps of IAV assembly and the 
roles (positive or negative) of the actin cytoskeleton during these steps are depicted in Figure 1.4. 
In addition, the roles of specific actin cytoskeletal components at different steps of IAV 
assembly are summarized in Table 1.2. 
Trafficking of viral transmembrane proteins to the apical membrane: 
As mentioned above, IAV assembles at the apical surface of polarized epithelial cells, which 
requires targeting of virus components to the apical plasma membrane [64,72,73,164-173]. F-actin 
disruption has no obvious effect on apical targeting of transmembrane proteins HA and NA or 
spherical virus assembly in polarized MDCK cells [160,174]. In one study, impairment in 
glycosylation of HA and NA was observed upon F-actin disruption; however, this did not have 
an effect on apical targeting of the proteins [160]. Cdc42, the Rho GTPase that regulates F-actin 
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branching, promotes the apical trafficking of NA [128]. However, it is not clear whether this 
positive role of Cdc42 in IAV assembly is via its effect on F-actin dynamics or via its other 
regulatory roles during the cell cycle. 
Trafficking of viral cytoplasmic components to the assembly sites: 
In addition to viral transmembrane protein trafficking, M1 protein trafficking to the plasma 
membrane is also thought to at least partially rely on the ER-Golgi transport pathway, since M1 
associates with HA- and NA-enriched membranes both at the ER-Golgi and the plasma 
membrane [27,28]. In the cytoplasm, M1 may also associate with F-actin, since it remains 
insoluble after a detergent treatment that disrupts M1-lipid interactions but still allows M1-actin 
interactions [148].  However, it is not clear whether this association of M1 with F-actin mediates 
the trafficking of M1 to HA- and/or NA-enriched membranes or is involved in the cytoplasmic 
transport of the M1-vRNP complex.  
 Trafficking of the viral genome or vRNPs to the apical membrane is also a key step in the 
assembly of infectious IAV particles. Upon export from the nucleus, vRNPs associate with both 
the actin cytoskeleton [149] and microtubules [122,175]. While the association with F-actin is 
proposed to govern the intracellular localization of vRNPs [149] and partially drive their 
movement in the cytoplasm [113], their association with microtubules appears to be a key driver 
for vRNP trafficking [106,113,114,122,175]. Overall, the findings from previous studies support a 
minimal role for the actin cytoskeleton in apical targeting of IAV components.  
Association between viral components at the plasma membrane: 
Viral proteins have been shown to co-cluster in microdomains of the plasma membrane 
[18,163,176]. However, it is not known whether these associations between viral proteins are 
initiated during ER-Golgi transport or occur post arrival at the plasma membrane. Since HA and 
NA accelerate each other’s apical trafficking [23], they are likely to co-traffic and associate with 
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each other prior to their arrival at the plasma membrane. In contrast, it is not clear whether M2 
co-traffics with HA and/or NA to the apical membrane. While earlier studies suggested that HA 
and M2 traffic together through the ER-Golgi [177-179], a more recent study suggests that the two 
proteins use distinct pathways for trafficking to the plasma membrane [23]. Hence, we currently 
do not know the exact sequence of association between the transmembrane proteins as well as 
their association with M1 and vRNPs. In addition, very little is known about the host cell 
mechanisms that regulate these associations.  
 The cortical actin cytoskeleton is likely to be involved in the regulation of co-clustering 
of viral transmembrane proteins through its ability to regulate the structure of plasma membrane 
microdomains. In fact, the concentration of cortical actin is apparently increased close to the 
plasma membrane in response to IAV infection, and this reorganization of F-actin is proposed to 
be important for efficient virus assembly and budding [155]. The cortical actin lowers the 
mobility of HA at the plasma membrane and enhances the clustering of HA molecules [180]. 
While HA movement is restricted to regions of the plasma membrane with an underlying F-actin 
network, HA mobility negatively correlates with the density of the underlying F-actin [180]. A 
role for the actin cytoskeleton in modulating HA clustering is further supported by the presence 
of HA aggregates at the plasma membrane when the activity of myosin II motors is inhibited 
[159]. Association or co-clustering between HA with M2 is also regulated by the actin 
cytoskeleton. Thaa et al. used fluorescence resonance energy transfer (FRET) approaches, where 
fluorescent probes were fused to the cytoplasmic domains of HA and M2, and observed that 
cytochalasin D treatment reduces FRET between fluorescent protein fusions of HA and M2. 
Hence, these data indicate that the actin cytoskeleton plays a positive role in the association 
between the two proteins in the absence of any other viral proteins [181]. However, it is not clear 
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whether the actin cytoskeleton promotes HA-M2 association during the transport of the proteins 
in the ER-golgi or after their arrival at the plasma membrane.  
Morphogenesis of nascent particles at the plasma membrane: 
In addition to regulating association between viral proteins, the actin cytoskeleton also plays 
direct roles in particle morphogenesis. As described above, the effect of F-actin disruption on 
particle morphogenesis varies depending on the virus morphology with no obvious effects of F-
actin disruption observed for IAV strains that assemble solely spherical particles (WSN or PR8) 
[137,160]. However, one caveat of previous studies with epithelial cells is that they were all 
performed using epithelial cell lines and not primary epithelial cells. It is becoming increasingly 
clear that some steps in the IAV particle assembly process are more stringently regulated in 
primary human cells than in cells lines [91,163], hence, highlighting the need for more studies 
looking at the role of actin cytoskeleton in primary cells.  
 In case of an IAV strain that forms filamentous particles (A/Udorn/72 [H3/N2]), particle 
morphogenesis is highly dependent on F-actin. Both stabilization and disruption of F-actin 
impedes filamentous particle formation at the apical surface [82,137]. The mechanisms by which 
the actin cytoskeleton supports filamentous IAV assembly are not well understood. The actin 
cytoskeleton may provide mechanical support at the base of, or inside the viral filament. Of note, 
while proteomic studies showed incorporation of actin molecules into released virions [104,105], 
F-actin has been observed to localize only at the base of the viral filament [137]. In such 
locations, it is possible that the actin cytoskeleton interacts with one or more viral structural 
proteins and drives their incorporation into the growing filamentous particle. This role of the 
actin cytoskeleton might not be as important for spherical particle assembly since there are fewer 
copies of the structural proteins such as HA, NA, M1 and M2 to be incorporated into spherical 
particles relative to filamentous particles [5]. Of note, the role of F-actin in particle 
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morphogenesis has thus far been examined for only a limited number of the laboratory strains; 
whether the observations above hold true for morphogenesis of a broad range of IAV strains with 
varied tendency to form filamentous versus spherical particles remains to be tested. 
 
 
Figure 1.4: Roles of the actin cytoskeleton at different steps of IAV Assembly. Whether the actin 
cytoskeleton promotes (pos), suppresses (neg) or has no (no) roles during individual IAV assembly steps 
is depicted. 
 
Overview of the thesis 
IAV assembly is driven by five viral components: HA, NA, M1, M2 and vRNPs. As highlighted 
in this chapter, previous studies have described the role(s) of these individual viral components 
in IAV particle assembly and budding. However, limited information is available in terms of the 
nature as well as the sequence of interactions between these viral components that drive 
assembly of virus particles at the plasma membrane. In addition, very few host cellular proteins 
that play a role during IAV assembly and budding have been identified. Of the identified cellular 
proteins, the mechanism by which they contribute to virus assembly has been fully described for 
only a handful of them. Since IAV assembly is not a target for anti-IAV drugs that are either 
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available in clinics or are undergoing clinical trials, an understanding of the viral and host 
proteins that are involved in this stage will potentially reveal targets for future anti-IAV drugs. 
The potential of virus assembly as a target for antiviral drugs is evident in the case of other 
viruses such as human immunodeficiency virus (HIV-1) [182] and hepatitis C virus (HCV) [183], 
where several drugs targeting virus assembly are currently under development.  
My dissertation focuses on studying the viral-viral and viral-host protein interactions that drive 
IAV assembly in host cells. To better facilitate identification of interactions important for IAV 
assembly, I have compared cells that support IAV assembly (permissive) to cells that are unable 
to do so (non-permissive). In chapter 2, I characterize the primary human monocyte-derived 
macrophage as a cell type that is non-permissive to IAV assembly. In addition, using this cell 
type, I show that association between HA and M2 is a discrete step in IAV assembly, which is 
susceptible to suppression by the host cell’s actin cytoskeleton in a cell-type-specific manner. In 
chapter 3, I elucidate the molecular mechanisms by which the actin cytoskeleton restricts IAV 
particle assembly in a cell-type-dependent manner.  
 In chapter 4, I summarize the results of chapters 2 and 3 and highlight the questions 
that need to be addressed in the future. In addition, I present the implications of my work for 
understanding and targeting IAV assembly in host cells. 
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Table 1.1: Roles of host cellular proteins at different steps of IAV Assembly. 
IAV Assembly Step Host cellular protein Role of host cellular 
protein 
Reference 
vRNP trafficking Rab11 Positive [39,40,106-112] 
HRB Positive [117] 
STAU1 Positive [121] 
YB-1 Positive [42,122] 
hCLE Positive [126] 
Transmembrane 
protein trafficking 
 
COPI Positive [127] 
Cdc42 Positive [128] 
UBR4 Positive [100] 
Rab11 Positive [16] 
TRAPPC6AΔ Negative  [129] 
Cyclin D3 Negative [130] 
Particle 
assembly/budding 
CD81 Positive [131] 
Rack1 Positive [132] 
F1Fo ATPase Positive [133] 
Annexin A6 Negative [134] 
Viperin Negative [136] 
Actin cytoskeleton Positive [82,137] 
 
Table 1.2: Roles of specific actin cytoskeletal components at different steps of IAV 
Assembly. 
IAV Assembly Step Actin cytoskeletal 
component 
Role of cytoskeletal 
component 
Refere
nce 
HA trafficking F-actin No role [160] 
NA trafficking Cdc42 Positive [128] 
vRNP trafficking Myosin II No role [159] 
HA clustering  
 
F-actin Positive [180] 
Myosin II Positive [159] 
HA-M2 coclustering  F-actin Positive [181] 
Spherical particle 
assembly 
F-actin No role [137,160
] 
Filamentous particle 
assembly 
F-actin Positive [82,137] 
Release of nascent 
particles 
F-actin Moderately negative/ 
positive 
[82,137,1
59] 
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Chapter 2  
A Defect In Influenza A Virus Particle Assembly Specific To Primary Human 
Macrophages 
	
	
Abstract 
 
Influenza A virus (IAV) propagates efficiently in epithelial cells, its primary target in the 
respiratory tract. In contrast, productive infection of most IAV strains is either blocked or highly 
inefficient in macrophages. The exact nature of the defect in IAV replication in human 
macrophages remains unknown. In this study, we showed that even when compared to a 
monocytic cell line differentiated to macrophage-like cells, primary human monocyte-derived 
macrophages (MDM) are inefficient in IAV production, despite comparable levels of expression 
of viral glycoproteins at the plasma membrane. Correlative fluorescence scanning electron 
microscopy revealed that formation of budding structures at the cell surface is inefficient in 
MDM even though clustering of a viral glycoprotein, hemagglutinin (HA), is observed, 
suggesting that a step in IAV particle assembly is blocked in MDM. Using an in situ proximity 
ligation assay, we further determined that HA associates with neuraminidase (NA) but fails to 
associate with another viral transmembrane protein M2 at the MDM plasma membrane. Notably, 
the defects in HA-M2 association and particle assembly in MDM were reversed upon 
cytochalasin D treatment that inhibits actin polymerization. These results suggest that HA-M2 
association on the plasma membrane is a discrete step in IAV production, which is susceptible to 
suppression by actin cytoskeleton in MDM. Virus release remained inefficient in MDM upon 
cytochalasin D treatment, suggesting the presence of additional defect(s) in virus release in this 
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cell type. Overall, our study revealed the presence of multiple cell-type-specific mechanisms 
negatively regulating IAV production at the plasma membrane in MDM. 
Introduction 
 
Influenza A virus (IAV) is a negative strand RNA virus that mainly infects and replicates in 
epithelial cells in the respiratory tract. However, the virus has also been shown to infect other 
cell types such as macrophages, dendritic cells, and mast cells ex vivo [184-186]. Host-cell-
specific differences have been observed for various properties of IAV including morphology and 
replication [for example, [82,187-190]]. These differences could be due to differences in 
expression levels or functions of host cellular proteins between cell types. In cases where cell-
type-specific differences affect productive infection of a virus, detailed comparison between 
permissive and non-permissive cell types often leads to identification of virus cofactors [189,191-
194] or host factors that restrict replication of viruses [190,195-198]. This approach, which often 
determines the specific function of the host factor of interest even prior to the identity of the 
factor, can serve as a complementary approach to genome-wide approaches [94-103]. 
 Ex vivo infection studies have shown that in comparison to epithelial cells, macrophages 
are less permissive or non-permissive to productive infection of seasonal IAV strains [199-205]. 
Murine macrophages are non-permissive to IAV replication [199,201,205,206]. Primary human 
blood-derived or alveolar macrophages do support seasonal IAV replication at detectable levels 
although they are still much less permissive to virus growth than human epithelial cells 
[200,202,203,206]. As for the defective stages of the IAV life cycle, a block at the entry stage of 
infection has been identified in murine macrophages for most H1N1 strains [199,201,205]. In 
addition, the presence of a defect(s) at a later stage has been known for IAV infection in murine 
macrophages [201,205]. However, there are apparently conflicting data as to whether the defect is 
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at pre- or post-translation stage [201,205]. Moreover, the mechanism in either case has yet to be 
determined. In contrast to murine macrophages, human macrophages support early stages of 
replication of all tested IAV strains yet are unable to complete the virus life cycle [205]. While 
the defect appears to be post-translational, the exact nature of this defect in human macrophages 
and the molecular mechanism behind it are not known. 
 Determining the nature of the human macrophage-specific defect in IAV replication is 
likely to advance our understanding of the roles played by cellular functions in late phases of the 
IAV life cycle and potentially facilitate identification of human host factors involved in this 
process. In the current study, we used primary human monocyte-derived macrophages (MDM) in 
order to identify the defective step in IAV replication in human macrophages. We show that 
MDM support early stages of the IAV assembly process, i.e. trafficking of the viral 
glycoproteins hemagglutinin (HA), neuraminidase (NA), and the ion channel protein M2 to the 
plasma membrane, but are inefficient at virus particle formation and subsequent virus release. 
This defect in virus particle formation and release is specific to primary MDM, since a 
monocytic cell line THP1 differentiated into macrophage-like cells supports efficient virus 
particle production. Notably, we observed that the association of HA with M2 on the plasma 
membrane, as determined by the close proximity of <40 nm, is highly inefficient in MDM 
relative to the differentiated THP1 cells. In contrast, HA and NA associate efficiently on the 
surface of MDM. The defective association between HA and M2 is rescued in MDM upon 
treatment with an actin polymerization inhibitor, cytochalasin D, whereas this defect is recreated 
in differentiated THP1 cells by treatment with jasplakinolide, which promotes actin 
polymerization. Consistent with the restoration of HA-M2 association in MDM, treatment with 
cytochalasin D also increases formation of budding structures in this cell type. However, virus 
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release is not restored in MDM upon cytochalasin D treatment, suggesting the presence of an 
additional block in IAV assembly/release in this cell type. Overall, this study has identified virus 
particle formation, more specifically association between HA and M2, as a step defective in IAV 
life cycle in primary human macrophages and revealed that this macrophage-specific block of 
IAV assembly requires actin polymerization. 
 
Materials and Methods 
 
Cells and reagents: Monocytes were isolated by plate adhesion from peripheral blood 
mononuclear cells, which were obtained from buffy coats derived from unidentified healthy 
donors (New York Blood Center, NY). Cells were cultured in RPMI 1640 (Gibco) supplemented 
with 10% fetal bovine serum (FBS, Hyclone) for 7 days before they were used for experiments. 
THP1 (ATCC® TIB202™) cells were cultured in RPMI 1640 supplemented with 10% FBS, 1 
mM Sodium Pyruvate (Gibco) and 0.05 mM  2-mercaptoethanol. To generate differentiated 
THP1 cells (dTHP1), THP1 cells were cultured in the medium containing 0.1 µM phorbol 12-
myristate 13-acetate (PMA; Sigma) and 0.1 µM Vitamin D3 (Sigma) for 2-3 days. Madin-Darby 
canine kidney (MDCK) cells were provided by Dr. Arnold S. Monto (University of Michigan) 
and were cultured in DMEM (Gibco) supplemented with 10% FBS and 25 mM HEPES. Human 
lung carcinoma cell line A549 was provided by Dr. Mike Bachman (University of Michigan) and 
was cultured in DMEM (Gibco) supplemented with 10% FBS and 25 mM HEPES. Human 
embryonic kidney-derived 293T cell line (ATCC) was cultured and maintained in DMEM 
(Lonza) supplemented with 10% FBS. 
The following antibodies were used for immunofluorescence microscopy: mouse anti-HA 
monoclonal antibody (clone C179 [207]; Takara), mouse anti-M2 monoclonal antibody (clone 
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14C2 [93]; Thermofisher), mouse anti-vRNP monoclonal antibody (clone 61A5 [114]; a kind gift 
from Dr. Fumitaka Momose, Kitasato University), goat anti-HA antiserum (BEI NR-3148), 
mouse anti-transferrin receptor (TfR) monoclonal antibody (clone M-A712; BD Biosciences). 
Rabbit anti-NA antiserum was a kind gift from Dr. Christopher Brooke (University of Illinois). 
Mouse anti-actin (ACTN05) was purchased from Thermofisher. All secondary antibodies used 
for immunofluorescence and Alexa Fluor 488-labeled phalloidin were purchased from 
Thermofisher. Cytochalasin D and jasplakinolide were purchased from Sigma and re-constituted 
in DMSO and 100% Ethanol, respectively. 
Plasmids and virus stocks: A/WSN/1933 (H1N1) virus was generated by reverse genetics [208] 
using the 8 pPolI plasmids encoding different segments of IAV genome and the 4 pCAGGS 
plasmids that express the PA, PB1, PB2, and NP proteins. The titers of the stocks were 
determined using the plaque assay with MDCK cells. A/Wyoming/03/2003 (H3N2) [Wyoming 
(H3N2)], A/Panama/2007/1999 (H3N2) [Panama (H3N2)], and A/California/04/2009 (H1N1) 
[California (H1N1)] viruses were kind gifts from Dr. Arnold S. Monto (University of Michigan) 
and were received as low passage stocks (less than 5 passages in MDCK cells) of virus isolated 
from clinical specimen. Virus infection was performed and monitored using the plaque assay and 
flow cytometry as described in Supplementary Information. 
Measurement of vRNA levels: Virus-containing cell culture supernatants were centrifuged at 
3000 rpm for 5 minutes in a microfuge, filtered through a 0.45-µm filter, and subjected to 
ultracentrifugation at 30,800 rpm (AH650 swinging bucket rotor, Thermofisher) for 90 minutes 
to prepare virus pellets.  Virus and cell-associated vRNA was measured using a previously 
described protocol [209]. Briefly, total RNA was extracted from virus pellets and cell lysates 
using TRIzol reagent (Ambion) according to the manufacturer’s protocol. Complementary DNA 
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was generated using random hexamer priming and the SuperScript III First-Strand Synthesis 
System (Invitrogen). Quantitative PCR was performed on a CFX96 Real Time PCR system 
(Biorad) using Platinum SYBR Green pPCR SuperMiX-UDG (Thermo Scientific Fisher). Serial 
ten-fold dilutions of pPolI plasmids containing specific viral gene of WSN were used to generate 
a standard curve for quantification of cDNA copy number based on cycle threshold (Ct) values. 
The primer sequences are shown in Supplementary Information.  
Correlative fluorescence and scanning electron microscopy (CFSEM): CFSEM experiments 
were performed as described before [210]. Briefly, cells cultured on gridded coverslips (Bellco 
Biotechnology) were infected with WSN at MOI 0.1. Cells were fixed with 4% PFA in PBS at 
20 hpi. After rinsing in PBS, quenching of PFA with PBS containing 0.1 M glycine (Sigma), and 
blocking with PBS containing 3% bovine serum albumin (BSA, Sigma), cells were 
immunostained with mouse anti-HA and fluorescently labeled secondary antibody. Cells were 
imaged using a Leica Inverted SP5X Confocal Microscope with a 40× PL APO objective and 10-
20× scanning zoom. After fluorescence imaging, cells were fixed with PBS containing 2.5% 
glutaraldehyde (Electron Microscopy Sciences), stained with 1% OsO4,dehydrated in a series of 
ethanol washes, rinsed in hexamethyldisilazane (Electron Microscopy Sciences) and allowed to 
dry overnight. Coverslips were affixed to specimen mounts and sputter coated with gold for 90 s 
(Polaron). Cells were identified by their location on the gridded coverslip and imaged on an 
Amray 1910FEG scanning electron microscope at 5-10 kV. Fluorescence and SEM images were 
roughly brought into registration by scaling and rotating images in Adobe Illustrator, similarly to 
other correlative fluorescence/SEM studies [210]. Landmarks used for registration included cell 
edges. Cell surface structures visible in SEM were manually classified as virus-like buds if they 
appeared spherical and near 100 nm in diameter. To identify HA clusters in fluorescence images 
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unambiguously, we removed uniform non-puncta HA signal from the images. To do this, we 
calculated a 20-pixel radius median filter and subtracted the median filtered image from the 
original using the Image Calculator function in ImageJ. Number of HA-positive puncta was 
measured in the background-subtracted fluorescence images using the Analyze particle function 
in ImageJ. Since MDM have substantial membrane folds on the cell surface especially towards 
the center of the cell, we focused on areas towards the edge of the cells, which have a flatter 
topology, for quantification of efficiency of virus bud formation.  
In situ Proximity Ligation Assay (PLA): PLA was performed using Duolink® PLA 
fluorescence kit following the manufacturer’s instruction (Sigma). Cells fixed with 4% PFA 
(non-permeabilized) were incubated with following primary antibody combinations: goat anti-
HA and mouse anti-M2 for PLA and rabbit anti-NA for identification of infected cells; mouse 
anti-HA and rabbit anti-NA for PLA and goat anti-HA for identification of infected cells; or goat 
anti-HA and mouse anti-TfR for PLA and rabbit anti-NA for identification of infected cells.  
Detection of PLA signals and identification of infected cells were performed using PLA probes 
specific to goat, mouse or rabbit IgG and AlexaFluor-488-labeled secondary antibody 
recognizing anti-NA or anti-HA, respectively. Cells were observed using a Leica Inverted SP5X 
Confocal Microscope System with a 63X objective. Z-stacks extending from the focal plane 
corresponding to the middle plane of the nucleus (identified by DAPI staining) to the bottom of 
cells were acquired for each cell, and the maximum intensity projection for each cell was 
constructed using ImageJ. The PLA signal in projection images was thresholded to eliminate 
weak and hazy background signal in the nucleus, and the number of PLA-positive spots was 
counted using the Analyze particle function in ImageJ.  
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Actin fractionation assay: Actin fractionation was performed as previously described [211]. 
Briefly, dTHP1 cells were treated with 0.5% ethanol (vehicle) or 1 µM jasplakinolide for 4 
hours. Cells were incubated with cytoskeleton stabilization buffer (4M glycerol, 25 mM Pipes 
pH 6.9, 1mM EGTA, 1mM CaCl2) containing 0.1% TritonX-100 for 2-3 minutes. Cells were 
centrifuged for 5 minutes at 7,500 g at 4°C. The pellet was re-suspended in the cytoskeleton 
stabilization buffer. Supernatant (S) and pellet (P) fractions were run on a reducing and 
denaturing polyacrylamide gel and analyzed by immunoblotting. 
Statistical analysis: Statistical analyses were performed using GraphPad Prism version 7. Two-
tailed paired student t test was used to calculate p-values in Figures 2.1-2.5, 2.8, 2.10, and 2.12. 
Two-tailed unpaired student t test was performed in Figures 2.6, 2.7, 2.9, 2.11, 2.13, and 2.15.  
 
Results 
 
MDM are inefficient in supporting productive IAV infection relative to differentiated 
THP1 cells 
 To determine the extent to which human epithelial cells and macrophages differ in their 
ability to support productive IAV infection, we compared infectious IAV release from three 
different human cell types: the lung-derived epithelial cell line A549, the monocytic cell line 
THP1, which has been differentiated to adopt macrophage-like morphology (dTHP1), and 
primary monocyte-derived macrophages (MDM). The dTHP1 cells were obtained via treatment 
of THP1 cells with phorbol 12-myristate 13-acetate (PMA) and vitamin D3 for 2-3 days. A549, 
dTHP1, and MDM were infected with the laboratory strain A/WSN/1933 (H1N1) (WSN) at MOI 
0.01 based on the plaque forming units of virus stocks determined using MDCK cells. At 11 
hours post infection (hpi), we observed that virus titers in MDM culture supernatants were up to 
100-fold reduced in comparison to that in A549 culture supernatants. Unexpectedly, virus titers 
35	
in culture supernatants were similar between A549 and dTHP1 cells (Figure 2.1A). Since dTHP1 
cells support influenza virus replication efficiently unlike MDM and yet belong to the same 
cellular lineage, to facilitate the analyses of MDM-specific defect(s), we chose to compare IAV 
replication in MDM with that in dTHP1 cells in subsequent experiments. We noticed that while 
MDM isolated from the vast majority of the tested human donors showed a defect in productive 
IAV infection relative to dTHP1 at 24 hpi (denoted as Group 1 in Figure 2.1B), MDM from 
some donors (denoted as Group 2 in Figure 2.1B; ~20%) showed no significant difference. The 
differences between the two groups of MDM could be due to differences in the genetic 
background and/or the infection history of the donors. Therefore, to identify the MDM-specific 
defect, the subsequent experiments were performed using MDM from the donors in Group 1. In 
particular, in the mechanistic experiments (Figures 2.6, 2.7, 2.9, and 2.11), we verified in each 
experiment that MDM used show 10-20 fold reduction in the supernatant virus titers or released 
vRNA relative to dTHP1 cells at the indicated time point of the corresponding assays (data not 
shown).  
 To assess whether other IAV strains also replicate inefficiently in MDM relative to 
dTHP1 cells, we compared productive infection in dTHP1 cells and MDM of three previously or 
currently circulating IAV strains, in addition to WSN: A/Wyoming/03/2003 (H3N2) [Wyoming 
(H3N2)], A/Panama/2007/1999 (H3N2) [Panama (H3N2)], and A/California/04/2009 (H1N1) 
[California (H1N1)]. Infectious virus titers of all tested IAV strains, as measured by the plaque 
assay, were reduced by 10-50-fold in MDM in comparison to dTHP1 cells (Figure 2.1C). These 
data suggest that MDM are highly inefficient at producing infectious IAV particles in 
comparison to dTHP1 cells.   
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Figure 2.1: MDM are defective in productive IAV infection.  (A) A549 cells, dTHP1 cells and MDM 
were infected with WSN at MOI 0.01. Infectious virus titers in culture supernatants were measured at 11 
hpi. (B) Infectious virus titers in culture supernatants were measured for WSN-infected dTHP1 cells and 
MDM at 24 hpi. For all tested donors, the relative virus titers in MDM cultures were calculated in 
comparison to the titer in dTHP1 cell cultures tested in parallel within the same experiment. Two groups 
of donors (Groups 1 and 2) were denoted based on the reduction in the titers or lack thereof. For Group 1, 
the values for virus titers were in the range 1.9-5.07 log10 PFU/ml. For Group 2, the values were identical 
to those of corresponding dTHP1 cultures and in the range 4.39-5.17 log10 PFU/ml. (C) dTHP1 and MDM 
(Group 1) were infected with the given IAV strains at MOI 0.01, and infectious virus titers in culture 
supernatants at 24 hpi were determined by plaque assays using MDCK cells that have been passaged 20-
30 times. Each circle represents an independently prepared culture. A black and a red circle connected by 
a line represent each independent experiment. For panel A, data are shown as mean +/- SD.  *, P<0.05; 
***, P<0.001; ****, P<0.0001; ns, non-significant. 
 
Both efficiency of virus release and infectivity of released particles are impaired in infected 
MDM relative to infected dTHP1 cells 
The results shown above and the results of time-course experiments suggest that infectious virus 
release is reduced in MDM relative to dTHP1 cells even though flow cytometry using anti-vRNP 
antibody (clone 61A5 [114]) showed that similar fractions of cells in the cultures are infected 
(Figures 2.1 and 2.2). We sought to address whether the reduction in viral titers in MDM culture 
supernatants is due to a reduction in infectivity of released particles or whether it is due to a 
reduction in release of physical particles. To this end, we used viral RNA (vRNA) release as a 
surrogate to measure release of physical particles from dTHP1 cells and MDM. Number of 
vRNA copies released from MDM were 7-8-fold reduced in comparison to that from dTHP1 
Figure 1: MDM are defective in productive IAV infection.  (A) A549 cells, dTHP1 cells and MDM were infected with WSN at MOI 0.01. Infectious virus
titers in culture supernatants were measured at 11 hpi. (B) Infectious virus titers in culture supernatants were measured for WSN-infected dTHP1 
cells and MDM at 24 hpi. For all tested donors, the relative virus titers in MDM cultures were calculated in comparison to the titer in dTHP1 cell 
cultures tested in parallel within the same experiment. Two groups of donors (Groups 1 and 2) w re denoted based on the reduction in the titers or 
lack thereof. For Group 1, the values for virus titers were in the range 1.9-5.07 log10 PFU/ml. For Group 2, the values were in the range 4.39-5.17 
log10 PFU/ml. (C) dTHP1 and MDM (Group 1) were infected with the given IAV strains at MOI 0.01, and infectious virus titers in culture 
supernatants at 24 hpi were determined by plaque assays using MDCK cells that have been passaged 20-30 times. Each circle represents an 
independently prepared culture. A black and a red cir le connected by a line represent each independent exp riment. For pa el A, data are shown 
as mean +/- SD.  *, P<0.05; ***, P<0.001; ****, P<0.0001; ns, non-significant.
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cells for all eight vRNA segments. However, there were no significant decrease in cell-
associated vRNA levels in MDM relative to dTHP1 cells, indicating that MDM support viral 
RNA replication and earlier steps as efficiently as dTHP1 cells. vRNA release efficiency was 
calculated as the ratio of number of vRNA copies in virus pellets from cell culture supernatants 
to the total number of vRNA copies (cell + virus). For all eight vRNA segments, we observed a 
5-10-fold reduction in vRNA release efficiency in MDM relative to dTHP1 cells (Figure 2.3A). 
We also measured vRNA release efficiency in dTHP1 cells and MDM after a single round of 
virus replication (Figure 2.3B). To block virus entry after the first round on infection, cells were 
treated with media containing 10 µg/ml C179, a neutralizing antibody that binds to the HA stem 
[207,212], at 2 hpi. At 12 hpi, we observed a 2-3 fold reduction in vRNA release efficiency in 
MDM relative to dTHP1 cells. These data suggest that efficiency of physical viral particle 
release from MDM is reduced in comparison to that from dTHP1 cells in the context of both 
single and multiple rounds of virus replication. Notably, virus spread, as determined by the 
increase in number of infected cells over time, is still supported in MDM as efficiently as in 
dTHP1 cells (Figure 2.2), suggesting that MDM allow for virus spread by mechanisms 
independent of cell-free infectious viruses. 
 Importantly, the reduction in vRNA release (7-8-fold) from MDM does not entirely 
account for reduction in infectious virus release (up to 50-fold) (Figure 2.3C). The ratio of 
released PFU (representing infectious virions) to released vRNA (representing total number of 
particles) was calculated as the infectivity per particle. Infectivity per particle for virus particles 
released from MDM was 5-6-fold reduced versus that released from dTHP1 cells (Figure 2.3C). 
Overall, our data suggest that the total number of virus particles released as well as the 
infectivity of released virus particles is reduced in MDM relative to dTHP1 cells. 
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Figure 2.2: Infectious virus release is reduced in MDM cultures relative to dTHP1 cells despite 
similar number of infected cells in both cultures.  dTHP1 cells and MDM were infected with given 
IAV strains at MOI 0.01. At the indicated time points post infection, culture supernatants and cells were 
collected and assessed for virus titer (top panels) and % vRNP+ cells (lower panels), respectively. Data 
from at least three independent experiments are shown as mean +/- SD.  *, P<0.05; **, P<0.01. 
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Figure 2.3: Both efficiency of virus release and infectivity of released particles are reduced in MDM 
than in dTHP1 cells. dTHP1 cells and MDM were infected with WSN at MOI 0.1. (A) vRNA copy 
numbers were measured in lysates of virus pelleted from cell culture supernatants and cell lysates at 20 
hpi. vRNA release efficiency was calculated as the ratio of number of vRNA copies in virus lysates 
versus total number of vRNA copies (cell + virus) for each vRNA segment. Note that differences between 
dTHP1 cells and MDM were not significant for virus-associated and cell-associated vRNA levels when 
compared as pooled data in most cases (except for cell-associated HA vRNA). However, vRNA release 
efficiency calculated for individual experiments showed a significant reduction in MDM cultures relative 
to dTHP1 cell cultures. (B) vRNA release efficiency was measured for infected dTHP1 cells and MDM at 
12 hpi. To prevent the second cycle of infection, 10 µg/ml C179 was added to the cultures at 2 hpi. (C) 
PB2 vRNA copy number and virus titer were measured in dTHP1 and MDM culture supernatants at 16 
hpi. Infectivity per particle was calculated as the ratio of virus titer to PB2 vRNA copy number in culture 
supernatants. Data are from experiments done with MDM from at least three independent donors and 
shown as mean +/- S.D. *, P<0.05; **, P<0.01; ***, P<0.001, ****, P<0.0001. 
 
Formation of budding structures is inefficient in MDM relative to dTHP1 cells despite 
similar levels of viral glycoprotein expression at the plasma membrane 
We observed using flow cytometry that total expression levels of vRNP, HA, and M1 are 
comparable between dTHP1 cells and MDM in both the size of positive cell populations and the 
expression levels per cell (Figure 2.4), indicating that protein translation and earlier steps are 
unlikely to be impaired in MDM. Henceforth, we focused on steps post viral protein translation: 
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virus assembly, budding and release. Virus assembly is initiated by targeting of the glycoproteins 
HA and NA to the plasma membrane [17,18,21]. The third transmembrane protein M2 is also 
recruited to the assembly sites at the plasma membrane and allows for completion of the virus 
budding process [16,18]. To determine whether trafficking of the three glycoproteins occurs 
similarly in dTHP1 cells and MDM, we next compared levels of HA, NA and M2 proteins on the 
surface of WSN-infected cells. We found that sizes of cell populations positive for surface 
expression of the three proteins are comparable between MDM and dTHP1 cells (Figures 2.5A 
and 2.5B). The mean fluorescence intensity (MFI) for the three viral proteins in positive cell 
populations was also similar between MDM and dTHP1 cells (Figure 2.5C), indicating that 
trafficking of viral glycoproteins to the plasma membrane is comparable between MDM and 
dTHP1 cells.  
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Figure 2.4: MDM express viral proteins as efficiently as dTHP1 cells. dTHP1 cells and MDM were 
infected with WSN at MOI 0.01 for 24 hours. Infected cells were fixed, permeabilized and analyzed for 
cellular levels of vRNP, HA and M1 by flow cytometry. (A) Representative flow plots for mock- and 
WSN-infected cells are shown. Gates for positive cell populations were set in comparison to mock-
infected cells. Due to differences in the side scatter (SSC) profile between dTHP1 cells and MDM, the Y-
axis (SSC) range is different between the two cell types. (B) Percentages of cells positive for vRNP, HA, 
and M1 are compared between dTHP1 and MDM. (C) MFIs (normalized to dTHP1 cells) for all three 
viral components are shown for positive cell populations (gated in panel A). Data are from at least three 
independent experiments and are shown as mean +/- SD. ns, non-significant.
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Supplementary Figure 2: MDM express viral proteins as efficiently as dTHP1 cells. dTHP1 cells and MDM were infected with 
WSN at MOI 0.01 for 24 hours. Infected cells were fixed, permeabilized and analyzed for cellular levels of vRNP, HA and M1 by 
flow cytom try. (A) Representative flow plots for mock- and WSN-infected cells are shown. Gate  for positive cell popu ations 
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are compared between dTHP1 and MDM. (C) MFIs (normalized to dTHP1 cells) for all three viral components are shown for 
positive cell populations (gated in panel A). Data are from at least three independent experiments and are shown as mean 
+/- SD. ns, non-significant.
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Figure 2.5: MDM are efficient at trafficking of viral glycoproteins to the cell surface. dTHP1 cells 
and MDM were infected with WSN at MOI 0.1. (A) Infected cells were analyzed for cell surface 
expression of HA, NA, and M2 by flow cytometry at 16 hpi. Representative flow plots for mock-infected 
(top row) and virus-infected (bottom row) cells are shown. Percentages of cells positive for viral proteins 
(boxed) are shown. Due to differences in the side scatter (SSC) profile between dTHP1 cells and MDM, 
the Y-axis (SSC) range is different between the two cell types. (B) Percentages of cells positive for 
surface expression of NA, HA, and M2 are compared between dTHP1 and MDM. (C) Relative MFIs for 
surface signal of indicated proteins for positive cell populations (gated in panel A) are shown. Data are 
shown as mean +/- SD and are from at least three independent experiments. ns, non-significant. 
Figure 3: MDM are efficient at trafficking of viral glycoproteins to the cell surface. dTHP1 cells and MDM were 
infect  with WSN at MOI 0.1. (A) Infected cells were analyzed for cell surfac  expression of HA, NA, and M2 by 
flow cytometry at 16 hpi. Representative flow plots for mock-infected (top row) and virus-infected (bottom row) 
cells are shown. Percentages of cells positive for viral proteins (boxed) are shown. Due to differences in the side 
scatter (SSC) profile between dTHP1 cell  nd MDM, the Y-axis (SSC) range is differ nt between the two cell 
types. (B) Percentages of cells positive for surface expression of NA, HA, and M2 are compared between dTHP1 
and MDM. (C) Relative MFIs for surface signal of indicated proteins for positive cell populations (gated in panel A) 
are shown. Data are shown as mean +/- SD and are from at least three independent experiments. 
ns, non-significant.
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 We next asked whether dTHP1 cells and MDM expressing HA on the cell surface 
support virus particle formation. To address this question in a single cell basis, we performed 
correlative fluorescence and scanning electron microscopy (CFSEM) in which we first identify 
cells with surface HA expression using fluorescence microscopy and then examine formation of 
virus particle-like buds on the surface of the same cells using scanning electron microscopy 
(SEM). Fluorescence microscopy showed that HA is uniformly distributed on the surface of both 
dTHP1 cells and MDM with some local accumulation. These HA-enriched clusters or puncta, 
which likely represent sites of virus assembly, were clearly distinguished on the surface of 
infected cells after the median filter was applied to the confocal images to remove signal for 
uniformly distributed non-punctate HA. These HA-enriched sites often corresponded to budding 
structures with a diameter of approximately 100 nm on the surface of WSN-infected dTHP1 cells 
(Figure 2.6A). Very few budding structures with the similar size were observed on the surface of 
mock-infected cells. MDM also form ~100-nm virus particle-like buds on the surface in HA-
positive cells, albeit the number of buds observed in MDM were markedly lower than in dTHP1 
cells (Figure 2.6A). To assess the formation of budding structures quantitatively, we counted the 
number of HA-positive puncta and the number of virus particle-like buds within the same sized 
area (100 µm2 in size) of each cell. Even though MDM showed higher numbers of HA-positive 
puncta on the cell surface than dTHP1 cells, the numbers of virus buds were drastically reduced 
in MDM relative to dTHP1 cells (Figure 2.6B). Overall, these results indicate that virus particle 
assembly/budding are inefficient in MDM despite efficient trafficking of HA, NA and M2 to the 
plasma membrane.  
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Figure 2.6: MDM are defective in virus bud formation despite expression of HA on the cell surface. 
dTHP1 cells and MDM grown on gridded coverslips were infected with WSN at MOI 0.1 for 20 hours. 
Cells were fixed and immunostained with anti-HA. After identification of HA-positive cells by confocal 
microscopy, cells were prepared for SEM. The same cells were identified based on grid positions and 
analyzed by SEM. (A) Representative SEM images for mock-infected and WSN-infected HA-positive 
cells are shown in the top and bottom rows, respectively. For WSN-infected cells, fluorescence images 
corresponding to the SEM images of WSN-infected cells are shown. Boxed areas are magnified and 
shown below the original images.  Alphabetic labels are used to distinguish between individual boxed 
areas. (B) The number of HA-positive puncta identified in fluorescence images (left panel) and ~100-nm 
buds identified in SEM images (right panel) were counted within the same sized area (100 µm2 in size) in 
each cell. Data are shown for 8-15 cells from two independent experiments. Error bars represent standard 
error of mean. ***, P<0.0001; ns, non-significant. 
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Association between HA and M2 is impaired in MDM but not in dTHP1 cells 
Based on results shown above, we hypothesize that local co-enrichment of HA, NA and M2, 
which leads to formation of virus assembly sites, is not efficient in MDM relative to dTHP1 
cells. To compare formation of the putative assembly sites between dTHP1 cells and MDM, we 
used in situ proximity ligation assay (PLA). PLA allows for detection of two proteins localized 
within 40-nm distance of each other and has been used to visualize IAV assembly sites on the 
plasma membrane [42]. In addition to measuring PLA signal between the given pair of proteins, 
we also co-stained cells for cell surface NA to identify infected cells. As a negative control, we 
performed PLA between HA and transferrin receptor (TfR). TfR does not associate with lipid 
rafts [213], the plasma membrane microdomains associated with IAV assembly sites [18,22]. 
Infected dTHP1 cells showed high PLA signal for HA-M2 association. In contrast, infected 
MDM showed very few PLA spots between HA and M2 (Figures 2.7A and 2.7C). As expected, 
no PLA signal was observed between HA and M2 in mock-infected cells or between HA and 
TfR in infected cells (Figure 2.7A). The majority (80-90%) of surface NA-positive MDM and 
dTHP1 cells express HA and M2 on their surface at comparable levels (Figure 2.8). Therefore, 
the significant reduction in HA-M2 PLA signal in MDM relative to dTHP1 cells is not due to the 
lack of expression of HA and/or M2 in NA-positive cells.  
 To determine whether the defect in association between transmembrane proteins in MDM 
is specific to HA and M2 or whether association between other pairs of viral transmembrane 
proteins is defective as well, we next measured PLA signal between HA and NA. In this case, to 
identify infected cells, we co-stained cells for cell surface HA using an antibody different from 
the one used for PLA. PLA signal between HA and NA was similar for dTHP1 cells and MDM, 
suggesting that HA and NA associate with each other as efficiently on the surface of MDM as on 
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dTHP1 cells (Figures 2.7B and 2.7C). Overall, our data indicate that association between HA and 
M2 is a virus assembly step specifically impaired in MDM.   
 
 
 
Figure 2.7: Association between HA and M2 is defective in MDM relative to dTHP1 cells. dTHP1 
cells and MDM were infected with WSN at MOI 0.1 for 16 hours. (A) Cells were examined by PLA 
using goat anti-HA and mouse anti-M2 or goat anti-HA and mouse anti-TfR antibodies. To identify 
infected cells, surface NA was also detected by rabbit anti-NA. Nuclei were stained with DAPI (blue). 
Representative maximum intensity projection images, which were reconstructed from z-stacks 
corresponding to the focal planes ranging from the middle plane of the nucleus to the bottom of the cells, 
are shown. (B) Cells were examined by PLA using mouse anti-HA and rabbit anti-NA antibodies. Goat 
anti-HA was used for detection of infected cells. Representative maximum intensity projection images are 
shown as in panel A. Note regions of intense NA (in A) and HA (in B) signal on the surface of MDM due 
to the presence of membrane ruffles. (C) Number of PLA spots were counted for each cell. Data are 
shown for three independent experiments, and 8-10 cells were analyzed per experiment. These 
experiments were performed in parallel with the experiments shown in Figure 3 using MDM from the 
same donors. Error bars represent standard error of mean. ****, p <0.0001; ns, non-significant. 
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Figure 2.8: Majority of NA-expressing dTHP1 cells and MDM co-express both HA and M2. dTHP1 
cells and MDM were infected with WSN at MOI 0.1 for 16 hours. Cells were fixed and stained for 
surface HA, M2, and NA. Representative plots are shown in the left panel. % cells expressing HA and M2 
within the NA-positive cell population were determined and shown in the right panel. Data are from at 
least three independent experiments and shown as mean +/- SD. ns, non-significant. 
 
 
 
Inhibition of actin polymerization increases HA-M2 PLA and bud formation in MDM  
HA associates with lipid rafts on the plasma membrane, while M2 mainly localizes in non-lipid 
raft areas [18,22]. It is suggested that M2 is recruited to cholesterol-rich lipid rafts during IAV 
particle assembly [25,86]; however, host cell functions and factors that regulate this step are not 
known. It is possible that in MDM, HA-containing plasma membrane microdomains stay 
segregated from those containing M2, leading to defective association between the two 
glycoproteins. The cortical actin cytoskeleton, a network of filaments that underlies and interacts 
with the plasma membrane, is suggested to play a role in formation and maintenance of plasma 
membrane microdomains [143-145]. Therefore, we next asked whether the actin network regulates 
the association between HA and M2 in dTHP1 cells and MDM. Infected cells were treated with 
cytochalasin D (Cyto D), an inhibitor of actin polymerization, at 14 hpi for 2 hours, fixed, and 
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examined for HA-M2 association using PLA. Phalloidin staining confirmed that Cyto D disrupts 
the cellular actin network in both dTHP1 cells and MDM under these treatment conditions 
(Figure 2.10A). Infected dTHP1 cells showed high PLA signal for HA-M2 association under 
both vehicle-and Cyto D-treated conditions. As observed in Figure 2.7A, vehicle-treated MDM 
showed very few PLA spots between HA and M2. In contrast, Cyto D-treated MDM showed 
PLA signal between HA and M2 at levels similar to that observed for dTHP1 cells (Figures 2.9A 
and 2.9B). No PLA signal was observed between HA and TfR in untreated or Cyto D-treated 
dTHP1 cells and MDM. The increase in HA-M2 PLA signal upon Cyto D treatment of MDM 
was not due to an increase in surface expression of HA and M2 in drug-treated cells, as shown 
by the flow cytometry analysis (Figures 2.10B and 2.10C).  These results suggest that actin 
polymerization suppresses HA-M2 association in MDM. 
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Figure 2.9: Cytochalasin D treatment restores HA-M2 PLA in MDM to levels comparable to that in 
dTHP1 cells. dTHP1 cells and MDM were infected with WSN at MOI 0.1. At 14 hpi, cells were treated 
with vehicle control (DMSO) or 20 µM cytochalasin D (Cyto D) for 2 hours before fixation. (A) Cells 
were analyzed as in Figure 2.7A. Representative maximum intensity projection images are shown. (B) 
Number of PLA spots were counted for each cell. These experiments were performed in parallel with the 
experiments shown in Figures 2.8A and 2.8B using MDM from the same donors. Data are from at least 
three independent experiments, and 8-10 cells were analyzed per experiment. Error bars represent 
standard error of mean.  ****, p <0.0001; ns, non-significant.  
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Figure 2.10: Effects of cytochalasin D treatment on the actin cytoskeleton, cell surface expression of 
viral transmembrane proteins, and released virus titers in dTHP1 cells and MDM. dTHP1 cells and 
MDM were infected with WSN at MOI 0.1 for 14 hours. Cells were treated with vehicle control (DMSO) 
or 20 µM Cyto D for 2 hours (A-C) or 4 hours (D). (A) Cells were fixed at 16 hpi, and the actin 
cytoskeleton was visualized using fluorescently tagged-phalloidin. Images are representative of three 
independent experiments with 10 cells visualized per experiment. Image with enhanced brightness is also 
shown for Cyto D-treated MDM. (B and C) Cells were fixed at 16 hpi. % cells expressing HA, NA, and 
M2 on the cell surface (B) and MFIs for the indicated proteins in positive cell populations (C) are shown. 
(D) Infectious virus titers released in culture supernatants were measured at 18 hpi. Data are from three 
independent experiments and shown as mean +/- SD. *, p<0.05; **,p<0.01; ***p<0.005. 
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 We next asked whether treatment with Cyto D restores virus budding in MDM. To this 
end, we performed CFSEM of dTHP1 cells and MDM treated either with vehicle or Cyto D at 14 
hpi for 4 hours and examined virus bud formation in cells expressing HA on the cell surface. We 
counted the number of virus particle-like buds (~100 nm in diameter) within the same sized area 
(100 µm2 in size) of each cell. Consistent with the results shown in Figure 2.6, vehicle-treated, 
HA-positive MDM showed significantly lower number of buds on the cell surface than vehicle-
treated, HA-positive dTHP1 cells. Notably, Cyto D treatment significantly increased the number 
of buds on the surface of MDM to levels comparable to those in vehicle-treated dTHP1 cells 
(Figures 2.11A and 2.11B). Cyto D-treated dTHP1 cells showed no significant increase in bud 
formation relative to vehicle-treated dTHP1 cells. Very few such budding structures 
corresponding to the size of IAV particles were observed on the surface of untreated or Cyto D-
treated, mock-infected dTHP1 cells and MDM (Figure 2.11B). These data suggest that disruption 
of the actin cytoskeleton promotes IAV particle assembly in MDM. To determine whether the 
increase in efficiency of bud formation leads to an increase in virus release, we measured the 
PB2 vRNA release efficiency as shown in Figure 3A. Again, vRNA release efficiency was 4-5 
fold reduced in vehicle-treated MDM cultures relative to vehicle-treated dTHP1 cell cultures. 
Contrary to expectation, Cyto D treatment did not enhance vRNA release efficiency (Figure 
2.11C). We also did not observe any increase in infectious virus titers (Figure 2.10D) in 
supernatants of MDM cultures upon Cyto D treatment. These results indicate that disruption of 
the actin cytoskeleton promotes virus budding but not virus release. It is conceivable that there is 
an additional MDM-specific block in the late assembly/release stages of IAV life cycle, which 
cannot be reversed by Cyto D. Overall, these data show that virus particle assembly, more 
specifically HA-M2 association, is negatively regulated by the actin cytoskeleton in MDM. 
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Figure 2.11: Cytochalasin D treatment increases bud formation in MDM to levels comparable to 
that in dTHP1 cells. dTHP1 cells and MDM were infected with WSN at MOI 0.1. At 14 hpi, cells were 
treated with vehicle control (DMSO) or 20 µM Cyto D for 4 hours before fixation and immunostaining 
with anti-HA. After identification of HA-positive cells by confocal fluorescence microscopy, cells were 
processed for SEM. The same cells were identified based on grid positions and analyzed by SEM. (A) 
Representative SEM images for WSN-infected HA-positive cells are shown. Fluorescence images 
corresponding to the SEM images are also included. Boxed areas for SEM images are magnified and 
shown on the right of original images. Alphabetic labels are used to distinguish between the individual 
boxed areas.  (B) The number of ~100-nm buds identified in SEM images were counted within the same 
sized area (100 µm2 in size) in each cell. Data are shown for 10-20 cells from three independent 
experiments. (C) vRNA release efficiency was measured in infected MDM and dTHP1 cell cultures 
treated with DMSO or Cyto D for 4 hours. For B, error bars represent standard error of mean. For C, error 
bars represent SD. **, P<0.01; ns, non-significant. 
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Promotion of actin polymerization reduces HA-M2 PLA in dTHP1 cells   
Since inhibition of actin polymerization restores association of HA and M2 in MDM, we next 
asked whether promoting actin polymerization inhibits HA-M2 association in dTHP1 cells. To 
this end, infected dTHP1 cells were treated with jasplakinolide (Jasp), which nucleates and 
stabilizes actin polymerization, at 14 hpi for 2 hours and examined for HA-M2 association using 
PLA at 16 hpi as in Figure 2.9. Two hours of Jasp treatment reduced HA-M2 PLA in 50% of the 
examined dTHP1 cells, while the remaining infected cell population showed HA-M2 PLA signal 
comparable to that in untreated cells (data not shown). We reasoned that high HA-M2 PLA 
signal in 50% of Jasp-treated dTHP1 cells is due to pre-existing association between HA and M2 
at the time of Jasp addition. Therefore, we next examined the effect of Jasp on HA-M2 
association at an earlier time point in infection when pre-existing HA-M2 coclusters are unlikely 
to be abundant. We treated infected dTHP1 cells with Jasp or Cyto D at 10 hpi for 4 hours and 
examined for HA-M2 association using PLA at 14 hpi. Since Jasp and phalloidin compete for 
binding to the same site on F-actin [214], we were unable to use phalloidin staining to determine 
the effect of Jasp treatment on the actin cytoskeleton in dTHP1 cells. However, using an actin 
fractionation assay [211], we confirmed that treatment with Jasp for 4 hours increases the ratio of 
insoluble (i.e., polymerized) actin to soluble actin in dTHP1 cells, in comparison to vehicle-
treated cells (Figure 2.12A). Under these conditions, most Jasp-treated dTHP1 cells showed 
reduced HA-M2 PLA signal, in comparison to vehicle- or Cyto D-treated cells (Figures 2.13A 
and 2.13B). We note that surface HA and M2 expression in Jasp-treated cells was somewhat 
reduced relative to that in vehicle-treated cells (Figures 2.12B and 2.12C). However, this 
reduction in surface expression of HA and M2 does not explain the decrease in HA-M2 PLA 
signal upon Jasp treatment; when HA or M2 expression on the cell surface and number of HA-
M2 PLA spots were simultaneously assessed in the same cells, little correlation was observed 
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between them (Figure 2.14). Despite diminished HA-M2 association, vRNA release efficiency of 
Jasp-treated cells was not reduced in comparison to those of vehicle- and CytoD-treated cells 
(Figure 2.13C), suggesting that HA-M2 association, as measured by PLA, may not play as 
important a role in virus particle assembly/release in dTHP1 cells as it does in MDM (see 
discussion). Consistent with this possibility, at 14 hpi, no obvious difference was observed in 
virus bud formation on the cell surface of dTHP1 cells following 4 hours of treatment with Jasp 
versus vehicle or Cyto D (Figure 2.15).  
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Figure 2.12: Effect of jasplakinolide treatment on the actin cytoskeleton and cell surface expression 
of HA and M2 in dTHP1 cells. (A) dTHP1 cells were treated with vehicle control (0.5% Ethanol) or 1 
µM Jasp for 4 hours. Cells were extracted with actin stabilization buffer and centrifuged. Pellet (P) and 
supernatant (S) fractions were analyzed using immunoblotting. (B, C) dTHP1 cells were infected with 
WSN at MOI 0.1 for 10 hours. Cells were treated with vehicle control or 1 µM Jasp for 4 hours. (B) % 
cells expressing HA and M2 on the cell surface are shown. (C) MFIs for the indicated proteins in positive 
cell populations are shown. Data are from three independent experiments and shown as mean +/- SD. ns, 
non-significant; *, p<0.05. 
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Figure 2.13: Jasplakinolide treatment reduces HA-M2 PLA in dTHP1 cells. dTHP1 cells were 
infected with WSN at MOI 0.1. (A, B) At 10 hpi, cells were treated with vehicle control (0.5% Ethanol), 
1 µM jasplakinolide (Jasp), or 20 µM Cyto D for 4 hours before fixation. (A) Representative maximum 
intensity projection images are shown as in Figure 5A.  (B) Number of PLA spots were counted for each 
cell, and data are shown for 7-10 cells per experiment. (C) vRNA release efficiency was measured in 
infected dTHP1 cell cultures treated with vehicle, Jasp, and Cyto D for 4 hours. Data are from at least 
three independent experiments. For panel B, error bars represent standard error of mean. For panel C, 
error bars represent SD. *, p <0.05; ns, non-significant. 
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Figure 2.14: Weak correlation observed between the level of expression of HA or M2 and number 
of HA-M2 PLA spots in dTHP1 cells. dTHP1 cells were infected with WSN at MOI 0.1 for 10 hours. 
Cells were treated with vehicle control or 1 µM Jasp for 4 hours. (A) Cells were fixed and labeled with 
goat anti-HA and mouse anti-M2. Subsequently, cells were treated with PLA probes and then with 
fluorescently tagged secondary antibodies. Cells with similar levels of cell surface HA and M2 expression 
were compared for PLA signals. (B) Scatterplots between fluorescence intensity (FI) for cell surface HA 
or M2 signals and number of HA-M2 PLA plots are shown for vehicle- and Jasp-treated cells. The best-fit 
line was determined for each set of X-Y data points using linear regression analyses. Correlation between 
the MFI and PLA values was calculated as R2 values for each plot. Note that the correlation between MFI 
and PLA values are generally low and that vehicle-treated cultures generally show higher PLA signals 
than Jasp-treated cultures when compared at similar MFI values. Data are pooled from two independent 
experiments. 
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Figure 2.15: Jasplakinolide treatment has no effect on virus bud formation in dTHP1 cells. dTHP1 
cells were infected with WSN at MOI 0.1. At 10 hpi, cells were treated with vehicle control (0.5% 
Ethanol), 1 µM Jasp, or 20 µM Cyto D for 4 hours before fixation and immunostaining with anti-HA. 
After identification of HA-positive cells by confocal fluorescence microscopy, cells were processed for 
SEM. The same cells were identified based on grid positions and analyzed by SEM. (A) Fluorescence and 
SEM images for representative WSN-infected HA-positive cells are shown. Boxed areas for SEM images 
are magnified and shown on the right of original images. Alphabetic labels are used to distinguish 
between individual boxed areas. (B) The number of ~100-nm buds identified in SEM images were 
counted within the same sized area (100 µm2 in size) in each cell. Data are shown for 10-20 cells from 
two independent experiments. Error bars represent standard error of mean. 
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 It is important to emphasize, however, that the defect in HA-M2 association is rescued 
upon inhibition of actin polymerization in MDM, while it is induced upon stabilization of actin 
in dTHP1 cells. Therefore, regardless of the effect on release of assembled particles, our data 
overall highlight a macrophage-specific role for actin polymerization in suppressing association 
between HA and M2 at the plasma membrane. 
 
Discussion 
 
In a previous study, a post-translational defect in productive IAV infection was observed in 
human MDM [205]. A similar defect was also reported for murine macrophages in one study [201] 
but not the other [205]. The exact nature of these defects that lead to inefficient IAV production 
has not been determined. Here, we have shown that despite efficient trafficking of the viral 
glycoproteins to the cell surface (Figure 2.5), infectious virus particle formation at the plasma 
membrane is inefficient in human MDM (Figures 2.3 and 2.6). The current study further 
identified HA-M2 association as an IAV assembly step suppressed in MDM (Figure 2.7). This 
restriction is specific to primary macrophages, as the THP1 monocytic cell line differentiated to 
macrophage-like cells (dTHP1 cells) support HA-M2 association and efficient IAV production. 
Notably, defective HA-M2 association and bud formation in MDM can be ameliorated by the 
disruption of actin polymerization, revealing a role for the actin cytoskeleton in suppressing IAV 
particle assembly in MDM (Figures 2.9 and 2.11). However, virus particle release remains 
inefficient even when HA-M2 association and bud formation are restored by actin disruption 
(Figure 2.11C), implying the presence of an additional defect in a post-assembly step in MDM. 
Consistent with the restrictive role of actin polymerization, HA-M2 association in dTHP1 cells 
was blocked upon a treatment that promotes actin polymerization (Figure 2.13).  
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 Previous studies observed strain-specific differences for IAV replication in human 
macrophages. Some strains such as highly pathogenic H5N1 and pandemic 1918 strains can 
replicate in macrophages albeit at a lower efficiency than in epithelial cells [199,200,203,206]. 
Marvin et al. recently reported that the laboratory strain WSN is able to overcome blocks in IAV 
replication in human macrophages, while replication of the A/California/04/2009 strain is 
completely blocked [205]. In our study, we observed that all tested strains, including WSN and 
A/California/04/2009, released significantly lower titers in MDM than in dTHP1 cells (Figure 
2.1C). Thus, it is likely that the cell-type-specific difference observed in this study is distinct 
from the previously reported strain-specific difference. 
 In addition to identifying a defective step for IAV replication in primary human 
macrophages, our study also lends mechanistic insights into the assembly and budding process of 
IAV in host cells. IAV is thought to assemble in cholesterol-enriched microdomains, or 
membrane rafts, of the plasma membrane in host cells [14,15,215,216]. HA and NA accumulate at 
these assembly sites [17,18,21-23], also known as the budozones, while the third transmembrane 
protein M2 is suggested to localize at the edge of the budozone [16,25,26]. Coclustering between 
HA and M2 has been observed at steady state in epithelial cells [26,86,176]. However, the 
sequence of events leading to recruitment of M2 to the budozone is unknown. Whether there is a 
mechanism regulating these events, other than simple diffusion over the plasma membrane, also 
remains to be determined. Our PLA data suggest that different molecular mechanisms mediate 
association between HA and NA and association between HA and M2 at the plasma membrane. 
Consistent with this possibility, a recent study showed that NA but not M2 accelerates HA 
trafficking to the apical surface of epithelial cells, presumably through co-trafficking [23]. Thus, 
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recruitment of M2 to assembly sites enriched in HA (and perhaps NA) is a discrete and host-cell-
dependent step in the IAV assembly process.  
 The actin cytoskeleton has been implicated in assembly of IAV particles, in particular 
formation of filamentous particles [82,137,159]. However, the actin-dependent mechanism(s) 
regulating IAV assembly are not well understood. Previous studies have shown that disruption of 
actin dynamics by both inhibition of actin polymerization [82,137] (by latrunculin A or 
cytochalasin D) and promotion of actin polymerization [137] (by jasplakinolide) disrupts 
filamentous IAV assembly. In contrast, our study showed that drugs inhibiting actin 
polymerization and depolymerization have distinct and opposing effects on HA-M2 association: 
blocking actin polymerization in IAV non-permissive cells (MDM) restores HA-M2 association, 
whereas enhancement of polymerization in permissive cells (dTHP1 cells) reduces HA-M2 
association. Therefore, it is likely that distinct actin-dependent mechanisms regulate the 
association between HA and M2 at the plasma membrane and formation of filamentous particles. 
As for the mechanism regulating HA-M2 association, one can speculate that subcortical actin 
promotes the segregation of HA- and M2-enriched plasma membrane microdomains. Consistent 
with this possibility, previous studies support a role for actin polymerization in maintaining HA-
enriched microdomains compact and dense [180,217]. 
 Of note, even though particle assembly is enhanced in MDM upon disruption of the actin 
cytoskeleton, virus release still remains defective in this cell type (Figure 2.11). This suggests 
that additional defect(s), for example, incomplete scission between viral envelope and plasma 
membrane or tethering of nascent particles to the cell surface, occurs in MDM. In addition to the 
nature of this late defect, whether the defect manifests due to the absence of a host factor 
enabling virus release or whether it is caused by the presence of a restriction factor blocking 
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release of assembled virus particles warrants further investigation. It is also possible that 
cytochalasin D treatment blocks the release of assembled virus particles in an MDM-specific 
manner. These results, together with the pleiotropic effects of actin perturbation discussed above, 
also highlight the importance of specifically examining individual steps (e.g., HA-M2 
association) rather than just monitoring the end result, i.e., virus release efficiencies or released 
virus titers, when assessing the effect(s) of actin disruption on the virus assembly/release 
process.  
 The cytoplasmic domain of M2 comprises of an amphipathic helix, which plays a role in 
scission of the IAV particle after budding [16,26,59]. In epithelial (MDCK) or epithelial-like 
(293T) cell lines, viruses or VLP systems lacking M2 or expressing mutant M2 proteins are still 
able to initiate particle assembly and budding, presumably driven by HA and NA [21,31]. 
However, these buds adopt an abnormal morphology and/or fail to undergo scission or release 
[16,26,59], latter of which results in accumulation of particles at the cell surface. In contrast, 
MDM showed very few buds on their surface under conditions where HA-M2 association was 
impaired (Figures 2.6 and 2.11). These results suggest that in MDM, M2 plays an earlier role(s) 
in the assembly of virus particles, which is not apparent with 293T or MDCK cells that express 
M2-deficient virus or VLP systems. Such an earlier role may require other functions of M2. For 
example, in addition to scission of nascent particles, M2 functions in recruitment of M1 and 
vRNP to assembly sites [59,60,81,86-88,90], which is important for initiation of IAV particle 
assembly or elongation of filamentous particles [39,54,56,57,59,60,92,218,219].  A defect in 
incorporation of M1 and/or vRNP into budding virus particles due to the failure of M2 
recruitment may also explain the reduction in infectivity per particle observed for MDM-derived 
virus relative to dTHP1-derived virus (Figure 2.3B). We also do not rule out the possibility that a 
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failure in association of M1 and/or vRNP with the assembly sites may contribute to the observed 
defect in M2-HA association specific to MDM.  
 While jasplakinolide reduces HA-M2 association in dTHP1 cells, no reduction in virus 
bud formation is observed under this condition (Figure 2.15), which is consistent with previous 
studies performed with M2-lacking viruses in epithelial cell lines [16,26,59]. However, we do not 
observe an arrest in virus release from dTHP1 cells, which was observed in the previous studies 
using M2-deficient viruses. In this regard, it is important to note that, unlike cells infected with 
M2-lacking mutant viruses, dTHP1 cells treated with jasplakinolide still show a residual level of 
M2 recruitment based on HA-M2 association detected by PLA. It is possible that this residual 
level of HA-M2 association is sufficient to promote the scission of virus buds in dTHP1 cells. 
 Overall, in this study, we have compared IAV replication in MDM with that in dTHP1 
cells and found that MDM replicate vRNA, express viral proteins, and traffic HA, NA and M2 to 
the plasma membrane at levels similar to those in dTHP1 cells. However, MDM are defective in 
assembling virus particles, likely due to actin-dependent suppression of association between the 
viral transmembrane proteins HA and M2. Comparison of actin regulatory mechanisms operating 
in MDM and dTHP1 cells, which are of the same lineage, will likely facilitate identification of 
additional host cellular factors involved in the assembly stage of the IAV life cycle.  
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Chapter 3  
The Actin Cytoskeleton Suppresses Influenza A Virus Assembly In Primary 
Human Macrophages In An M2-Dependent Manner 
 
Abstract 
 
Influenza A virus (IAV) assembly at the plasma membrane is orchestrated by at least five viral 
components: hemagglutinin (HA), neuraminidase (NA), matrix (M1), the ion channel M2, and 
viral ribonucleoprotein (vRNP) complexes. While these five viral components are expressed in 
primary human monocyte-derived macrophages (MDM) upon IAV infection, this cell type is 
inefficient at supporting IAV assembly. Notably, the defect in IAV assembly in MDM correlates 
with a defect in HA-M2 association at the plasma membrane of this cell type. Moreover, the 
defects in HA-M2 association and IAV particle assembly, which are specific to MDM and not 
observed in a monocytic cell line differentiated into macrophage-like cells, are reversed upon 
disruption of the actin cytoskeleton. Hence, the actin network plays a negative role in IAV 
assembly in MDM. In this chapter, I determine the viral and host mechanisms that are involved 
in the F-actin-mediated suppression of IAV assembly in MDM. Using drugs that specifically 
block F-actin elongation or branching, I show that both linear and branched actin filaments 
contribute to the suppressive role of the actin cytoskeleton in HA-M2 association in MDM. In 
addition, I elucidate the viral components involved in the MDM-specific suppression of virus 
assembly by the actin cytoskeleton. To address whether HA-M2 association precedes and is 
essential for virus particle formation upon F-actin disruption in MDM, I generated an M2-
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deficient virus and analyzed formation of budding structures at the cell surface using correlative 
fluorescence scanning electron microscopy. While MDM infected with the M2-expressing wild-
type virus gain the ability to support particle assembly upon F-actin disruption, cells infected 
with the M2-deficient virus remain defective at particle formation even after F-actin disruption. 
These data indicate that M2 plays a role in virus particle formation in MDM, perhaps in addition 
to the well-known role in particle release, and suggest that the actin cytoskeleton in MDM 
suppresses IAV particle assembly by restricting HA-M2 association. 
 
Introduction 
 
Events at the plasma membrane during IAV assembly 
IAV buds from cholesterol-rich microdomains or lipid rafts, which are also known as budozones, 
of the plasma membrane. Assembly of new virus particles requires trafficking of at least four 
viral structural proteins, HA, NA, M1, and M2 as well as vRNPs to the plasma membrane [14,15]. 
In epithelial cells, IAV transmembrane proteins HA and NA intrinsically localize to cholesterol-
rich microdomains of the apical plasma membrane [17-19,22,23] and drive their coalescence into 
larger domains [17,18,23], which could lead to stabilization of lipid rafts. The third transmembrane 
protein M2 also intrinsically traffics to the apical plasma membrane [169]; however, it does not 
associate with lipid rafts when expressed by itself [22]. In infected cells, M2 is shown to associate 
closely with HA [176] while still localizing to the boundary of lipid rafts [18]. The M1 protein is 
predominantly cytosolic when expressed alone [21,28,65,75]. However, in infected cells, the 
cytoplasmic tails of HA [27,28], NA [27,28], and M2 [86,87] recruit M1 to cholesterol-rich 
membranes. The vRNP complex, which also promotes IAV assembly, is recruited to the 
budozones by several viral proteins such as HA [70], M1 [34,74,220], and M2 [59,60,90,91]. 
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Mechanisms driving association of M2 with the HA-enriched budozones 
As mentioned above, M2 intrinsically traffics to the apical plasma membrane [169]. The 
transmembrane domain and the cytoplasmic tail of M2 are important for its targeting to the 
plasma membrane [221,222]. As for whether M2 traffics along with and/or associates with HA 
and NA in the ER-Golgi transport pathway, earlier studies showed that the M2 ion channel raises 
the pH of the Golgi and prevents the premature exposure of the HA fusion peptide in the low pH 
environment of the Golgi, suggesting that HA and M2 traffic together through the ER-Golgi 
pathway [223,224]. However, a recent study showed that while HA and NA mutually accelerate 
their apical targeting, M2 inhibits apical targeting of HA, suggesting that HA and M2 might 
compete for the same transport mechanism [23]. Once at the plasma membrane, M2 localizes to 
microdomains distinct from HA-enriched microdomains [18,22] but is later recruited to the 
assembling virus particle [25,86,176]. As for the timing of this recruitment, some in silico data 
suggest that M2 is preferentially recruited to curved membranes versus flat membranes [225,226]. 
Hence, it has been proposed that M2 is recruited to the edge of the budozone after induction of 
membrane curvature by other viral structural proteins. My data in chapter 2 suggest that 
association between HA and M2 at the cell surface is a discrete step that occurs after trafficking 
of the two proteins to the plasma membrane. However, the timing (prior to or post initiation of 
particle assembly) of association of M2 with HA-enriched budozones has not been determined in 
cells. In addition, the viral and host components that drive this association at the plasma 
membrane are not known.  While an early study proposed that localization of M2 at the 
budozone edge depends on acylation and cholesterol binding sites in the cytoplasmic tail of the 
protein [227], later studies show that HA and M2 cocluster at the plasma membrane and virus 
particles are formed even when M2 lacks acylation and/or cholesterol-binding sites [228-231]. 
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Other viral proteins may also be involved in promoting HA-M2 association. For instance, M1 
may play a role in promoting HA-M2 association since mutations in M2 that reduce its 
interactions with M1 lead to reduced coclustering between HA and M2 [86,176]. With respect to 
the host proteins involved in recruitment of M2 to the budozone, my findings in chapter 2 show 
that the actin cytoskeleton suppresses this association in a cell-type-dependent manner. However, 
it is not clear whether F-actin suppresses HA-M2 association prior to initiation of particle 
assembly or whether it suppresses induction of membrane curvature, which in turn reduces the 
efficiency of M2 recruitment to the budozone. 
Role(s) of M2 in IAV particle assembly and budding 
Of the three transmembrane proteins involved in particle assembly, HA and/or NA expression at 
the plasma membrane has been shown to be sufficient for induction of curvature for spherical 
virus bud formation [21,31]. On the other hand, M2 is thought to be dispensable for curvature 
induction but rather plays important roles in pinching off of the spherical virus bud prior to virus 
release [16,26,46]. However, some lines of evidence suggest that M2 may play a role(s) during the 
early stages of spherical IAV particle assembly. First, mutations in M2 alter the morphology of 
assembling virus particles [57,59,60]. Second, M segment-encoded proteins (M1 and M2) stabilize 
curvature induced by HA and/or NA and allow for formation and release of virus-like particles 
[31]. Third, incorporation of M1 into assembling virus particles, which is important for providing 
structure to the virus particle, is at least partially dependent on M2 [86,87]. Despite these lines of 
evidence, there is little data in support of a direct role(s) of M2 during the early stages of 
spherical IAV particle formation.  
Potential mechanisms behind restriction of IAV assembly by F-actin   
As described in chapter 2, the actin cytoskeleton suppresses IAV assembly, which correlates 
with inefficient HA-M2 association, in MDM. The restrictive role of F-actin in MDM could 
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either be due to the distinct structure and/or function of the actin network or due to the 
differential function or expression of an actin-dependent host factor(s) in this cell type. Taking 
into account the previously described role of M2 and other viral structural proteins during IAV 
assembly, I propose three different possible mechanisms by which the actin cytoskeleton 
suppresses IAV assembly in macrophages: 
i. Microdomain segregation: In this model, the actin cytoskeleton restricts the movement of 
HA- and M2-enriched microdomains and keeps the microdomains (and hence, HA and 
M2) segregated from each other. This is consistent with previous findings that M2 is 
present in microdomains distinct from HA-enriched microdomains early on in the 
assembly process [18,22] but is later recruited to these assembly sites [25,86,176]. The 
cortical actin network in primary macrophages may keep these plasma membrane 
microdomains apart via interactions with either lipids [232,233] or cytoplasmic tails of 
transmembrane proteins [211,234,235].  
ii. Suppression of membrane curvature: According to this model, the actin cytoskeleton 
suppresses HA- and/or NA-induced membrane curvature by modulating the plasma 
membrane stiffness [236,237]. This possibility is consistent with several studies that have 
shown that M2 is not required for induction of membrane curvature during particle 
assembly [16,25,59,87] and that M2 may be recruited after induction of membrane 
curvature [225,226], which is likely mediated by HA, NA or M1. Therefore, F-actin may 
be modulating membrane curvature in a manner that is independent of recruitment of M2 
to assembly sites.  
iii. Blocking of cytoplasmic components: In this model, the actin network inhibits IAV 
assembly by restricting the trafficking, incorporation or function of additional 
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components essential for IAV assembly, that is, M1 and vRNPs. Both M1 [148] and NP 
[149] are reported to associate with F-actin, and this association might suppress their 
mobility and trafficking to assembly sites. In addition, the dense F-actin cortex could also 
serves as a physical barrier to diffusion of proteins or vesicles carrying these proteins 
[238,239]. 
 These three potential mechanisms of action for the actin cytoskeleton in IAV assembly in 
MDM are depicted in Figure 3.1. In some cases, disruption of F-actin in epithelial cells modestly 
increases spherical virus production [82,137]. Therefore, it is possible that the mechanisms 
described above may also operate in IAV-permissive cells depending on the condition. 
 
 
Figure 3.1: Proposed mechanisms by which F-actin restricts spherical IAV assembly in primary 
human macrophages. (i) Microdomain segregation: F-actin partitions HA- and M2-enriched plasma 
membrane microdomains. (ii) Suppression of membrane curvature: F-actin restricts HA-mediated 
curvature induction at the plasma membrane, which is required for M2 recruitment to the assembling 
particle. (iii) Blocking of cytoplasmic components: F-actin restricts trafficking and incorporation of other 
curvature-inducing structural components, that is, M1 and vRNP, to virus assembly sites. 
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 In this chapter, I use drugs that specifically inhibit elongation or branching of actin 
filaments to show that both linear and branched F-actin contributes to suppression of HA-M2 
association in MDM. In addition, using an M2-deficient virus, I show that actin disruption fails 
to restore IAV particle assembly in MDM in the absence of M2. In addition, M2 is also required 
for efficient particle assembly in dTHP1 cells, which are macrophage-like but are inherently 
permissive to IAV assembly. Hence, in addition to its role in scission of the virus bud late during 
IAV assembly, M2 plays a role(s) early during virus particle formation in macrophages. My data 
also suggest that HA-M2 association likely precedes IAV particle assembly in macrophages. 
Overall, the findings presented in this chapter suggest that both linear and branched actin 
filaments suppress IAV particle assembly in MDM by directly restricting HA-M2 association 
(model (i)) or by blocking trafficking of viral components that promote HA-M2 association 
(model (iii)).. 
 
Materials and methods 
 
Cells and reagents: Monocytes were isolated by plate adhesion from peripheral blood 
mononuclear cells, which were obtained from buffy coats derived from unidentified healthy 
donors (New York Blood Center, NY). Cells were cultured in RPMI 1640(Gibco) supplemented 
with 10% fetal bovine serum (FBS, Hyclone) for 7 days before they were used for experiments. 
THP1 (ATCC® TIB202™) cells were cultured in RPMI 1640 supplemented with 10% FBS, 1 
mM Sodium Pyruvate (Gibco) and 0.05 mM  2-mercaptoethanol. To generate differentiated 
THP1 cells (dTHP1), THP1 cells were cultured in the medium containing 0.1 µM phorbol 12-
myristate 13-acetate (PMA; Sigma) and 0.1 µM Vitamin D3 (Sigma) for 2-3 days. Madin-Darby 
canine kidney (MDCK) cells were provided by Dr. Arnold S. Monto (University of Michigan) 
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and were cultured in DMEM (Gibco) supplemented with 10% FBS and 25 mM HEPES. Human 
embryonic kidney-derived 293T cell line (ATCC) was cultured and maintained in DMEM 
(Lonza) supplemented with 10% FBS. 
 The following antibodies were used for immunofluorescence microscopy: mouse anti-HA 
monoclonal antibody (clone C179 [207]; Takara), mouse anti-M2 monoclonal antibody (clone 
14C2 [93]; Thermofisher), goat anti-HA antiserum (BEI NR-3148), rabbit anti-M1 (GTX125928; 
GeneTex) All secondary antibodies used for immunofluorescence and Alexa Fluor 488-labeled 
phalloidin were purchased from Thermofisher. All actin-disrupting drugs were purchased from 
Sigma and re-constituted in DMSO. 
Generation of M2-MDCK stable cell line: cDNA corresponding to the M2 protein was cloned 
into the pCABSD plasmid, which expresses a blasticidin S resistance gene. MDCK cells were 
transfected with the pCABSD-M2 plasmid using lipofectamine (Invitrogen). Cells stably 
expressing M2 were selected in growth medium containing 1 µg/ml blasticidin and were 
enriched for high M2 expression by staining with an anti-M2 antibody (clone 14C2) and an 
Alexa 488-conjugated secondary antibody followed by fluorescence-activated cell sorting 
(FACSAria II, BD Biosciences). 
Generation of ΔM2 WSN virus: Virus deficient in expression of M2 was generated as 
described previously [240]. Briefly, a WSN M segment with a disrupted splicing signal (WSN M 
SS) was generated by introducing mutations in the 3’ splice site of the WSN M segment using 
QuikChange II site-directed mutagenesis protocol (Agilent). Wild-type (WT) WSN virus was 
generated using reverse genetics as described in chapter 2. ΔM2 WSN virus was generated in 
293T cells using the pPolI plasmids encoding the 7 RNA segments of the WT WSN strain, pPolI 
WSN M SS, and the 5 pCAGGS plasmids that express the PA, PB1, PB2, NP, and M2 proteins. 
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Virus generated from 293T cells was propagated in M2-MDCK cells. Viral titers were 
determined by plaque assays performed using M2-MDCK cells. 
Correlative fluorescence and scanning electron microscopy (CFSEM): CFSEM experiments 
were performed as described in chapter 2.  
In situ Proximity Ligation Assay (PLA): PLA was performed using Duolink® PLA 
fluorescence kit as described in chapter 2. Cells fixed with 4% PFA (non-permeabilized) were 
incubated with goat anti-HA and mouse anti-M2 primary antibodies. PLA signals and 
identification of infected cells were performed using PLA probes specific to goat and mouse 
IgG. AlexaFluor-488-labeled secondary antibody was used to recognize anti-HA and hence, to 
identify HA-positive cells. Cells were observed using a Leica Inverted SP5X Confocal 
Microscope System with a 63X objective. Z-stacks extending from the focal plane corresponding 
to the middle plane of the nucleus (identified by DAPI staining) to the bottom of cells were 
acquired for each cell, and the maximum intensity projection for each cell was constructed using 
ImageJ. The PLA signal in projection images was thresholded to eliminate weak and hazy 
background signal in the nucleus, and the number of PLA-positive spots was counted using the 
Analyze particle function in ImageJ.  
 
Results 
 
Both linear and branched actin filaments contribute to the suppressive role of the actin 
cytoskeleton in HA-M2 association in MDM 
Growth and organization of the actin cytoskeleton is driven by actin-nucleating factors, which 
bind actin and stimulate the formation and growth of an actin filament [140,141]. The most well 
studied actin-nucleating factors are: Arp2/3 and formins. While the Arp2/3 complex nucleates 
branched actin structures, formins nucleate unbranched actin filaments and serve as elongation 
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factors for the growing actin filament. To determine whether branched and/or linear actin 
filaments are involved in the suppressive role of the actin cytoskeleton during IAV assembly in 
MDM, we used inhibitors that specifically disrupt Arp2/3 and formins. CK666 [241] and 
SMIFH2 [242] were used to inhibit the Arp2/3 complex and formins, respectively. MDM were 
infected with the laboratory strain A/WSN/1933 (H1N1) (WSN) at MOI 0.1. Infected cells were 
treated with actin altering drugs, at 14 hpi for 2 hours, fixed, and examined for HA-M2 
association using PLA. In addition to CK666 and SMIFH2, we treated cells with actin disrupting 
drugs Cytochalasin D (Cyto D ) and Latrunculin B (Lat B).  The effects of these drugs on the 
actin network in MDM were determined by staining drug-treated cells with Phalloidin-Alexa-
Fluor-488. As expected, both Cyto D and Lat B (which inhibits F-actin polymerization) 
disrupted the actin network in MDM. Consistent with previous studies [242,243], the effects of 
CK666 and SMIFH2 were not detected by Phalloidin staining, suggesting that these drugs alter 
specific aspects of the actin network without its complete disruption in MDM (Figure 3.2A). 
Upon examining HA-positive cells for HA-M2 PLA, we observed very few HA-M2 PLA spots 
on the surface of vehicle (DMSO)-treated MDM. As observed in chapter 2, Cyto D treatment 
significantly increased the number of HA-M2 PLA spots on the surface of MDM. As expected, 
disruption of F-actin by Lat B also significantly increased HA-M2 PLA signal on the surface of 
MDM. Notably, treatment with CK666 or SMIFH2 significantly increased HA-M2 PLA signal 
on the surface of MDM even though the actin cytoskeleton was not completely disrupted under 
these conditions (Figures 3.2B and 3.2C). Overall, my data suggest that both linear and branched 
actin filaments contribute to the suppressive role of the actin cytoskeleton in HA-M2 association 
in MDM.  
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Figure 3.2: The effects of different actin-altering drugs on F-actin and HA-M2 association in MDM. 
(A) MDM were treated with Vehicle (DMSO), 20 µM cytochalasin D (Cyto D), 5 µM Latrunculin B (Lat 
B), 100 µM CK666, 25 µM SMIFH2 for 2 hours. Drug-treated cells were fixed, permeabilized and the 
actin cytoskeleton was visualized using fluorescently tagged-phalloidin. Images are representative of 10 
cells. (B and C) MDM were infected with WSN at MOI 0.1 for 14 hours. Infected cells were treated with 
the indicated drugs for 2 hours and fixed. Cells were analyzed as in chapter 2. (B) Representative 
maximum intensity projection images are shown. (C) Number of PLA spots was counted for each cell. 
Data are shown for 8-10 cells per condition. Error bars represent standard error of mean. *, p<0.05; **, 
p<0.01; ***, p<0.005. 
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Expression levels of HA and M1 are comparable between ΔM2 virus- and WT virus-
infected MDM 
Since the actin cytoskeleton suppresses HA-M2 association and IAV assembly in MDM, we 
asked whether HA-M2 association precedes and is essential for particle assembly (mechanism (i) 
in Figure 3.1) or particle assembly is initiated prior to association of M2 with HA (mechanisms 
(ii) and (iii) in Figure 3.1). To distinguish between the M2-dependent (i) and M2-independent 
mechanisms ((ii) and (iii)) for the role of F-actin in IAV assembly in MDM, we generated a 
mutant WSN virus that fails to express M2 (WSN ΔM2) in infected cells. This virus incorporates 
the WSN M segment with a disrupted 3’ splice site (WSN M SS), which allows for generation of 
the M1-encoding mRNA but not the M2-encoding mRNA from the M segment [240] (Figure 
3.3A). Since the WSN ΔM2 virus is produced in MDCK cells stably expressing the WSN M2 
protein, M2 is incorporated into virus particles and is able to complete its roles during the entry 
of IAV into cells; however, the virus is defective in expressing nascent M2 required during IAV 
assembly. To determine whether other viral structural proteins are expressed at comparable 
levels between WT virus- and ΔM2 virus-infected cells, I used flow cytometry to measure the 
total expression of M1 and cell surface expression of HA in cells infected with WT or ΔM2 
virus. For comparison with MDM, I used the monocytic cell line THP1, which has been 
differentiated to adopt macrophage-like morphology (dTHP1) as described in chapter 2. dTHP1 
cells, unlike MDM, support all steps of the IAV assembly process and have been used for 
comparison with MDM in chapter 2. dTHP1 cells and MDM were infected with WT or ΔM2 
virus at MOI 0.1 for 18 hours, after which cell surface expression of HA was measured in non-
permeabilized cells and total expression of M1 was measured in permeabilized cells. In addition, 
we measured the expression of M2 on the cell surface. As expected, dTHP1 cells and MDM 
infected with the ΔM2 virus failed to express M2 on the cell surface. Both HA and M1 were 
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expressed in ΔM2 virus-infected MDM at levels comparable to that in WT virus-infected cells. 
Cell surface expression of HA was about 2-fold reduced in dTHP1 cells infected with ΔM2 
virus, relative to WT virus. Total M1 expression was comparable between dTHP1 cells infected 
with WT or ΔM2 virus. Overall, our data show that in MDM, cell surface expression of HA and 
total expression of M1 are comparable between cells infected with ΔM2 and WT viruses. 
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Figure 3.3: Generation and characterization of ΔM2 WSN virus. (A) The strategy used for generation 
of the WSN M segment that fails to encode for the M2 protein (WSN M SS) is depicted. (B-D) dTHP1 
cells (B) and MDM (C) were infected with WT or ΔM2 virus at MOI 0.1 for 18 hours. (B and C) Infected 
cells were analyzed for cell surface expression of HA and M2 and intracellular expression of M1 by flow 
cytometry. Representative flow plots for mock-infected and virus-infected cells are shown. Percentages of 
cells positive for viral proteins (boxed) are shown. (D) Relative MFIs for signal of indicated proteins for 
positive cell populations (gated in panels B and C) are shown. Data are shown as mean +/- SD and are 
from at least three independent experiments. *, p<0.05; ns, non-significant. 
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Latrunculin B treatment restores IAV particle formation in MDM in an M2-dependent 
manner 
I next asked whether restoration of IAV particle assembly upon F-actin disruption in MDM 
depends on expression of M2. To this end, I performed CFSEM with MDM infected with WT or 
ΔM2 virus and treated either with vehicle or Lat B at 14 hpi for 4 hours and examined virus bud 
formation in cells expressing HA on the cell surface. I counted the number of virus particle-like 
buds (~100 nm in diameter) within the same sized area (100 µm2 in size) of each cell. Consistent 
with the results shown in chapter 2, WT virus-infected, vehicle-treated MDM showed very few 
buds on the cell surface. Similar to Cyto D treatment in chapter 2, Lat B treatment significantly 
increased the number of buds on the surface of WT virus-infected MDM (Figures 3.4A and 
3.4B). As expected, very few bud-like structures were observed on the surface of vehicle-treated, 
ΔM2 virus-infected cells. Notably, no increase in number of buds was observed on the surface of 
ΔM2 virus-infected MDM upon treatment with Lat B, relative to treatment with vehicle (Figures 
3.4A and 3.4B). These data show that disruption of the actin cytoskeleton promotes IAV particle 
assembly in MDM in an M2-dependent manner. Overall, these data suggest that HA-M2 
association likely precedes and is essential for virus particle assembly in MDM. 
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Figure 3.4: F-actin disruption restores virus bud formation in MDM in an M2-dependent manner. 
MDM were infected with WSN at MOI 0.1 for 14 hours. Infected cells were treated with vehicle (DMSO) 
or 5 µM Lat B for 4 hours, before fixation and immunostaining with anti-HA. After identification of HA-
positive cells by confocal fluorescence microscopy, cells were processed for SEM. The same cells were 
identified based on grid positions and analyzed by SEM. (A) Representative SEM images for WSN-
infected HA-positive cells are shown. Fluorescence images corresponding to the SEM images are also 
included. Boxed areas for SEM images are magnified and shown on the right of original images. 
Alphabetic labels are used to distinguish between the individual boxed areas. (B) The number of ~100-nm 
buds identified in SEM images were counted within the same sized area (100 µm2 in size) in each cell. 
Data are shown for 10-20 cells from two independent experiments. Error bars represent standard error of 
mean. ***, P<0.005; ns, non-significant. 
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dTHP1 cells support virus particle assembly in an M2-dependent manner 
Since previous studies have shown that spherical IAV particle assembly is initiated in IAV-
permissive epithelial cell lines even in the absence of M2 [16,25], we next asked whether dTHP1 
cells, which are also permissive to IAV assembly, require M2 for particle formation on the cell 
surface. dTHP1 cells were infected with WT or ΔM2 virus and virus bud formation was analyzed 
on the surface of HA-positive cells by SEM. As expected, cells infected with the WT virus 
showed high number of bud-like structures on the cell surface. Notably, the number of buds 
observed on the surface of ΔM2 virus-infected dTHP1 cells was significantly reduced in 
comparison to that on WT virus-infected cells (Figures 3.5A and B). Since HA expression on the 
surface of ΔM2 virus-infected dTHP1 cells is reduced in comparison to WT virus-infected 
dTHP1 cells (Figure 3.3C), the reduction in bud formation in ΔM2 virus-infected cells may be 
due to the reduction in HA expression on these cells. However, in these experiments, cells 
expressing comparable levels of HA on the surface were analyzed for bud formation using SEM. 
This is more clearly observed upon measuring the fluorescence intensity of surface HA staining 
in dTHP1 cells that were analyzed by SEM. The fluorescence intensity of surface HA staining 
was comparable between the WT virus- and ΔM2 virus-infected dTHP1 cells (Figure 3.5C). 
Hence, the difference in surface HA expression does not explain the difference in bud formation 
between WT virus- versus ΔM2 virus-infected dTHP1 cells. These data indicate that both dTHP1 
cells and MDM rely on M2 for efficient particle formation. Overall, these data suggest that in 
addition to its role in bud scission late during IAV assembly, M2 plays important roles early 
during IAV particle formation in MDM and dTHP1 cells.  
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Figure 3.5: dTHP1 cells support IAV particle assembly in an M2-dependent manner. dTHP1 cells 
were infected with WT or ΔM2 virus for 18 hours. Infected cells were fixed and immunostained with 
anti-HA antibody. After identification of HA-positive cells by confocal fluorescence microscopy, cells 
were processed for SEM. The same cells were identified based on grid positions and analyzed by SEM. 
(A) Representative SEM images for WSN-infected HA-positive cells are shown. Fluorescence images 
corresponding to the SEM images are also included. Boxed areas for SEM images are magnified and 
shown on the right of original images. Alphabetic labels are used to distinguish between the individual 
boxed areas. (B) The number of ~100-nm buds identified in SEM images were counted within the same 
sized area (100 µm2 in size) in each cell. (C) Fluorescence intensity (FI) of surface HA expression was 
determined for each cell analyzed for virus bud formation using SEM. Data are shown for 10-20 cells 
from two independent experiments. Error bars represent standard error of mean. **, P<0.01; ns, non-
significant. 
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Discussion 
 
In chapter 2, I showed that both HA-M2 association and IAV assembly are suppressed by the 
actin cytoskeleton in MDM. In this chapter, I delve into the mechanisms by which the actin 
cytoskeleton suppresses IAV assembly in MDM. I show that disruption of F-actin elongation or 
branching restores HA-M2 association in MDM, suggesting that both linear and branched actin 
filaments are important for the suppressive role of F-actin in HA-M2 association in MDM 
(Figure 3.2). In terms of the viral proteins involved in the F-actin-dependent suppression of IAV 
assembly in MDM, I propose three possible mechanisms in Figure 3.1. While the ‘microdomain 
segregation’ model suggests an essential role for recruitment of M2 to HA-enriched budozones 
for initiation of particle assembly upon F-actin disruption, the remaining two models suggest that 
other viral structural proteins initiate particle assembly upon F-actin disruption, after which M2 
is recruited to the virus bud.  Using a virus that fails to express M2 but expresses HA and M1 in 
infected cells (Figure 3.3), I show that F-actin suppresses IAV assembly in MDM in an M2-
dependent manner (Figure 3.4). Hence, my data support the M2-dependent ‘microdomain 
segregation’ model for F-actin-dependent restriction of IAV assembly in MDM. In addition, I 
show that similar to the case with MDM, initiation of IAV assembly in dTHP1 cells also depends 
on M2 (Figure 3.5). Overall, my data indicate that in macrophages, M2 plays important roles 
early in the process of IAV particle formation.  
 The cortical actin cytoskeleton, which underlies the plasma membrane to organize and 
maintain the structure of the plasma membrane, is likely the component of the cellular actin 
network that regulates HA-M2 association at the plasma membrane. The cortical actin 
cytoskeleton consists of both linear and branched actin filaments [244], which influence the shape 
and structure of the plasma membrane to regulate processes such as microdomain segregation, 
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formation of membrane protrusions, cell migration, and endocytosis [245]. My data suggest that 
the cortical actin cytoskeleton restricts association between HA and M2 at the plasma membrane 
of MDM, which results in a defect in IAV particle assembly in this cell type. Since HA and M2 
are present in distinct microdomains of the plasma membrane early during IAV assembly [18,22], 
the cortical F-actin may prevent mixing between HA- and M2-enriched microdomains. In an 
apparent contrast with my findings, Thaa et al. previously used Fluorescence Resonance Energy 
Transfer (FRET) microscopy and observed that cytochalasin D treatment reduces co-clustering 
between fluorescent protein fusions of HA and M2, indicating that the actin cytoskeleton plays a 
positive role in the association between the two proteins in the absence of any other viral proteins 
[181]. The discrepancies in the role of F-actin in HA-M2 association between my study and the 
previous study might be due to differences in the cell types used in these studies (Chinese 
Hamster Ovary cells in [181] versus primary human blood derived macrophages in my study). In 
addition, technical differences could account for the discrepancies; for example, the presence of 
other viral components in infection-based experiments (my study) or attachment of fluorescent 
proteins to the cytoplasmic domains of HA and M2 in the FRET study [181] may affect the 
interaction with cortical actin. Future studies focusing on the live cell tracking of HA and M2 on 
the surface of infected cells using super-resolution microscopy will help address whether the 
‘microdomain segregation’ model explains the role of actin cytoskeleton in IAV assembly in 
MDM. 
 The cortical actin cytoskeleton regulates plasma membrane structure via both lipid-actin 
and protein-actin interactions [245]. Hence, differential expression or function of a factor, which 
bridges interactions between the cortical F-actin and the plasma membrane, between different 
cell types may explain how F-actin suppresses HA-M2 association in one cell type (MDM) but 
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not another (dTHP1 cells). Alternatively, it is possible that the cortical F-actin suppresses HA-
M2 association in both cell types; however, dTHP1 cells (and likely epithelial cells) express an 
additional factor(s) that helps overcome this suppressive role of F-actin. As for the mechanisms 
by which the cortical actin network segregates plasma membrane-associated proteins, the most 
well accepted model in the field is the ‘picket-fence’ model [211,246-248]. According to this 
model, the actin network (fence) interacts with membrane linker proteins (pickets) to 
compartmentalize the plasma membrane. Proteins diffuse freely within these individual 
compartments and, only occasionally, “hop” into an adjacent compartment, where they can again 
undergo free diffusion. It is possible that HA and M2 localize to distinct compartments of the 
plasma membrane in both dTHP1 cells and MDM; however, they are unable to overcome the 
barriers imposed by the ‘picket’ proteins in MDM but not in dTHP1 cells. 
 In addition to lending insight into the mechanism by which the cortical actin cytoskeleton 
suppresses IAV assembly in MDM, my data also suggest that association of M2 with HA is 
essential for initiation of IAV particle assembly. This is in contrast with previous studies in 
epithelial cell lines, which assemble spherical particles at the plasma membrane even without M2 
expression; however, the virus particles fail to undergo scission and remain attached to the 
plasma membrane [16,26]. This discrepancy between my study and previous studies could be due 
to a cell-type-dependency for the role of M2 in early stages of particle assembly. Future studies 
focusing on the role of M2 at specific stages of IAV assembly in different cell types, including 
primary epithelial cells, will provide a better understanding of the IAV assembly process. In 
addition, it remains to be understood whether the timing of recruitment of M2 to the HA-
enriched budozone varies between assembling spherical versus filamentous IAV particles.  As 
for the role of M2 during IAV assembly, M2 recruitment to HA-enriched microdomains may 
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either directly induce membrane curvature required for particle formation or M2 plays a more 
indirect role in particle formation by recruiting other curvature inducing components such as M1 
and/or vRNPs to HA-enriched budozones. 
 Overall, in this chapter, I show that both linear and branched actin filaments contribute to 
the suppressive role of the actin cytoskeleton in HA-M2 association in MDM. In addition, I 
provide evidence that the actin cytoskeleton suppresses IAV particle assembly in MDM by 
restricting HA-M2 association at the plasma membrane. Importantly, data in this chapter suggest 
that M2, in addition to its role in pinching off of assembled virus particles, plays an essential role 
early during IAV particle formation in macrophages. Overall, my data provide a better 
understanding of the viral and host mechanisms that operate during IAV assembly. 
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Chapter 4 
Discussion 
	
	
The focus of my thesis was to identify the mechanisms by which viral and host cell proteins 
regulate IAV assembly in host cells. The strategy I employed for this purpose is comparison 
between cells that support IAV assembly (permissive) and those that are defective at IAV 
assembly (non-permissive). In chapter 2, I characterize the primary human monocyte-derived 
macrophage as a cell type that is non-permissive to IAV particle assembly. In addition, I identify 
HA-M2 association as a discrete step in IAV assembly, which is defective in primary human 
monocyte-derived macrophages (MDM). With respect to the host cell mechanism regulating this 
step, I identify the actin cytoskeleton as the host cellular system that suppresses HA-M2 
association and IAV assembly in MDM. In chapter 3, I show that the actin cytoskeleton 
regulates IAV assembly in MDM in an M2-dependent manner. In addition, my data suggest that 
both elongation and branching of F-actin are important for restriction of HA-M2 association in 
MDM. In this chapter, I will summarize the findings from the previous two chapters and discuss 
the implications and future directions of my work.  
Summary of data 
 
(i) MDM are inefficient at supporting IAV replication due to a defect at a specific step in 
IAV assembly 
While several groups have identified species-specific defects in IAV replication 
[189,190,192,194,195], limited information is available with respect to cell-type-specific defects in 
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IAV replication. Abortive IAV infection in murine alveolar macrophages was first reported in 
1981 [249]. More recent studies show that while both human epithelial cells and macrophages can 
be infected by IAV ex vivo [250], macrophages are less permissive or non-permissive to 
replication of seasonal virus strains [199-205]. The respiratory tract is suggested to harbor two 
distinct macrophage populations: lung-resident alveolar macrophages and monocyte-derived 
macrophages [251,252]. In case of humans, both alveolar macrophages and monocyte-derived 
macrophages are similarly inefficient at supporting IAV propagation [200,204]. Notably, species-
specific differences exist for IAV propagation in macrophages. While murine macrophages are 
non-permissive to seasonal IAV strains [199,201,206], IAV replication is not completely blocked 
in human macrophages although it is still less efficient than in epithelial cells 
[200,202,203,205,206]. With respect to the nature of the block, human macrophages were shown to 
support early stages of IAV lifecycle but have a block in the late stage [205]. 
 My results in chapter 2 confirm the findings from previous studies that MDM are 
inefficient at supporting productive infection of seasonal H1N1 and H3N2 IAV strains. In 
addition, I identify particle assembly as a step in the IAV life cycle that is defective in MDM. 
Notably, I also identify association between HA and M2 at the plasma membrane as a discrete 
step that is defective in MDM. Overall, these findings have filled a major gap in the field. Future 
studies looking into whether HA-M2 association is blocked in terms of infection with other IAV 
strains will shed light on whether this MDM-specific defect is conserved between different IAV 
strains. In addition, it remains to be determined whether alveolar macrophages also block IAV 
replication by mechanisms similar to that in MDM. 
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(ii) The defect in IAV assembly in MDM is restored upon disruption of the actin 
cytoskeleton 
In addition to identifying HA-M2 association as a step that is defective in MDM in chapter 2, I 
also provide evidence that this defect manifests in an F-actin-dependent manner. Upon disruption 
of the actin cytoskeleton in MDM, HA-M2 association is restored at the plasma membrane, 
which correlates with a restoration in virus bud formation. Of note, virus release is not restored 
upon F-actin disruption even when particle assembly is restored, suggesting the presence of an 
additional defect(s) in particle assembly/release in MDM. The restrictive role of F-actin in MDM 
could either be due to the distinct structure and/or function of the actin network or due to the 
differential function or expression of an actin-dependent host factor(s) in this cell type. In 
chapter 3, I provide evidence that the complete disruption of the actin cytoskeleton is not 
necessary for restoration of HA-M2 association. Relatively more subtle alterations in the actin 
cytoskeleton such as halting of elongation or branching without complete disruption of the 
cytoskeleton also restore HA-M2 association in MDM, suggesting that a finer mechanism(s) 
underlies the suppressive role of the actin cytoskeleton in IAV assembly. 
 
(iii) The actin cytoskeleton regulates IAV assembly in MDM in an M2-dependent manner 
While the findings in chapter 2 indicate that the actin cytoskeleton regulates both HA-M2 
association and IAV assembly in MDM, it was not clear whether HA-M2 association precedes 
particle assembly or HA-M2 association takes place after particle assembly is initiated by other 
viral structural components (Figure 3.1, chapter 3). To better understand the mechanism(s) by 
which the actin cytoskeleton suppresses IAV assembly, in chapter 3, I use an M2-deficient virus 
to show that M2 expression is necessary for restoration of IAV assembly following F-actin 
disruption in MDM. These findings indicate that association between HA and M2 likely precedes 
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and is essential for IAV assembly upon F-actin disruption in MDM. Based on these results, in 
chapter 3, I propose that the actin cytoskeleton exerts its effect on IAV assembly in MDM by 
segregating HA- and M2-enriched microdomains at the plasma membrane. An alternative 
mechanism for the restrictive role of the actin cytoskeleton in HA-M2 association is also 
discussed in the following section. 
 
Implications and Future Directions 
 
Visualizing individual steps of IAV assembly 
Previously, most groups studying the role of viral and host factors in IAV assembly have used 
virus release as a read-out for IAV assembly and budding [26,39,59,60,82,86,91,92,137]. In some 
cases, transmission electron microscopy (TEM) or scanning electron microscopy (SEM) were 
used to analyze either the lack of assembled particles [25,26] or assembled virus particles that fail 
to be released from the cells [16,26,131,136]. However, the efficiency of particle formation on the 
cell surface has only been quantified in a few cases [42,131,136]. In addition, viral protein 
expression or clustering on the cell surface has not been correlated with the efficiency of particle 
formation before. In my studies, I use correlative fluorescence SEM (CFSEM) to simultaneously 
analyze HA clusters and virus buds on the surface of the same cell. Using this technique, virus 
particle formation can be specifically analyzed in cells that form HA clusters on the plasma 
membrane and the efficiency of virus particle formation can be determined with more 
confidence. Of note, my data in chapter 2 (Figure 2.6) show that HA clusters do not always 
correspond to virus buds. Hence, visualization and quantification of HA clusters is not a direct 
read-out for assembling virus particles and better tools are required to better visualize virus 
assembly sites. For this purpose, I employed an in situ proximity ligation assay (PLA), which 
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allows for detection of two proteins localized within 40-nm distance of each other, to quantify 
co-clustering between viral proteins at the plasma membrane. While this assay has been 
previously used to show sites of association between HA and M2 at the plasma membrane [42], it 
was not known whether these sites of HA-M2 association represent sites of virus assembly. My 
studies, which utilize both PLA and CFSEM, show that under conditions where either HA-M2 
association is not observed (on MDM infected with WT virus or on dTHP1 cells) or M2 is absent 
(on MDM and dTHP1 cells infected with virus lacking M2), virus particle assembly is highly 
inefficient. Therefore, sites of HA-M2 association likely represent sites of virus assembly. 
Overall, the tools developed in my thesis allow for better visualization of the individual steps of 
IAV assembly. In the future, these tools will potentially help advance our understanding of the 
different viral and host factors involved in different steps of IAV assembly. 
Potential mechanisms by which the actin cytoskeleton restricts association between HA and 
M2 in MDM 
My data in chapter 3 suggest that restoration in association between HA and M2 upon F-actin 
disruption is essential for IAV assembly in MDM under these conditions. Hence, the actin 
cytoskeleton may be suppressing HA-M2 association by two possible mechanisms: (i) mobility 
and organization of HA- and M2-containing plasma membrane microdomains; and/or (ii) 
blocking the trafficking of cytoplasmic viral components to the plasma membrane. These two 
non-mutually exclusive mechanisms are further described below. 
i. Mobility and organization of HA- and M2-containing plasma membrane microdomains: 
The plasma membrane is heterogeneous in composition and fluidic in nature.  It is 
composed of discrete but often dynamic domains with unique physical and biological 
properties. These specialized regions are referred to as microdomains. Of these, the most 
extensively studied are lipid rafts or membrane rafts, which are enriched in cholesterol 
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and sphingolipids [253,254]. IAV is thought to assemble in cholesterol-enriched 
microdomains, or membrane rafts, of the plasma membrane in host cells [14,15,215,216]. 
While HA and NA accumulate in membrane rafts [17,18,21-23], also known as the 
budozones, M2 is suggested to localize at the edge of the budozone [16,25,26]. While lipid 
compositions were initially thought to be the main determinant for formation and stability 
of the microdomains, it has been suggested more recently that membrane-associated 
proteins also play important roles in formation and maintenance of plasma membrane 
microdomains [254]. The cortical actin cytoskeleton, which underlies the plasma 
membrane, plays an important role in stabilizing microdomains [255]. In addition, 
increases in local F-actin concentration in response to activation signals drive the large-
scale clustering of microdomains [145,256-258]. Since M2 is present in microdomains 
distinct from HA-enriched microdomains early on in the assembly process [18,22] but is 
later recruited to these assembly sites [25,86,176], the cortical actin network in primary 
macrophages may keep these plasma membrane microdomains apart via interactions with 
either lipids [232,233] or cytoplasmic tails of transmembrane proteins [211,234,235]. Future 
studies focusing on the live cell tracking of HA and M2 on the surface of infected cells 
using super-resolution microscopy will help address whether the cortical actin 
cytoskeleton segregates HA- and M2-enriched plasma membrane microdomains 
ii. Blocking the trafficking of cytoplasmic viral components to the plasma membrane: While 
M2 functions in recruitment of M1 and vRNP to assembly sites [59,60,81,86-88,90], it is not 
clear whether interaction of M2 with M1 and/or vRNPs drives its recruitment to HA-
enriched budozones. Previously, it has been shown that mutations in the M2 cytoplasmic 
tail, which reduce the interaction of M2 with M1 and/or vRNP, reduce the extent of 
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coclustering between HA and M2 at the plasma membrane [86,176]. This suggests that the 
recruitment of M2 to HA-enriched budozones may at least be partially dependent on its 
association with M1 and/or vRNPs. Therefore, the actin network may inhibit HA-M2 
association by restricting the trafficking, incorporation or function of additional 
components essential for IAV assembly, that is, M1 and vRNPs. Both M1 [148] and NP 
[149] are reported to associate with F-actin, and this association might suppress their 
mobility and trafficking to virus assembly sites. In addition, the dense F-actin cortex 
could also serve as a physical barrier to diffusion of proteins or vesicles carrying these 
proteins [238,239].  
Additional defect(s) in IAV assembly/release in macrophages 
While F-actin disruption restores HA-M2 association and IAV particle assembly in MDM, virus 
release is still defective in this cell type. This suggests the presence of an additional defect(s) in 
virus assembly, budding or release in MDM. For example, recruitment of M1 and/or vRNPs may 
still be defective and thus, particle assembly or scission of assembled particles may not be 
completed in MDM. Future studies aimed towards studying the localization of these cytoplasmic 
viral components are necessary to determine whether their trafficking/recruitment is defective in 
MDM. My preliminary data, using anti-M1 and anti-vRNP antibodies, show that while both M1 
and vRNPs are readily detected in the cytoplasm, their detection at the plasma membrane is poor 
(Figures 4.1A and B). This is likely due to the inaccessibility of antibody epitopes due to the 
tight packaging of these components into the assembling virus particle. This is more clearly 
observable in the case of M1 when viral uncoating is artificially induced at the plasma membrane 
using an acidic buffer (Figure 4.1C). In comparison to treatment with a neutral buffer, treatment 
with an acidic buffer allows for visualization of M1 at the HA-enriched budozones. However, 
since, an acidic environment reduces the membrane binding efficiency of M1 [76,259,260], only a 
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sub-population of membrane-bound M1 may be visualized using this approach. Therefore, better 
approaches utilizing viruses encoding fluorescently-tagged proteins are needed to visualize M1 
and vRNPs at the plasma membrane of infected cells. Comparisons between dTHP1 and MDM 
using fluorescently-tagged viral proteins is likely to lend insight into whether trafficking of M1 
and vRNPs is efficient in MDM, in comparison to that in dTHP1 cells.  
 
Figure 4.1: Detecting HA and vRNPs at the plasma membrane of IAV-infected cells. (A, B) dTHP1 
cells and MDM were infected with WSN at MOI 0.01. At 24 hours post infection, cells were stained with 
a cell surface marker, ConA. Cells were then permeabilized and immunostained with anti-M1 (A) or anti-
vRNP (B) antibodies. (C) MDCK cells were infected with WSN at MOI 0.01 for 12 hours. Cells were 
incubated in PBS at pH 7.0 or 5.2 for 10 minutes at room temperature, following which they were fixed 
and immunostained with anti-HA antibody. Cells were then permeabilized and immunostained with anti-
M1 antibody. Boxed areas from the images in the top panel are shown in the lower panel. Data are 
representative of at least two experiments. 
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 Alternative to defects in particle assembly and/or pinching off, fully assembled nascent 
particles may remain tethered to the cell surface in MDM. While IAV is not sensitive to 
membrane retention via tetherin [261,262], other host cellular proteins such as viperin [136] may be 
involved. NA, which cleaves sialic acid residues prior to virus release, associates efficiently with 
HA at the plasma membrane in MDM. However, it remains to be determined whether the 
sialidase function of NA, which is required for release of nascent virus particles, is efficient in 
this cell type. 
Virus spread despite defective virus release in IAV-infected cells 
My data in chapter 2 (Figure 2.2) show that the fraction of infected cells increase over time with 
comparable efficiency in both dTHP1 and MDM cultures despite a drastic reduction in virus 
particle release from MDM, relative to dTHP1 cells. However, the mechanism(s) by which 
MDM support virus spread despite reduced virus release is not understood. The other virus 
population that can allow for virus spread when infectious cell-free virions are scarce is 
comprised of cell-associated virus particles. Cell-associated virus particles use cell-to-cell 
transmission for spread. It is possible that IAV-infected MDM rely more on cell-to-cell spread 
than cell-free spread, in comparison to dTHP1 cells or epithelial cells. MDM promote HIV-1 
transmission via cell-cell contact with T cells to allow viruses to spread efficiently and in some 
cases to evade antiviral drugs or immunity [263-265]. For IAV, cell-to-cell spread, mediated by 
cell-bound virus, may allow the virus to evade respiratory tract conditions that can restrict 
infection of a distant cell. Notably, cell-to-cell virus spread of IAV can occur in the presence of 
oseltamivir [266], an anti-NA drug that abolishes virus release. While long-distance intercellular 
bridges were implicated in spread of cell-associated virus [267,268], it is not clear whether all 
infected cell types employ this mechanism for virus spread. In the context of HIV-1 infection, 
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intercellular bridges have been implicated in cell-to-cell virus spread in macrophages [269]. The 
extent to which cell-to-cell spread contributes to IAV transmission is also dependent on the 
morphology of IAV particles. My preliminary data show that both spherical and filamentous 
variants of the same IAV strain spread with comparable kinetics in epithelial cells even when 
significantly lower levels of cell-free filamentous virus particles are present, relative to spherical 
particles, suggesting that the filamentous IAV particles use the cell-to-cell mode of virus spread 
to a higher extent than spherical viruses (Figure 4.2B). To understand the extent to which cell-to-
cell spread contributes to spherical IAV propagation in MDM, virus spread kinetics need to be 
measured under conditions that block cell-free virus spread (such as in the presence of 
oseltamivir).  
 Alternative to cell-associated virus, cell-free semi-infectious virus particles, which are not 
detected by viral plaque assays, may contribute to spread in MDM. The presence of a relatively 
high number of semi-infectious particles in MDM culture supernatants is suggested by my data 
showing higher proportion of non-fully infectious particles in MDM culture supernatants, 
relative to dTHP1 culture supernatants (Figure 2.3, chapter 2). 
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Figure 4.2: Virus spread and infectious virion release of spherical and filamentous IAV strains. 
MDCK (A) or A549 (B) cells were infected with WSN; reassortant WSN encoding the M segment of 
Udorn (UdM), a filamentous IAV strain; or reassortant WSN encoding a mutant version of the Udorn M 
segment (UdM1A). (A) MDCK cells inoculated with indicated viral strains were immunostained with 
anti-HA antibody at 24 hours post infection and analyzed by confocal microscopy. While WSN forms 
spherical virus particles, which are represented by HA-positive puncta on the cell surface, WSN-Udorn 
assembles both filamentous and spherical particles. An A41V mutation in UdM (UdM1A) abolishes the 
ability of UdM to assemble filamentous virus particles. (B) Titers in culture supernatants were measured 
using plaque assays (left panel) and virus spread in the cultures was measured by flow cytometry using 
anti-HA antibody. Data are representative of four independent experiments. 
 
Physiological relevance of defective IAV replication in macrophages 
Macrophages play a central role in controlling IAV infection. Alveolar macrophages, which 
reside in the lung, are important for clearance of virus and reducing IAV-related morbidity and 
mortality in mice [270-273]. In addition, monocyte-derived macrophages (MDM) also infiltrate 
into the respiratory tract in response to viral or bacterial infection, ageing, and smoking-induced 
damage [274,275]. A recently published study shows that human MDM, and not alveolar 
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macrophages, express receptors for IAV binding and subsequent endocytosis [276], suggesting a 
role for MDM in interacting with IAV. While MDM may serve as a ‘dead end’ for IAV 
infection, the ability of MDM to support the early stages but not the late stages of the IAV life 
cycle may have additional implications for the innate immune response against IAV.  
 IAV is sensed by different pathogen recognition receptors (PRRs), which leads to 
secretion of type I IFNs, proinflammatory cytokines, and chemokines, and acquisition of 
activation status [277]. PRRs such as C-type lectin receptors (CLR) and Toll-like receptors (TLR) 
2 and 4 detect IAV on the cell surface of innate immune cells such as monocytes, macrophages, 
neutrophils, dendritic cells (DCs). Other TLRs such as TLR3 and TLR7/8, which are expressed 
in the endosome of innate immune cells, sense viral RNA or DNA.  While CLRs and TLRs are 
mainly expressed in immune cells, cytoplasmic PRRs such as NOD-like receptors (NLRs) and 
RIG-I-like receptors (RLRs) are expressed in both innate immune and epithelial cells. In IAV-
infected cells as well as in immune cells that have phagocytosed IAV-infected cells, the NLRs 
NLRP3, NLRC3, and NLRX1 sense viral RNA or other viral proteins generated upon active 
viral replication in the cell [278]. The most well studied PRR for IAV is the RLR RIG-I, which 
senses the 5’-triphosphate-RNA containing the dsRNA panhandle generated upon active viral 
replication within the cell [279-281]. More recent studies have also shown that RIG-I 
preferentially binds shorter genomic segments, which include mini viral RNAs and defective 
interfering (DI) RNAs, and not full-length genomes [282-284].  
 While the interferon response is likely induced upon IAV infection in both MDM and 
epithelial cells (and dTHP1 cells), the defect(s) in IAV assembly and release in MDM may 
further enhance interferon induction in this cell type. The defect(s) in particle assembly and 
release in MDM may lead to intracellular accumulation of viral genomes, which could then be 
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sensed by cytoplasmic PRRs. In addition, it is tempting to speculate whether higher levels of 
short viral genomic RNAs, which are more efficient at binding RIG-I, are produced in MDM, 
relative to dTHP1 cells or epithelial cells. My preliminary data show that vRNPs, which are a 
proxy for viral RNA, are more dispersed in the cytoplasm of MDM, in comparison to a more 
clustered localization at the perinuclear region in dTHP1 cells (similar to epithelial cells [42,285]) 
(Figure 4.3). These data suggest that viral RNAs may rely on a different pathway for cytoplasmic 
transport in MDM, in comparison to dTHP1 cells. In cells infected with Sendai virus, which is 
also a single-stranded negative sense RNA virus that is sensed by RIG-I, shorter defective viral 
genomes show a more disperse cytoplasmic distribution whereas, full-length genomes 
accumulate in the perinuclear region of the cell [286]. Therefore, the mode of cytoplasmic 
transport may vary between full-length and incomplete viral genomes. If IAV defective 
genomes, like in the case of Sendai virus, use transport pathways distinct from that of full-length 
genomes for trafficking to the plasma membrane, my data suggest the possibility that higher 
levels of shorter defective viral RNAs may be present in MDM, in comparison to dTHP1 cells. 
More detailed studies will provide more insight into the differences in viral RNA populations 
present in infected MDM versus dTHP1 cells (and epithelial cells). 
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Figure 4.3: vRNP distribution is altered in MDM, in comparison to dTHP1 cells. dTHP1 cells and 
MDM were infected with WSN at MOI 0.01 for 24 hours. Infected cells were fixed, permeabilized, 
immunostained for Rab11 and vRNP, and analyzed by confocal microscopy. (B) Distances from typical 
positions in a WSN-infected cell to the nearest vRNP signal were measured (black) using an ImageJ 
plugin, Spatial Statistics 2D/3D, and shown as cumulative frequency. Gray lines represent estimated 
random pattern for the same number of vRNP signals. While vRNPs show a more random distribution in 
MDM, they are more clustered in dTHP1 cells. Distances at cumulative frequency= 0.5 were calculated 
for the each cell and averages per experiment are shown in the right panel. Data are averages of three 
independent experiments with 8-10 cells analyzed per experiment. *, p<0.05 
 
Cell-type-dependent role of M2 in IAV particle formation  
Previous studies using epithelial cells show that while M2 is required for pinching off of virus 
bud and its subsequent release, it is not required for induction of membrane curvature during 
spherical particle assembly [16,25,59,87]. It has also been proposed that M2 is recruited after 
induction of membrane curvature [225,226], which is likely mediated by HA, NA or M1. At sites 
of virus assembly, M2 is enriched at the neck of the virus bud [16,25,26] and is thought to induce 
positive membrane curvature, which may be sufficient for membrane scission [16,46]. Contrary to 
the case with spherical IAV assembly, M2 is required for assembly as well as membrane scission 
of filamentous particles in epithelial cells [25]. In contrast with epithelial cells, M2 is essential for 
induction of membrane curvature during spherical IAV assembly in both dTHP1 cells and MDM 
(chapter 3). In addition, I show that HA-M2 association likely precedes initiation of spherical 
IAV particle assembly in MDM, suggesting that M2 plays an important role(s) early during IAV 
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assembly in macrophages. This discrepancy between macrophages (dTHP1 and MDM) and 
epithelial cells may be due to the differences in the stoichiometry of other viral structural 
proteins at the plasma membrane of different cell types. Since there is some redundancy in the 
roles of M1 and M2 during IAV assembly [92,287], it is possible that in the absence of M2, other 
viral structural proteins such as M1 can compensate for its functions in epithelial cells. In 
contrast, in dTHP1 cells and MDM, other viral structural proteins may either not be present at 
the plasma membrane at a high enough concentration or may not cocluster to a high enough 
density. Under such circumstances, recruitment of M2 to HA-enriched virus budozones is 
required to initiate particle assembly. Alternatively, M2 may induce membrane curvature 
indirectly through its association with and subsequent recruitment of M1 and/vRNPs [59,60,81,86-
88,90] to viral budozones. While HA and NA are also involved in the recruitment of M1 
[27,28,176] and vRNPs [69], it is not clear which of the two modes of recruitment, M2- or HA/NA-
dependent, is more dominant. It is possible that in epithelial cells, both modes of recruitment are 
equally efficient. On the other hand, HA/NA-dependent recruitment of M1 and/or vRNPs may be 
inefficient in dTHP1 cells and MDM and hence, M2-dependent recruitment may be more 
dominant in these cell types. In the future, analysis of M2 truncation mutants for their ability to 
support virus particle assembly in dTHP1 cells and MDM will provide more insight into the 
functions of M2 that are important for induction of membrane curvature during IAV assembly in 
macrophages. 
Actin-dependent host factor(s) regulate IAV assembly 
In MDM, the actin cytoskeleton plays a negative role in assembly of spherical (and likely 
filamentous) IAV particles, likely by restricting HA-M2 association at assembly sites. The 
restrictive role of F-actin in MDM could either be due to the distinct structure and/or function of 
the actin network or be due to the differential function or expression of an actin-dependent host 
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factor(s) in this cell type. Since the actin cytoskeleton is highly conserved among mammalian 
cells, it is unlikely that the structure or function of the actin network in MDM is drastically 
different from that in dTHP1 cells. If subtle differences exist in the actin network between these 
two cell types, they are likely to be due to differential expression or function of an actin-binding 
protein. As for the nature of this host factor, it could either serve as a restriction factor that 
suppresses particle assembly in MDM or as a dependency factor that allows the virus to 
overcome the suppressive effect of the actin cytoskeleton in IAV-permissive cells (epithelial and 
dTHP1 cells). To distinguish between these two possibilities, our future studies will focus on 
generating MDM-dTHP1 heterokaryons and analyzing their ability to support IAV assembly. 
This approach is described in Figure 4.4. Since the host factor of interest regulates IAV assembly 
by modulating HA-M2 association at the plasma membrane, it is likely to be either a 
transmembrane protein or a cytoplasmic factor that localizes close to the plasma membrane. A 
cytoplasmic host protein can associate with the actin network and/or the membrane lipids or 
membrane-associated viral proteins. Some examples of cytosolic proteins that associate with 
both the actin network and membrane lipids or membrane-associated viral proteins are the ERM 
(Ezrin, Radixin and Moesin) proteins [288-290] and talin [291,292]. On the other hand, a 
transmembrane host protein can associate with the actin network via its cytoplasmic domain 
and/or with lipids or membrane-associated viral proteins via its ecto- or transmembrane domains. 
Some examples of transmembrane proteins that associate with actin and aid in organization of 
other plasma membrane-associated proteins are CD44 [211], Cystic Fibrosis Transmembrane 
Conductance Regulator (CFTR) [234,293], and Csk-binding protein (CBP) [235]. Irrespective of 
whether the host factor is cytoplasmic or transmembrane in nature, it may function in regulating 
IAV assembly by organizing HA- and M2-containing microdomains. Alternatively, if the defect 
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in HA-M2 association in MDM is due to a block in trafficking/recruitment of M1 and/or vRNPs, 
the host factor regulating this step is more likely to be a cytoplasmic protein. In the future, 
heterokaryon studies and more high-throughput approaches such as proteomics or RNAseq will 
potentially help identify the host factor regulating IAV assembly in MDM.  
 
 
 
 
 
 
Figure 4.4: Using heterokaryons to determine the nature of the host factor suppressing HA-M2 
association in MDM. dTHP1-MDM heterokaryons can be used to the determine whether the defect in 
HA-M2 association in MDM is due to the presence of restriction factor that blocks HA-M2 association or 
the absence of a dependency factor that supports HA-M2 association in dTHP1 cells. 
 
The actin cytoskeleton as a potential drug target 
The actin cytoskeleton plays positive and/or negative roles during infection of many enveloped 
viruses such as HIV-1 [294-297], IAV [137,155,159,161,163,298,299], Measles virus [300-303], and 
Ebola virus [304,305]. Since F-actin disruption promotes IAV assembly in MDM, which are non-
permissive to virus assembly, stabilization of the actin cytoskeleton in cell types permissive to 
IAV assembly (dTHP1 and epithelial cells) may potentially restrict association between HA and 
M2 and hence, block IAV assembly in these cells. However, the actin cytoskeleton is a highly 
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conserved network that is required for many key cellular functions and hence, its disruption or 
stabilization results in cell death. An important implication of my data in chapters 2 and 3 is 
that subtle cell-type-dependent differences in the structure and/or function of the actin 
cytoskeleton or actin-dependent proteins can have a substantial impact on IAV replication. The 
distinct structure and/or function of the actin cytoskeleton in MDM accounts for the ability of 
this cell type to suppress IAV assembly without compromising essential cellular functions. 
Hence, identification of the host factor(s) that regulates these differences in the structure and/or 
function of the actin cytoskeleton between different cell types will potentially help develop 
strategies to target more specific aspects of F-actin dynamics and hence, block IAV assembly, 
without affecting the essential functions of the cell.  
 
 
 
 
 
 
 
 
 
	
	
	
	
	
	
	
	
	
	
	
	
105	
	
References 
	
1. Wahlgren, J. Influenza A viruses: an ecology review. Infect Ecol Epidemiol 2011, 1, 
doi:10.3402/iee.v1i0.6004. 
2. Iuliano, A.D.; Roguski, K.M.; Chang, H.H.; Muscatello, D.J.; Palekar, R.; Tempia, S.; 
Cohen, C.; Gran, J.M.; Schanzer, D.; Cowling, B.J., et al. Estimates of global seasonal 
influenza-associated respiratory mortality: a modelling study. Lancet 2018, 391, 1285-
1300, doi:10.1016/S0140-6736(17)33293-2. 
3. Zimmer, S.M.; Burke, D.S. Historical perspective--Emergence of influenza A (H1N1) 
viruses. N Engl J Med 2009, 361, 279-285, doi:10.1056/NEJMra0904322. 
4. Simonsen, L.; Spreeuwenberg, P.; Lustig, R.; Taylor, R.J.; Fleming, D.M.; Kroneman, 
M.; Van Kerkhove, M.D.; Mounts, A.W.; Paget, W.J.; Teams, G.C. Global mortality 
estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study. 
PLoS Med 2013, 10, e1001558, doi:10.1371/journal.pmed.1001558. 
5. Calder, L.J.; Wasilewski, S.; Berriman, J.A.; Rosenthal, P.B. Structural organization of a 
filamentous influenza A virus. Proc Natl Acad Sci U S A 2010, 107, 10685-10690, 
doi:10.1073/pnas.1002123107. 
6. Compans, R.W.; Content, J.; Duesberg, P.H. Structure of the ribonucleoprotein of 
influenza virus. J Virol 1972, 10, 795-800. 
7. Chen, W.; Calvo, P.A.; Malide, D.; Gibbs, J.; Schubert, U.; Bacik, I.; Basta, S.; O'Neill, 
R.; Schickli, J.; Palese, P., et al. A novel influenza A virus mitochondrial protein that 
induces cell death. Nat Med 2001, 7, 1306-1312, doi:10.1038/nm1201-1306. 
8. Wise, H.M.; Foeglein, A.; Sun, J.; Dalton, R.M.; Patel, S.; Howard, W.; Anderson, E.C.; 
Barclay, W.S.; Digard, P. A complicated message: Identification of a novel PB1-related 
protein translated from influenza A virus segment 2 mRNA. J Virol 2009, 83, 8021-8031, 
doi:10.1128/JVI.00826-09. 
9. Jagger, B.W.; Wise, H.M.; Kash, J.C.; Walters, K.A.; Wills, N.M.; Xiao, Y.L.; Dunfee, 
R.L.; Schwartzman, L.M.; Ozinsky, A.; Bell, G.L., et al. An overlapping protein-coding 
region in influenza A virus segment 3 modulates the host response. Science 2012, 337, 
199-204, doi:10.1126/science.1222213. 
10. Muramoto, Y.; Noda, T.; Kawakami, E.; Akkina, R.; Kawaoka, Y. Identification of novel 
influenza A virus proteins translated from PA mRNA. J Virol 2013, 87, 2455-2462, 
doi:10.1128/JVI.02656-12. 
11. Greber, U.F. Virus and Host Mechanics Support Membrane Penetration and Cell Entry. J 
Virol 2016, 90, 3802-3805, doi:10.1128/JVI.02568-15. 
12. Dou, D.; Revol, R.; Östbye, H.; Wang, H.; Daniels, R. Influenza A Virus Cell Entry, 
Replication, Virion Assembly and Movement. Front Immunol 2018, 9, 1581, 
doi:10.3389/fimmu.2018.01581. 
13. Smrt, S.T.; Lorieau, J.L. Membrane Fusion and Infection of the Influenza Hemagglutinin. 
Adv Exp Med Biol 2017, 966, 37-54, doi:10.1007/5584_2016_174. 
106	
14. Rossman, J.S.; Lamb, R.A. Influenza virus assembly and budding. Virology 2011, 411, 
229-236, doi:10.1016/j.virol.2010.12.003. 
15. Nayak, D.P.; Balogun, R.A.; Yamada, H.; Zhou, Z.H.; Barman, S. Influenza virus 
morphogenesis and budding. Virus Res 2009, 143, 147-161, 
doi:10.1016/j.virusres.2009.05.010. 
16. Rossman, J.S.; Jing, X.; Leser, G.P.; Lamb, R.A. Influenza virus M2 protein mediates 
ESCRT-independent membrane scission. Cell 2010, 142, 902-913, 
doi:10.1016/j.cell.2010.08.029. 
17. Takeda, M.; Leser, G.P.; Russell, C.J.; Lamb, R.A. Influenza virus hemagglutinin 
concentrates in lipid raft microdomains for efficient viral fusion. Proc Natl Acad Sci U S 
A 2003, 100, 14610-14617, doi:10.1073/pnas.2235620100. 
18. Leser, G.P.; Lamb, R.A. Influenza virus assembly and budding in raft-derived 
microdomains: a quantitative analysis of the surface distribution of HA, NA and M2 
proteins. Virology 2005, 342, 215-227, doi:10.1016/j.virol.2005.09.049. 
19. Hess, S.T.; Kumar, M.; Verma, A.; Farrington, J.; Kenworthy, A.; Zimmerberg, J. 
Quantitative electron microscopy and fluorescence spectroscopy of the membrane 
distribution of influenza hemagglutinin. J Cell Biol 2005, 169, 965-976, 
doi:10.1083/jcb.200412058. 
20. Kerviel, A.; Thomas, A.; Chaloin, L.; Favard, C.; Muriaux, D. Virus assembly and 
plasma membrane domains: which came first? Virus Res 2013, 171, 332-340, 
doi:10.1016/j.virusres.2012.08.014. 
21. Chen, B.J.; Leser, G.P.; Morita, E.; Lamb, R.A. Influenza virus hemagglutinin and 
neuraminidase, but not the matrix protein, are required for assembly and budding of 
plasmid-derived virus-like particles. J Virol 2007, 81, 7111-7123, 
doi:10.1128/JVI.00361-07. 
22. Zhang, J.; Pekosz, A.; Lamb, R.A. Influenza virus assembly and lipid raft microdomains: 
a role for the cytoplasmic tails of the spike glycoproteins. J Virol 2000, 74, 4634-4644. 
23. Ohkura, T.; Momose, F.; Ichikawa, R.; Takeuchi, K.; Morikawa, Y. Influenza A virus 
hemagglutinin and neuraminidase mutually accelerate their apical targeting through 
clustering of lipid rafts. J Virol 2014, 88, 10039-10055, doi:10.1128/JVI.00586-14. 
24. Scolari, S.; Engel, S.; Krebs, N.; Plazzo, A.P.; De Almeida, R.F.; Prieto, M.; Veit, M.; 
Herrmann, A. Lateral distribution of the transmembrane domain of influenza virus 
hemagglutinin revealed by time-resolved fluorescence imaging. J Biol Chem 2009, 284, 
15708-15716, doi:10.1074/jbc.M900437200. 
25. Rossman, J.S.; Jing, X.; Leser, G.P.; Balannik, V.; Pinto, L.H.; Lamb, R.A. Influenza 
virus m2 ion channel protein is necessary for filamentous virion formation. J Virol 2010, 
84, 5078-5088, doi:10.1128/JVI.00119-10. 
26. Roberts, K.L.; Leser, G.P.; Ma, C.; Lamb, R.A. The amphipathic helix of influenza A 
virus M2 protein is required for filamentous bud formation and scission of filamentous 
and spherical particles. J Virol 2013, 87, 9973-9982, doi:10.1128/JVI.01363-13. 
27. Barman, S.; Ali, A.; Hui, E.K.; Adhikary, L.; Nayak, D.P. Transport of viral proteins to 
the apical membranes and interaction of matrix protein with glycoproteins in the 
assembly of influenza viruses. Virus Res 2001, 77, 61-69. 
28. Ali, A.; Avalos, R.T.; Ponimaskin, E.; Nayak, D.P. Influenza virus assembly: effect of 
influenza virus glycoproteins on the membrane association of M1 protein. J Virol 2000, 
74, 8709-8719. 
107	
29. Jin, H.; Leser, G.P.; Zhang, J.; Lamb, R.A. Influenza virus hemagglutinin and 
neuraminidase cytoplasmic tails control particle shape. EMBO J 1997, 16, 1236-1247, 
doi:10.1093/emboj/16.6.1236. 
30. Zhang, J.; Lamb, R.A. Characterization of the membrane association of the influenza 
virus matrix protein in living cells. Virology 1996, 225, 255-266, 
doi:10.1006/viro.1996.0599. 
31. Chlanda, P.; Schraidt, O.; Kummer, S.; Riches, J.; Oberwinkler, H.; Prinz, S.; Kräusslich, 
H.G.; Briggs, J.A. Structural Analysis of the Roles of Influenza A Virus Membrane-
Associated Proteins in Assembly and Morphology. J Virol 2015, 89, 8957-8966, 
doi:10.1128/JVI.00592-15. 
32. Elster, C.; Larsen, K.; Gagnon, J.; Ruigrok, R.W.; Baudin, F. Influenza virus M1 protein 
binds to RNA through its nuclear localization signal. J Gen Virol 1997, 78 ( Pt 7), 1589-
1596, doi:10.1099/0022-1317-78-7-1589. 
33. Bui, M.; Wills, E.G.; Helenius, A.; Whittaker, G.R. Role of the influenza virus M1 
protein in nuclear export of viral ribonucleoproteins. J Virol 2000, 74, 1781-1786. 
34. Baudin, F.; Petit, I.; Weissenhorn, W.; Ruigrok, R.W. In vitro dissection of the membrane 
and RNP binding activities of influenza virus M1 protein. Virology 2001, 281, 102-108, 
doi:10.1006/viro.2000.0804. 
35. Sakaguchi, A.; Hirayama, E.; Hiraki, A.; Ishida, Y.; Kim, J. Nuclear export of influenza 
viral ribonucleoprotein is temperature-dependently inhibited by dissociation of viral 
matrix protein. Virology 2003, 306, 244-253. 
36. Elton, D.; Simpson-Holley, M.; Archer, K.; Medcalf, L.; Hallam, R.; McCauley, J.; 
Digard, P. Interaction of the influenza virus nucleoprotein with the cellular CRM1-
mediated nuclear export pathway. J Virol 2001, 75, 408-419, doi:10.1128/JVI.75.1.408-
419.2001. 
37. O'Neill, R.E.; Talon, J.; Palese, P. The influenza virus NEP (NS2 protein) mediates the 
nuclear export of viral ribonucleoproteins. EMBO J 1998, 17, 288-296, 
doi:10.1093/emboj/17.1.288. 
38. Jo, S.; Kawaguchi, A.; Takizawa, N.; Morikawa, Y.; Momose, F.; Nagata, K. 
Involvement of vesicular trafficking system in membrane targeting of the progeny 
influenza virus genome. Microbes Infect 2010, 12, 1079-1084, 
doi:10.1016/j.micinf.2010.06.011. 
39. Amorim, M.J.; Bruce, E.A.; Read, E.K.; Foeglein, A.; Mahen, R.; Stuart, A.D.; Digard, 
P. A Rab11- and microtubule-dependent mechanism for cytoplasmic transport of 
influenza A virus viral RNA. J Virol 2011, 85, 4143-4156, doi:10.1128/JVI.02606-10. 
40. Eisfeld, A.J.; Kawakami, E.; Watanabe, T.; Neumann, G.; Kawaoka, Y. RAB11A is 
essential for transport of the influenza virus genome to the plasma membrane. J Virol 
2011, 85, 6117-6126, doi:10.1128/JVI.00378-11. 
41. de Castro Martin, I.F.; Fournier, G.; Sachse, M.; Pizarro-Cerda, J.; Risco, C.; Naffakh, N. 
Influenza virus genome reaches the plasma membrane via a modified endoplasmic 
reticulum and Rab11-dependent vesicles. Nat Commun 2017, 8, 1396, 
doi:10.1038/s41467-017-01557-6. 
42. Kawaguchi, A.; Hirohama, M.; Harada, Y.; Osari, S.; Nagata, K. Influenza Virus Induces 
Cholesterol-Enriched Endocytic Recycling Compartments for Budozone Formation via 
Cell Cycle-Independent Centrosome Maturation. PLoS Pathog 2015, 11, e1005284, 
doi:10.1371/journal.ppat.1005284. 
108	
43. Amorim, M.J.; Kao, R.Y.; Digard, P. Nucleozin targets cytoplasmic trafficking of viral 
ribonucleoprotein-Rab11 complexes in influenza A virus infection. J Virol 2013, 87, 
4694-4703, doi:10.1128/JVI.03123-12. 
44. Bialas, K.M.; Bussey, K.A.; Stone, R.L.; Takimoto, T. Specific nucleoprotein residues 
affect influenza virus morphology. J Virol 2014, 88, 2227-2234, doi:10.1128/JVI.03354-
13. 
45. Chlanda, P.; Mekhedov, E.; Waters, H.; Sodt, A.; Schwartz, C.; Nair, V.; Blank, P.S.; 
Zimmerberg, J. Palmitoylation Contributes to Membrane Curvature in Influenza A Virus 
Assembly and Hemagglutinin-Mediated Membrane Fusion. J Virol 2017, 91, 
doi:10.1128/JVI.00947-17. 
46. Martyna, A.; Bahsoun, B.; Badham, M.D.; Srinivasan, S.; Howard, M.J.; Rossman, J.S. 
Membrane remodeling by the M2 amphipathic helix drives influenza virus membrane 
scission. Sci Rep 2017, 7, 44695, doi:10.1038/srep44695. 
47. Palese, P.; Tobita, K.; Ueda, M.; Compans, R.W. Characterization of temperature 
sensitive influenza virus mutants defective in neuraminidase. Virology 1974, 61, 397-410. 
48. Palese, P.; Compans, R.W. Inhibition of influenza virus replication in tissue culture by 2-
deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. J 
Gen Virol 1976, 33, 159-163, doi:10.1099/0022-1317-33-1-159. 
49. KILBOURNE, E.D.; MURPHY, J.S. Genetic studies of influenza viruses. I. Viral 
morphology and growth capacity as exchangeable genetic traits. Rapid in ovo adaptation 
of early passage Asian strain isolates by combination with PR8. J Exp Med 1960, 111, 
387-406. 
50. CHOPPIN, P.W.; MURPHY, J.S.; TAMM, I. Studies of two kinds of virus particles 
which comprise influenza A2 virus strains. III. Morphological characteristics: 
independence to morphological and functional traits. J Exp Med 1960, 112, 945-952. 
51. CHU, C.M.; DAWSON, I.M.; ELFORD, W.J. Filamentous forms associated with newly 
isolated influenza virus. Lancet 1949, 1, 602. 
52. Seladi-Schulman, J.; Steel, J.; Lowen, A.C. Spherical influenza viruses have a fitness 
advantage in embryonated eggs, while filament-producing strains are selected in vivo. J 
Virol 2013, 87, 13343-13353, doi:10.1128/JVI.02004-13. 
53. MOSLEY, V.M.; WYCKOFF, R.W. Electron micrography of the virus of influenza. 
Nature 1946, 157, 263. 
54. Burleigh, L.M.; Calder, L.J.; Skehel, J.J.; Steinhauer, D.A. Influenza a viruses with 
mutations in the m1 helix six domain display a wide variety of morphological 
phenotypes. J Virol 2005, 79, 1262-1270, doi:10.1128/JVI.79.2.1262-1270.2005. 
55. Bourmakina, S.V.; García-Sastre, A. Reverse genetics studies on the filamentous 
morphology of influenza A virus. J Gen Virol 2003, 84, 517-527. 
56. Elleman, C.J.; Barclay, W.S. The M1 matrix protein controls the filamentous phenotype 
of influenza A virus. Virology 2004, 321, 144-153, doi:10.1016/j.virol.2003.12.009. 
57. Roberts, P.C.; Lamb, R.A.; Compans, R.W. The M1 and M2 proteins of influenza A 
virus are important determinants in filamentous particle formation. Virology 1998, 240, 
127-137, doi:10.1006/viro.1997.8916. 
58. Campbell, P.J.; Danzy, S.; Kyriakis, C.S.; Deymier, M.J.; Lowen, A.C.; Steel, J. The M 
segment of the 2009 pandemic influenza virus confers increased neuraminidase activity, 
filamentous morphology, and efficient contact transmissibility to A/Puerto Rico/8/1934-
based reassortant viruses. J Virol 2014, 88, 3802-3814, doi:10.1128/JVI.03607-13. 
109	
59. Iwatsuki-Horimoto, K.; Horimoto, T.; Noda, T.; Kiso, M.; Maeda, J.; Watanabe, S.; 
Muramoto, Y.; Fujii, K.; Kawaoka, Y. The cytoplasmic tail of the influenza A virus M2 
protein plays a role in viral assembly. J Virol 2006, 80, 5233-5240, 
doi:10.1128/JVI.00049-06. 
60. Grantham, M.L.; Stewart, S.M.; Lalime, E.N.; Pekosz, A. Tyrosines in the influenza A 
virus M2 protein cytoplasmic tail are critical for production of infectious virus particles. J 
Virol 2010, 84, 8765-8776, doi:10.1128/JVI.00853-10. 
61. Chen, B.J.; Takeda, M.; Lamb, R.A. Influenza virus hemagglutinin (H3 subtype) requires 
palmitoylation of its cytoplasmic tail for assembly: M1 proteins of two subtypes differ in 
their ability to support assembly. J Virol 2005, 79, 13673-13684, 
doi:10.1128/JVI.79.21.13673-13684.2005. 
62. Scheiffele, P.; Roth, M.G.; Simons, K. Interaction of influenza virus haemagglutinin with 
sphingolipid-cholesterol membrane domains via its transmembrane domain. EMBO J 
1997, 16, 5501-5508, doi:10.1093/emboj/16.18.5501. 
63. Scolari, S.; Imkeller, K.; Jolmes, F.; Veit, M.; Herrmann, A.; Schwarzer, R. Modulation 
of cell surface transport and lipid raft localization by the cytoplasmic tail of the influenza 
virus hemagglutinin. Cell Microbiol 2016, 18, 125-136, doi:10.1111/cmi.12491. 
64. Lin, S.; Naim, H.Y.; Rodriguez, A.C.; Roth, M.G. Mutations in the middle of the 
transmembrane domain reverse the polarity of transport of the influenza virus 
hemagglutinin in MDCK epithelial cells. J Cell Biol 1998, 142, 51-57. 
65. Latham, T.; Galarza, J.M. Formation of wild-type and chimeric influenza virus-like 
particles following simultaneous expression of only four structural proteins. J Virol 2001, 
75, 6154-6165, doi:10.1128/JVI.75.13.6154-6165.2001. 
66. Gómez-Puertas, P.; Albo, C.; Pérez-Pastrana, E.; Vivo, A.; Portela, A. Influenza virus 
matrix protein is the major driving force in virus budding. J Virol 2000, 74, 11538-11547. 
67. Barman, S.; Adhikary, L.; Kawaoka, Y.; Nayak, D.P. Influenza A virus hemagglutinin 
containing basolateral localization signal does not alter the apical budding of a 
recombinant influenza A virus in polarized MDCK cells. Virology 2003, 305, 138-152. 
68. Mora, R.; Rodriguez-Boulan, E.; Palese, P.; García-Sastre, A. Apical budding of a 
recombinant influenza A virus expressing a hemagglutinin protein with a basolateral 
localization signal. J Virol 2002, 76, 3544-3553. 
69. Zhang, J.; Leser, G.P.; Pekosz, A.; Lamb, R.A. The cytoplasmic tails of the influenza 
virus spike glycoproteins are required for normal genome packaging. Virology 2000, 269, 
325-334, doi:10.1006/viro.2000.0228. 
70. Takizawa, N.; Momose, F.; Morikawa, Y.; Nomoto, A. Influenza A Virus Hemagglutinin 
is Required for the Assembly of Viral Components Including Bundled vRNPs at the 
Lipid Raft. Viruses 2016, 8, doi:10.3390/v8090249. 
71. Kundu, A.; Avalos, R.T.; Sanderson, C.M.; Nayak, D.P. Transmembrane domain of 
influenza virus neuraminidase, a type II protein, possesses an apical sorting signal in 
polarized MDCK cells. J Virol 1996, 70, 6508-6515. 
72. Barman, S.; Nayak, D.P. Analysis of the transmembrane domain of influenza virus 
neuraminidase, a type II transmembrane glycoprotein, for apical sorting and raft 
association. J Virol 2000, 74, 6538-6545. 
73. Barman, S.; Adhikary, L.; Chakrabarti, A.K.; Bernas, C.; Kawaoka, Y.; Nayak, D.P. Role 
of transmembrane domain and cytoplasmic tail amino acid sequences of influenza a virus 
neuraminidase in raft association and virus budding. J Virol 2004, 78, 5258-5269. 
110	
74. Noton, S.L.; Medcalf, E.; Fisher, D.; Mullin, A.E.; Elton, D.; Digard, P. Identification of 
the domains of the influenza A virus M1 matrix protein required for NP binding, 
oligomerization and incorporation into virions. J Gen Virol 2007, 88, 2280-2290, 
doi:10.1099/vir.0.82809-0. 
75. Arzt, S.; Petit, I.; Burmeister, W.P.; Ruigrok, R.W.; Baudin, F. Structure of a knockout 
mutant of influenza virus M1 protein that has altered activities in membrane binding, 
oligomerisation and binding to NEP (NS2). Virus Res 2004, 99, 115-119. 
76. Zhang, K.; Wang, Z.; Liu, X.; Yin, C.; Basit, Z.; Xia, B.; Liu, W. Dissection of influenza 
A virus M1 protein: pH-dependent oligomerization of N-terminal domain and 
dimerization of C-terminal domain. PLoS One 2012, 7, e37786, 
doi:10.1371/journal.pone.0037786. 
77. Ye, Z.; Liu, T.; Offringa, D.P.; McInnis, J.; Levandowski, R.A. Association of influenza 
virus matrix protein with ribonucleoproteins. J Virol 1999, 73, 7467-7473. 
78. Liu, T.; Ye, Z. Introduction of a temperature-sensitive phenotype into influenza 
A/WSN/33 virus by altering the basic amino acid domain of influenza virus matrix 
protein. J Virol 2004, 78, 9585-9591, doi:10.1128/JVI.78.18.9585-9591.2004. 
79. Ruigrok, R.W.; Barge, A.; Durrer, P.; Brunner, J.; Ma, K.; Whittaker, G.R. Membrane 
interaction of influenza virus M1 protein. Virology 2000, 267, 289-298, 
doi:10.1006/viro.1999.0134. 
80. Arzt, S.; Baudin, F.; Barge, A.; Timmins, P.; Burmeister, W.P.; Ruigrok, R.W. Combined 
results from solution studies on intact influenza virus M1 protein and from a new crystal 
form of its N-terminal domain show that M1 is an elongated monomer. Virology 2001, 
279, 439-446, doi:10.1006/viro.2000.0727. 
81. Wang, D.; Harmon, A.; Jin, J.; Francis, D.H.; Christopher-Hennings, J.; Nelson, E.; 
Montelaro, R.C.; Li, F. The lack of an inherent membrane targeting signal is responsible 
for the failure of the matrix (M1) protein of influenza A virus to bud into virus-like 
particles. J Virol 2010, 84, 4673-4681, doi:10.1128/JVI.02306-09. 
82. Roberts, P.C.; Compans, R.W. Host cell dependence of viral morphology. Proc Natl 
Acad Sci U S A 1998, 95, 5746-5751. 
83. Bialas, K.M.; Desmet, E.A.; Takimoto, T. Specific residues in the 2009 H1N1 swine-
origin influenza matrix protein influence virion morphology and efficiency of viral 
spread in vitro. PLoS One 2012, 7, e50595, doi:10.1371/journal.pone.0050595. 
84. Wharton, S.A.; Belshe, R.B.; Skehel, J.J.; Hay, A.J. Role of virion M2 protein in 
influenza virus uncoating: specific reduction in the rate of membrane fusion between 
virus and liposomes by amantadine. J Gen Virol 1994, 75 ( Pt 4), 945-948. 
85. Helenius, A. Unpacking the incoming influenza virus. Cell 1992, 69, 577-578. 
86. Chen, B.J.; Leser, G.P.; Jackson, D.; Lamb, R.A. The influenza virus M2 protein 
cytoplasmic tail interacts with the M1 protein and influences virus assembly at the site of 
virus budding. J Virol 2008, 82, 10059-10070, doi:10.1128/JVI.01184-08. 
87. McCown, M.F.; Pekosz, A. The influenza A virus M2 cytoplasmic tail is required for 
infectious virus production and efficient genome packaging. J Virol 2005, 79, 3595-3605, 
doi:10.1128/JVI.79.6.3595-3605.2005. 
88. McCown, M.F.; Pekosz, A. Distinct domains of the influenza a virus M2 protein 
cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus 
production. J Virol 2006, 80, 8178-8189, doi:10.1128/JVI.00627-06. 
111	
89. Martyna, A.; Rossman, J. Alterations of membrane curvature during influenza virus 
budding. Biochem Soc Trans 2014, 42, 1425-1428, doi:10.1042/BST20140136. 
90. Su, W.C.; Yu, W.Y.; Huang, S.H.; Lai, M.M.C. Ubiquitination of the Cytoplasmic 
Domain of Influenza A Virus M2 Protein is Crucial for Production of Infectious Virus 
Particles. J Virol 2017, doi:10.1128/JVI.01972-17. 
91. Wohlgemuth, N.; Lane, A.P.; Pekosz, A. Influenza A Virus M2 Protein Apical Targeting 
Is Required for Efficient Virus Replication. J Virol 2018, 92, doi:10.1128/JVI.01425-18. 
92. Liu, H.; Grantham, M.L.; Pekosz, A. Mutations in the Influenza A Virus M1 Protein 
Enhance Virus Budding To Complement Lethal Mutations in the M2 Cytoplasmic Tail. J 
Virol 2018, 92, doi:10.1128/JVI.00858-17. 
93. Zebedee, S.L.; Lamb, R.A. Influenza A virus M2 protein: monoclonal antibody 
restriction of virus growth and detection of M2 in virions. J Virol 1988, 62, 2762-2772. 
94. Hao, L.; Sakurai, A.; Watanabe, T.; Sorensen, E.; Nidom, C.A.; Newton, M.A.; Ahlquist, 
P.; Kawaoka, Y. Drosophila RNAi screen identifies host genes important for influenza 
virus replication. Nature 2008, 454, 890-893, doi:10.1038/nature07151. 
95. Shapira, S.D.; Gat-Viks, I.; Shum, B.O.; Dricot, A.; de Grace, M.M.; Wu, L.; Gupta, 
P.B.; Hao, T.; Silver, S.J.; Root, D.E., et al. A physical and regulatory map of host-
influenza interactions reveals pathways in H1N1 infection. Cell 2009, 139, 1255-1267, 
doi:10.1016/j.cell.2009.12.018. 
96. Karlas, A.; Machuy, N.; Shin, Y.; Pleissner, K.P.; Artarini, A.; Heuer, D.; Becker, D.; 
Khalil, H.; Ogilvie, L.A.; Hess, S., et al. Genome-wide RNAi screen identifies human 
host factors crucial for influenza virus replication. Nature 2010, 463, 818-822, 
doi:10.1038/nature08760. 
97. König, R.; Stertz, S.; Zhou, Y.; Inoue, A.; Hoffmann, H.H.; Bhattacharyya, S.; Alamares, 
J.G.; Tscherne, D.M.; Ortigoza, M.B.; Liang, Y., et al. Human host factors required for 
influenza virus replication. Nature 2010, 463, 813-817, doi:10.1038/nature08699. 
98. Su, W.C.; Chen, Y.C.; Tseng, C.H.; Hsu, P.W.; Tung, K.F.; Jeng, K.S.; Lai, M.M. Pooled 
RNAi screen identifies ubiquitin ligase Itch as crucial for influenza A virus release from 
the endosome during virus entry. Proc Natl Acad Sci U S A 2013, 110, 17516-17521, 
doi:10.1073/pnas.1312374110. 
99. Watanabe, T.; Kawakami, E.; Shoemaker, J.E.; Lopes, T.J.; Matsuoka, Y.; Tomita, Y.; 
Kozuka-Hata, H.; Gorai, T.; Kuwahara, T.; Takeda, E., et al. Influenza virus-host 
interactome screen as a platform for antiviral drug development. Cell Host Microbe 2014, 
16, 795-805, doi:10.1016/j.chom.2014.11.002. 
100. Tripathi, S.; Pohl, M.O.; Zhou, Y.; Rodriguez-Frandsen, A.; Wang, G.; Stein, D.A.; 
Moulton, H.M.; DeJesus, P.; Che, J.; Mulder, L.C., et al. Meta- and Orthogonal 
Integration of Influenza "OMICs" Data Defines a Role for UBR4 in Virus Budding. Cell 
Host Microbe 2015, 18, 723-735, doi:10.1016/j.chom.2015.11.002. 
101. Meliopoulos, V.A.; Andersen, L.E.; Birrer, K.F.; Simpson, K.J.; Lowenthal, J.W.; Bean, 
A.G.; Stambas, J.; Stewart, C.R.; Tompkins, S.M.; van Beusechem, V.W., et al. Host 
gene targets for novel influenza therapies elucidated by high-throughput RNA 
interference screens. FASEB J 2012, 26, 1372-1386, doi:10.1096/fj.11-193466. 
102. Heaton, N.S.; Moshkina, N.; Fenouil, R.; Gardner, T.J.; Aguirre, S.; Shah, P.S.; Zhao, N.; 
Manganaro, L.; Hultquist, J.F.; Noel, J., et al. Targeting Viral Proteostasis Limits 
Influenza Virus, HIV, and Dengue Virus Infection. Immunity 2016, 44, 46-58, 
doi:10.1016/j.immuni.2015.12.017. 
112	
103. Heaton, B.E.; Kennedy, E.M.; Dumm, R.E.; Harding, A.T.; Sacco, M.T.; Sachs, D.; 
Heaton, N.S. A CRISPR Activation Screen Identifies a Pan-avian Influenza Virus 
Inhibitory Host Factor. Cell Rep 2017, 20, 1503-1512, doi:10.1016/j.celrep.2017.07.060. 
104. Shaw, M.L.; Stone, K.L.; Colangelo, C.M.; Gulcicek, E.E.; Palese, P. Cellular proteins in 
influenza virus particles. PLoS Pathog 2008, 4, e1000085, 
doi:10.1371/journal.ppat.1000085. 
105. Hutchinson, E.C.; Charles, P.D.; Hester, S.S.; Thomas, B.; Trudgian, D.; Martínez-
Alonso, M.; Fodor, E. Conserved and host-specific features of influenza virion 
architecture. Nat Commun 2014, 5, 4816, doi:10.1038/ncomms5816. 
106. Avilov, S.V.; Moisy, D.; Naffakh, N.; Cusack, S. Influenza A virus progeny vRNP 
trafficking in live infected cells studied with the virus-encoded fluorescently tagged PB2 
protein. Vaccine 2012, 30, 7411-7417, doi:10.1016/j.vaccine.2012.09.077. 
107. Chou, Y.Y.; Heaton, N.S.; Gao, Q.; Palese, P.; Singer, R.H.; Singer, R.; Lionnet, T. 
Colocalization of different influenza viral RNA segments in the cytoplasm before viral 
budding as shown by single-molecule sensitivity FISH analysis. PLoS Pathog 2013, 9, 
e1003358, doi:10.1371/journal.ppat.1003358. 
108. Lakdawala, S.S.; Wu, Y.; Wawrzusin, P.; Kabat, J.; Broadbent, A.J.; Lamirande, E.W.; 
Fodor, E.; Altan-Bonnet, N.; Shroff, H.; Subbarao, K. Influenza a virus assembly 
intermediates fuse in the cytoplasm. PLoS Pathog 2014, 10, e1003971, 
doi:10.1371/journal.ppat.1003971. 
109. Momose, F.; Sekimoto, T.; Ohkura, T.; Jo, S.; Kawaguchi, A.; Nagata, K.; Morikawa, Y. 
Apical transport of influenza A virus ribonucleoprotein requires Rab11-positive recycling 
endosome. PLoS One 2011, 6, e21123, doi:10.1371/journal.pone.0021123. 
110. Nturibi, E.; Bhagwat, A.R.; Coburn, S.; Myerburg, M.M.; Lakdawala, S.S. Intracellular 
Colocalization of Influenza Viral RNA and Rab11A Is Dependent upon Microtubule 
Filaments. J Virol 2017, 91, doi:10.1128/JVI.01179-17. 
111. Avilov, S.; Magnus, J.; Cusack, S.; Naffakh, N. Time-Resolved Visualisation of Nearly-
Native Influenza A Virus Progeny Ribonucleoproteins and Their Individual Components 
in Live Infected Cells. PLoS One 2016, 11, e0149986, 
doi:10.1371/journal.pone.0149986. 
112. Vale-Costa, S.; Alenquer, M.; Sousa, A.L.; Kellen, B.; Ramalho, J.; Tranfield, E.M.; 
Amorim, M.J. Influenza A virus ribonucleoproteins modulate host recycling by 
competing with Rab11 effectors. J Cell Sci 2016, 129, 1697-1710, 
doi:10.1242/jcs.188409. 
113. Avilov, S.V.; Moisy, D.; Munier, S.; Schraidt, O.; Naffakh, N.; Cusack, S. Replication-
competent influenza A virus that encodes a split-green fluorescent protein-tagged PB2 
polymerase subunit allows live-cell imaging of the virus life cycle. J Virol 2012, 86, 
1433-1448, doi:10.1128/JVI.05820-11. 
114. Momose, F.; Kikuchi, Y.; Komase, K.; Morikawa, Y. Visualization of microtubule-
mediated transport of influenza viral progeny ribonucleoprotein. Microbes Infect 2007, 9, 
1422-1433, doi:10.1016/j.micinf.2007.07.007. 
115. Welz, T.; Wellbourne-Wood, J.; Kerkhoff, E. Orchestration of cell surface proteins by 
Rab11. Trends Cell Biol 2014, 24, 407-415, doi:10.1016/j.tcb.2014.02.004. 
116. Bruce, E.A.; Digard, P.; Stuart, A.D. The Rab11 pathway is required for influenza A 
virus budding and filament formation. J Virol 2010, 84, 5848-5859, 
doi:10.1128/JVI.00307-10. 
113	
117. Eisfeld, A.J.; Neumann, G.; Kawaoka, Y. Human immunodeficiency virus rev-binding 
protein is essential for influenza a virus replication and promotes genome trafficking in 
late-stage infection. J Virol 2011, 85, 9588-9598, doi:10.1128/JVI.05064-11. 
118. Neville, M.; Stutz, F.; Lee, L.; Davis, L.I.; Rosbash, M. The importin-beta family 
member Crm1p bridges the interaction between Rev and the nuclear pore complex during 
nuclear export. Curr Biol 1997, 7, 767-775. 
119. DesGroseillers, L.; Lemieux, N. Localization of a human double-stranded RNA-binding 
protein gene (STAU) to band 20q13.1 by fluorescence in situ hybridization. Genomics 
1996, 36, 527-529, doi:10.1006/geno.1996.0499. 
120. Kim, Y.K.; Furic, L.; Desgroseillers, L.; Maquat, L.E. Mammalian Staufen1 recruits 
Upf1 to specific mRNA 3'UTRs so as to elicit mRNA decay. Cell 2005, 120, 195-208, 
doi:10.1016/j.cell.2004.11.050. 
121. de Lucas, S.; Peredo, J.; Marión, R.M.; Sánchez, C.; Ortín, J. Human Staufen1 protein 
interacts with influenza virus ribonucleoproteins and is required for efficient virus 
multiplication. J Virol 2010, 84, 7603-7612, doi:10.1128/JVI.00504-10. 
122. Kawaguchi, A.; Matsumoto, K.; Nagata, K. YB-1 functions as a porter to lead influenza 
virus ribonucleoprotein complexes to microtubules. J Virol 2012, 86, 11086-11095, 
doi:10.1128/JVI.00453-12. 
123. Huarte, M.; Sanz-Ezquerro, J.J.; Roncal, F.; Ortín, J.; Nieto, A. PA subunit from 
influenza virus polymerase complex interacts with a cellular protein with homology to a 
family of transcriptional activators. J Virol 2001, 75, 8597-8604. 
124. Pérez-González, A.; Rodriguez, A.; Huarte, M.; Salanueva, I.J.; Nieto, A. hCLE/CGI-99, 
a human protein that interacts with the influenza virus polymerase, is a mRNA 
transcription modulator. J Mol Biol 2006, 362, 887-900, doi:10.1016/j.jmb.2006.07.085. 
125. Rodriguez, A.; Pérez-González, A.; Nieto, A. Cellular human CLE/C14orf166 protein 
interacts with influenza virus polymerase and is required for viral replication. J Virol 
2011, 85, 12062-12066, doi:10.1128/JVI.00684-11. 
126. Rodriguez-Frandsen, A.; de Lucas, S.; Pérez-González, A.; Pérez-Cidoncha, M.; Roldan-
Gomendio, A.; Pazo, A.; Marcos-Villar, L.; Landeras-Bueno, S.; Ortín, J.; Nieto, A. 
hCLE/C14orf166, a cellular protein required for viral replication, is incorporated into 
influenza virus particles. Sci Rep 2016, 6, 20744, doi:10.1038/srep20744. 
127. Sun, E.; He, J.; Zhuang, X. Dissecting the role of COPI complexes in influenza virus 
infection. J Virol 2013, 87, 2673-2685, doi:10.1128/JVI.02277-12. 
128. Wang, S.; Li, H.; Chen, Y.; Wei, H.; Gao, G.F.; Liu, H.; Huang, S.; Chen, J.L. Transport 
of influenza virus neuraminidase (NA) to host cell surface is regulated by ARHGAP21 
and Cdc42 proteins. J Biol Chem 2012, 287, 9804-9816, doi:10.1074/jbc.M111.312959. 
129. Zhu, P.; Liang, L.; Shao, X.; Luo, W.; Jiang, S.; Zhao, Q.; Sun, N.; Zhao, Y.; Li, J.; 
Wang, J., et al. Host Cellular Protein TRAPPC6AΔ Interacts with Influenza A Virus M2 
Protein and Regulates Viral Propagation by Modulating M2 Trafficking. J Virol 2017, 
91, doi:10.1128/JVI.01757-16. 
130. Fan, Y.; Mok, C.K.; Chan, M.C.; Zhang, Y.; Nal, B.; Kien, F.; Bruzzone, R.; Sanyal, S. 
Cell Cycle-independent Role of Cyclin D3 in Host Restriction of Influenza Virus 
Infection. J Biol Chem 2017, 292, 5070-5088, doi:10.1074/jbc.M117.776112. 
131. He, J.; Sun, E.; Bujny, M.V.; Kim, D.; Davidson, M.W.; Zhuang, X. Dual function of 
CD81 in influenza virus uncoating and budding. PLoS Pathog 2013, 9, e1003701, 
doi:10.1371/journal.ppat.1003701. 
114	
132. Demirov, D.; Gabriel, G.; Schneider, C.; Hohenberg, H.; Ludwig, S. Interaction of 
influenza A virus matrix protein with RACK1 is required for virus release. Cell 
Microbiol 2012, 14, 774-789, doi:10.1111/j.1462-5822.2012.01759.x. 
133. Gorai, T.; Goto, H.; Noda, T.; Watanabe, T.; Kozuka-Hata, H.; Oyama, M.; Takano, R.; 
Neumann, G.; Watanabe, S.; Kawaoka, Y. F1Fo-ATPase, F-type proton-translocating 
ATPase, at the plasma membrane is critical for efficient influenza virus budding. Proc 
Natl Acad Sci U S A 2012, 109, 4615-4620, doi:10.1073/pnas.1114728109. 
134. Ma, H.; Kien, F.; Manière, M.; Zhang, Y.; Lagarde, N.; Tse, K.S.; Poon, L.L.; Nal, B. 
Human annexin A6 interacts with influenza a virus protein M2 and negatively modulates 
infection. J Virol 2012, 86, 1789-1801, doi:10.1128/JVI.06003-11. 
135. Helbig, K.J.; Beard, M.R. The role of viperin in the innate antiviral response. J Mol Biol 
2014, 426, 1210-1219, doi:10.1016/j.jmb.2013.10.019. 
136. Wang, X.; Hinson, E.R.; Cresswell, P. The interferon-inducible protein viperin inhibits 
influenza virus release by perturbing lipid rafts. Cell Host Microbe 2007, 2, 96-105, 
doi:10.1016/j.chom.2007.06.009. 
137. Simpson-Holley, M.; Ellis, D.; Fisher, D.; Elton, D.; McCauley, J.; Digard, P. A 
functional link between the actin cytoskeleton and lipid rafts during budding of 
filamentous influenza virions. Virology 2002, 301, 212-225. 
138. Davidson, A.J.; Wood, W. Unravelling the Actin Cytoskeleton: A New Competitive 
Edge? Trends Cell Biol 2016, 26, 569-576, doi:10.1016/j.tcb.2016.04.001. 
139. Bezanilla, M.; Gladfelter, A.S.; Kovar, D.R.; Lee, W.L. Cytoskeletal dynamics: a view 
from the membrane. J Cell Biol 2015, 209, 329-337, doi:10.1083/jcb.201502062. 
140. Chesarone, M.A.; Goode, B.L. Actin nucleation and elongation factors: mechanisms and 
interplay. Curr Opin Cell Biol 2009, 21, 28-37, doi:10.1016/j.ceb.2008.12.001. 
141. Firat-Karalar, E.N.; Welch, M.D. New mechanisms and functions of actin nucleation. 
Curr Opin Cell Biol 2011, 23, 4-13, doi:10.1016/j.ceb.2010.10.007. 
142. Bravo-Cordero, J.J.; Magalhaes, M.A.; Eddy, R.J.; Hodgson, L.; Condeelis, J. Functions 
of cofilin in cell locomotion and invasion. Nat Rev Mol Cell Biol 2013, 14, 405-415, 
doi:10.1038/nrm3609. 
143. Liu, A.P.; Fletcher, D.A. Actin polymerization serves as a membrane domain switch in 
model lipid bilayers. Biophys J 2006, 91, 4064-4070, doi:10.1529/biophysj.106.090852. 
144. Gaus, K.; Chklovskaia, E.; Fazekas de St Groth, B.; Jessup, W.; Harder, T. Condensation 
of the plasma membrane at the site of T lymphocyte activation. J Cell Biol 2005, 171, 
121-131, doi:10.1083/jcb.200505047. 
145. Chichili, G.R.; Rodgers, W. Clustering of membrane raft proteins by the actin 
cytoskeleton. J Biol Chem 2007, 282, 36682-36691, doi:10.1074/jbc.M702959200. 
146. Hartman, M.A.; Spudich, J.A. The myosin superfamily at a glance. J Cell Sci 2012, 125, 
1627-1632, doi:10.1242/jcs.094300. 
147. Sit, S.T.; Manser, E. Rho GTPases and their role in organizing the actin cytoskeleton. J 
Cell Sci 2011, 124, 679-683, doi:10.1242/jcs.064964. 
148. Avalos, R.T.; Yu, Z.; Nayak, D.P. Association of influenza virus NP and M1 proteins 
with cellular cytoskeletal elements in influenza virus-infected cells. J Virol 1997, 71, 
2947-2958. 
149. Digard, P.; Elton, D.; Bishop, K.; Medcalf, E.; Weeds, A.; Pope, B. Modulation of 
nuclear localization of the influenza virus nucleoprotein through interaction with actin 
filaments. J Virol 1999, 73, 2222-2231. 
115	
150. Mayer, D.; Molawi, K.; Martínez-Sobrido, L.; Ghanem, A.; Thomas, S.; Baginsky, S.; 
Grossmann, J.; García-Sastre, A.; Schwemmle, M. Identification of cellular interaction 
partners of the influenza virus ribonucleoprotein complex and polymerase complex using 
proteomic-based approaches. J Proteome Res 2007, 6, 672-682, doi:10.1021/pr060432u. 
151. Bradel-Tretheway, B.G.; Mattiacio, J.L.; Krasnoselsky, A.; Stevenson, C.; Purdy, D.; 
Dewhurst, S.; Katze, M.G. Comprehensive proteomic analysis of influenza virus 
polymerase complex reveals a novel association with mitochondrial proteins and RNA 
polymerase accessory factors. J Virol 2011, 85, 8569-8581, doi:10.1128/JVI.00496-11. 
152. Yu, G.; Liang, W.; Liu, J.; Meng, D.; Wei, L.; Chai, T.; Cai, Y. Proteomic Analysis of 
Differential Expression of Cellular Proteins in Response to Avian H9N2 Virus Infection 
of A549 Cells. Front Microbiol 2016, 7, 1962, doi:10.3389/fmicb.2016.01962. 
153. Mindaye, S.T.; Ilyushina, N.A.; Fantoni, G.; Alterman, M.A.; Donnelly, R.P.; 
Eichelberger, M.C. Impact of Influenza A Virus Infection on the Proteomes of Human 
Bronchoepithelial Cells from Different Donors. J Proteome Res 2017, 16, 3287-3297, 
doi:10.1021/acs.jproteome.7b00286. 
154. Coombs, K.M.; Berard, A.; Xu, W.; Krokhin, O.; Meng, X.; Cortens, J.P.; Kobasa, D.; 
Wilkins, J.; Brown, E.G. Quantitative proteomic analyses of influenza virus-infected 
cultured human lung cells. J Virol 2010, 84, 10888-10906, doi:10.1128/JVI.00431-10. 
155. Liu, G.; Xiang, Y.; Guo, C.; Pei, Y.; Wang, Y.; Kitazato, K. Cofilin-1 is involved in 
regulation of actin reorganization during influenza A virus assembly and budding. 
Biochem Biophys Res Commun 2014, 453, 821-825, doi:10.1016/j.bbrc.2014.10.036. 
156. Chen, D.Y.; Husain, M. Caspase-mediated degradation of host cortactin that promotes 
influenza A virus infection in epithelial cells. Virology 2016, 497, 146-156, 
doi:10.1016/j.virol.2016.07.017. 
157. Jiang, W.; Wang, Q.; Chen, S.; Gao, S.; Song, L.; Liu, P.; Huang, W. Influenza A virus 
NS1 induces G0/G1 cell cycle arrest by inhibiting the expression and activity of RhoA 
protein. J Virol 2013, 87, 3039-3052, doi:10.1128/JVI.03176-12. 
158. Jiang, W.; Sheng, C.; Gu, X.; Liu, D.; Yao, C.; Gao, S.; Chen, S.; Huang, Y.; Huang, W.; 
Fang, M. Suppression of Rac1 Signaling by Influenza A Virus NS1 Facilitates Viral 
Replication. Sci Rep 2016, 6, 35041, doi:10.1038/srep35041. 
159. Kumakura, M.; Kawaguchi, A.; Nagata, K. Actin-myosin network is required for proper 
assembly of influenza virus particles. Virology 2015, 476, 141-150, 
doi:10.1016/j.virol.2014.12.016. 
160. Griffin, J.A.; Compans, R.W. Effect of cytochalasin B on the maturation of enveloped 
viruses. J Exp Med 1979, 150, 379-391. 
161. Arcangeletti, M.C.; De Conto, F.; Ferraglia, F.; Pinardi, F.; Gatti, R.; Orlandini, G.; 
Covan, S.; Motta, F.; Rodighiero, I.; Dettori, G., et al. Host-cell-dependent role of actin 
cytoskeleton during the replication of a human strain of influenza A virus. Arch Virol 
2008, 153, 1209-1221, doi:10.1007/s00705-008-0103-0. 
162. De Conto, F.; Di Lonardo, E.; Arcangeletti, M.C.; Chezzi, C.; Medici, M.C.; Calderaro, 
A. Highly dynamic microtubules improve the effectiveness of early stages of human 
influenza A/NWS/33 virus infection in LLC-MK2 cells. PLoS One 2012, 7, e41207, 
doi:10.1371/journal.pone.0041207. 
163. Bedi, S.; Noda, T.; Kawaoka, Y.; Ono, A. A Defect in Influenza A Virus Particle 
Assembly Specific to Primary Human Macrophages. MBio 2018, 9, 
doi:10.1128/mBio.01916-18. 
116	
164. Rindler, M.J.; Ivanov, I.E.; Plesken, H.; Sabatini, D.D. Polarized delivery of viral 
glycoproteins to the apical and basolateral plasma membranes of Madin-Darby canine 
kidney cells infected with temperature-sensitive viruses. J Cell Biol 1985, 100, 136-151. 
165. Rodriguez Boulan, E.; Sabatini, D.D. Asymmetric budding of viruses in epithelial 
monlayers: a model system for study of epithelial polarity. Proc Natl Acad Sci U S A 
1978, 75, 5071-5075. 
166. Rodriguez Boulan, E.; Pendergast, M. Polarized distribution of viral envelope proteins in 
the plasma membrane of infected epithelial cells. Cell 1980, 20, 45-54. 
167. Rodriguez-Boulan, E.; Paskiet, K.T.; Sabatini, D.D. Assembly of enveloped viruses in 
Madin-Darby canine kidney cells: polarized budding from single attached cells and from 
clusters of cells in suspension. J Cell Biol 1983, 96, 866-874. 
168. Rodriguez-Boulan, E.; Paskiet, K.T.; Salas, P.J.; Bard, E. Intracellular transport of 
influenza virus hemagglutinin to the apical surface of Madin-Darby canine kidney cells. J 
Cell Biol 1984, 98, 308-319. 
169. Hughey, P.G.; Compans, R.W.; Zebedee, S.L.; Lamb, R.A. Expression of the influenza A 
virus M2 protein is restricted to apical surfaces of polarized epithelial cells. J Virol 1992, 
66, 5542-5552. 
170. Bonilha, V.L.; Marmorstein, A.D.; Cohen-Gould, L.; Rodriguez-Boulan, E. Apical 
sorting of influenza hemagglutinin by transcytosis in retinal pigment epithelium. J Cell 
Sci 1997, 110 ( Pt 15), 1717-1727. 
171. Guerriero, C.J.; Lai, Y.; Weisz, O.A. Differential sorting and Golgi export requirements 
for raft-associated and raft-independent apical proteins along the biosynthetic pathway. J 
Biol Chem 2008, 283, 18040-18047, doi:10.1074/jbc.M802048200. 
172. Cresawn, K.O.; Potter, B.A.; Oztan, A.; Guerriero, C.J.; Ihrke, G.; Goldenring, J.R.; 
Apodaca, G.; Weisz, O.A. Differential involvement of endocytic compartments in the 
biosynthetic traffic of apical proteins. EMBO J 2007, 26, 3737-3748, 
doi:10.1038/sj.emboj.7601813. 
173. Carrasco, M.; Amorim, M.J.; Digard, P. Lipid raft-dependent targeting of the influenza A 
virus nucleoprotein to the apical plasma membrane. Traffic 2004, 5, 979-992, 
doi:10.1111/j.1600-0854.2004.00237.x. 
174. Salas, P.J.; Misek, D.E.; Vega-Salas, D.E.; Gundersen, D.; Cereijido, M.; Rodriguez-
Boulan, E. Microtubules and actin filaments are not critically involved in the biogenesis 
of epithelial cell surface polarity. J Cell Biol 1986, 102, 1853-1867. 
175. Husain, M.; Cheung, C.Y. Histone deacetylase 6 inhibits influenza A virus release by 
downregulating the trafficking of viral components to the plasma membrane via its 
substrate, acetylated microtubules. J Virol 2014, 88, 11229-11239, 
doi:10.1128/JVI.00727-14. 
176. Leser, G.P.; Lamb, R.A. Lateral Organization of Influenza Virus Proteins in the 
Budozone Region of the Plasma Membrane. J Virol 2017, 91, doi:10.1128/JVI.02104-16. 
177. Henkel, J.R.; Weisz, O.A. Influenza virus M2 protein slows traffic along the secretory 
pathway. pH perturbation of acidified compartments affects early Golgi transport steps. J 
Biol Chem 1998, 273, 6518-6524. 
178. Henkel, J.R.; Apodaca, G.; Altschuler, Y.; Hardy, S.; Weisz, O.A. Selective perturbation 
of apical membrane traffic by expression of influenza M2, an acid-activated ion channel, 
in polarized madin-darby canine kidney cells. Mol Biol Cell 1998, 9, 2477-2490. 
117	
179. Henkel, J.R.; Gibson, G.A.; Poland, P.A.; Ellis, M.A.; Hughey, R.P.; Weisz, O.A. 
Influenza M2 proton channel activity selectively inhibits trans-Golgi network release of 
apical membrane and secreted proteins in polarized Madin-Darby canine kidney cells. J 
Cell Biol 2000, 148, 495-504. 
180. Gudheti, M.V.; Curthoys, N.M.; Gould, T.J.; Kim, D.; Gunewardene, M.S.; Gabor, K.A.; 
Gosse, J.A.; Kim, C.H.; Zimmerberg, J.; Hess, S.T. Actin mediates the nanoscale 
membrane organization of the clustered membrane protein influenza hemagglutinin. 
Biophys J 2013, 104, 2182-2192, doi:10.1016/j.bpj.2013.03.054. 
181. Thaa, B.; Herrmann, A.; Veit, M. Intrinsic cytoskeleton-dependent clustering of influenza 
virus M2 protein with hemagglutinin assessed by FLIM-FRET. J Virol 2010, 84, 12445-
12449, doi:10.1128/JVI.01322-10. 
182. Spearman, P. HIV-1 Gag as an Antiviral Target: Development of Assembly and 
Maturation Inhibitors. Curr Top Med Chem 2016, 16, 1154-1166. 
183. Zeisel, M.B.; Crouchet, E.; Baumert, T.F.; Schuster, C. Host-Targeting Agents to Prevent 
and Cure Hepatitis C Virus Infection. Viruses 2015, 7, 5659-5685, 
doi:10.3390/v7112898. 
184. Rodgers, B.C.; Mims, C.A. Influenza virus replication in human alveolar macrophages. J 
Med Virol 1982, 9, 177-184. 
185. Hartmann, B.M.; Li, W.; Jia, J.; Patil, S.; Marjanovic, N.; Martínez-Romero, C.; 
Albrecht, R.A.; Hayot, F.; García-Sastre, A.; Wetmur, J.G., et al. Mouse dendritic cell 
(DC) influenza virus infectivity is much lower than that for human DCs and is 
hemagglutinin subtype dependent. J Virol 2013, 87, 1916-1918, doi:10.1128/JVI.02980-
12. 
186. Graham, A.C.; Hilmer, K.M.; Zickovich, J.M.; Obar, J.J. Inflammatory response of mast 
cells during influenza A virus infection is mediated by active infection and RIG-I 
signaling. J Immunol 2013, 190, 4676-4684, doi:10.4049/jimmunol.1202096. 
187. Lohmeyer, J.; Talens, L.T.; Klenk, H.D. Biosynthesis of the influenza virus envelope in 
abortive infection. J Gen Virol 1979, 42, 73-88, doi:10.1099/0022-1317-42-1-73. 
188. Gujuluva, C.N.; Kundu, A.; Murti, K.G.; Nayak, D.P. Abortive replication of influenza 
virus A/WSN/33 in HeLa229 cells: defective viral entry and budding processes. Virology 
1994, 204, 491-505, doi:10.1006/viro.1994.1563. 
189. Moncorgé, O.; Mura, M.; Barclay, W.S. Evidence for avian and human host cell factors 
that affect the activity of influenza virus polymerase. J Virol 2010, 84, 9978-9986, 
doi:10.1128/JVI.01134-10. 
190. Mehle, A.; Doudna, J.A. An inhibitory activity in human cells restricts the function of an 
avian-like influenza virus polymerase. Cell Host Microbe 2008, 4, 111-122, 
doi:10.1016/j.chom.2008.06.007. 
191. Feng, Y.; Broder, C.C.; Kennedy, P.E.; Berger, E.A. HIV-1 entry cofactor: functional 
cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996, 
272, 872-877. 
192. Bortz, E.; Westera, L.; Maamary, J.; Steel, J.; Albrecht, R.A.; Manicassamy, B.; Chase, 
G.; Martínez-Sobrido, L.; Schwemmle, M.; García-Sastre, A. Host- and strain-specific 
regulation of influenza virus polymerase activity by interacting cellular proteins. MBio 
2011, 2, doi:10.1128/mBio.00151-11. 
118	
193. Hudjetz, B.; Gabriel, G. Human-like PB2 627K influenza virus polymerase activity is 
regulated by importin-α1 and -α7. PLoS Pathog 2012, 8, e1002488, 
doi:10.1371/journal.ppat.1002488. 
194. Long, J.S.; Giotis, E.S.; Moncorgé, O.; Frise, R.; Mistry, B.; James, J.; Morisson, M.; 
Iqbal, M.; Vignal, A.; Skinner, M.A., et al. Species difference in ANP32A underlies 
influenza A virus polymerase host restriction. Nature 2016, 529, 101-104, 
doi:10.1038/nature16474. 
195. Kuo, S.M.; Chen, C.J.; Chang, S.C.; Liu, T.J.; Chen, Y.H.; Huang, S.Y.; Shih, S.R. 
Inhibition of Avian Influenza A Virus Replication in Human Cells by Host Restriction 
Factor TUFM Is Correlated with Autophagy. MBio 2017, 8, doi:10.1128/mBio.00481-17. 
196. Laguette, N.; Sobhian, B.; Casartelli, N.; Ringeard, M.; Chable-Bessia, C.; Ségéral, E.; 
Yatim, A.; Emiliani, S.; Schwartz, O.; Benkirane, M. SAMHD1 is the dendritic- and 
myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011, 474, 
654-657, doi:10.1038/nature10117. 
197. Neil, S.J.; Zang, T.; Bieniasz, P.D. Tetherin inhibits retrovirus release and is antagonized 
by HIV-1 Vpu. Nature 2008, 451, 425-430, doi:10.1038/nature06553. 
198. Sheehy, A.M.; Gaddis, N.C.; Choi, J.D.; Malim, M.H. Isolation of a human gene that 
inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002, 418, 
646-650, doi:10.1038/nature00939. 
199. Cline, T.D.; Karlsson, E.A.; Seufzer, B.J.; Schultz-Cherry, S. The hemagglutinin protein 
of highly pathogenic H5N1 influenza viruses overcomes an early block in the replication 
cycle to promote productive replication in macrophages. J Virol 2013, 87, 1411-1419, 
doi:10.1128/JVI.02682-12. 
200. Yu, W.C.; Chan, R.W.; Wang, J.; Travanty, E.A.; Nicholls, J.M.; Peiris, J.S.; Mason, 
R.J.; Chan, M.C. Viral replication and innate host responses in primary human alveolar 
epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 
viruses. J Virol 2011, 85, 6844-6855, doi:10.1128/JVI.02200-10. 
201. Londrigan, S.L.; Short, K.R.; Ma, J.; Gillespie, L.; Rockman, S.P.; Brooks, A.G.; 
Reading, P.C. Infection of Mouse Macrophages by Seasonal Influenza Viruses Can Be 
Restricted at the Level of Virus Entry and at a Late Stage in the Virus Life Cycle. J Virol 
2015, 89, 12319-12329, doi:10.1128/JVI.01455-15. 
202. Mok, C.K.; Lee, D.C.; Cheung, C.Y.; Peiris, M.; Lau, A.S. Differential onset of apoptosis 
in influenza A virus H5N1- and H1N1-infected human blood macrophages. J Gen Virol 
2007, 88, 1275-1280, doi:10.1099/vir.0.82423-0. 
203. Sakabe, S.; Iwatsuki-Horimoto, K.; Takano, R.; Nidom, C.A.; Le, M.; Nagamura-Inoue, 
T.; Horimoto, T.; Yamashita, N.; Kawaoka, Y. Cytokine production by primary human 
macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza 
viruses. J Gen Virol 2011, 92, 1428-1434, doi:10.1099/vir.0.030346-0. 
204. van Riel, D.; Leijten, L.M.; van der Eerden, M.; Hoogsteden, H.C.; Boven, L.A.; 
Lambrecht, B.N.; Osterhaus, A.D.; Kuiken, T. Highly pathogenic avian influenza virus 
H5N1 infects alveolar macrophages without virus production or excessive TNF-alpha 
induction. PLoS Pathog 2011, 7, e1002099, doi:10.1371/journal.ppat.1002099. 
205. Marvin, S.A.; Russier, M.; Huerta, C.T.; Russell, C.J.; Schultz-Cherry, S. Influenza 
overcomes cellular blocks to productively replicate impacting macrophage function. J 
Virol 2016, doi:10.1128/JVI.01417-16. 
119	
206. Perrone, L.A.; Plowden, J.K.; García-Sastre, A.; Katz, J.M.; Tumpey, T.M. H5N1 and 
1918 pandemic influenza virus infection results in early and excessive infiltration of 
macrophages and neutrophils in the lungs of mice. PLoS Pathog 2008, 4, e1000115, 
doi:10.1371/journal.ppat.1000115. 
207. Okuno, Y.; Isegawa, Y.; Sasao, F.; Ueda, S. A common neutralizing epitope conserved 
between the hemagglutinins of influenza A virus H1 and H2 strains. J Virol 1993, 67, 
2552-2558. 
208. Neumann, G.; Watanabe, T.; Ito, H.; Watanabe, S.; Goto, H.; Gao, P.; Hughes, M.; Perez, 
D.R.; Donis, R.; Hoffmann, E., et al. Generation of influenza A viruses entirely from 
cloned cDNAs. Proc Natl Acad Sci U S A 1999, 96, 9345-9350. 
209. Pauly, M.D.; Lauring, A.S. Effective lethal mutagenesis of influenza virus by three 
nucleoside analogs. J Virol 2015, 89, 3584-3597, doi:10.1128/JVI.03483-14. 
210. Hogue, I.B.; Grover, J.R.; Soheilian, F.; Nagashima, K.; Ono, A. Gag induces the 
coalescence of clustered lipid rafts and tetraspanin-enriched microdomains at HIV-1 
assembly sites on the plasma membrane. J Virol 2011, 85, 9749-9766, 
doi:10.1128/JVI.00743-11. 
211. Freeman, S.A.; Vega, A.; Riedl, M.; Collins, R.F.; Ostrowski, P.P.; Woods, E.C.; 
Bertozzi, C.R.; Tammi, M.I.; Lidke, D.S.; Johnson, P., et al. Transmembrane Pickets 
Connect Cyto- and Pericellular Skeletons Forming Barriers to Receptor Engagement. 
Cell 2018, 172, 305-317.e310, doi:10.1016/j.cell.2017.12.023. 
212. Doud, M.B.; Lee, J.M.; Bloom, J.D. How single mutations affect viral escape from broad 
and narrow antibodies to H1 influenza hemagglutinin. Nat Commun 2018, 9, 1386, 
doi:10.1038/s41467-018-03665-3. 
213. Harder, T.; Scheiffele, P.; Verkade, P.; Simons, K. Lipid domain structure of the plasma 
membrane revealed by patching of membrane components. J Cell Biol 1998, 141, 929-
942. 
214. Bubb, M.R.; Senderowicz, A.M.; Sausville, E.A.; Duncan, K.L.; Korn, E.D. 
Jasplakinolide, a cytotoxic natural product, induces actin polymerization and 
competitively inhibits the binding of phalloidin to F-actin. J Biol Chem 1994, 269, 
14869-14871. 
215. Schmitt, A.P.; Lamb, R.A. Influenza virus assembly and budding at the viral budozone. 
Adv Virus Res 2005, 64, 383-416, doi:10.1016/S0065-3527(05)64012-2. 
216. Veit, M.; Thaa, B. Association of influenza virus proteins with membrane rafts. Adv Virol 
2011, 2011, 370606, doi:10.1155/2011/370606. 
217. Gunewardene, M.S.; Subach, F.V.; Gould, T.J.; Penoncello, G.P.; Gudheti, M.V.; 
Verkhusha, V.V.; Hess, S.T. Superresolution imaging of multiple fluorescent proteins 
with highly overlapping emission spectra in living cells. Biophys J 2011, 101, 1522-1528, 
doi:10.1016/j.bpj.2011.07.049. 
218. Bourmakina, S.V.; García-Sastre, A. The morphology and composition of influenza A 
virus particles are not affected by low levels of M1 and M2 proteins in infected cells. J 
Virol 2005, 79, 7926-7932, doi:10.1128/JVI.79.12.7926-7932.2005. 
219. Moreira, É.; Weber, A.; Bolte, H.; Kolesnikova, L.; Giese, S.; Lakdawala, S.; Beer, M.; 
Zimmer, G.; García-Sastre, A.; Schwemmle, M., et al. A conserved influenza A virus 
nucleoprotein code controls specific viral genome packaging. Nat Commun 2016, 7, 
12861, doi:10.1038/ncomms12861. 
120	
220. Bui, M.; Whittaker, G.; Helenius, A. Effect of M1 protein and low pH on nuclear 
transport of influenza virus ribonucleoproteins. J Virol 1996, 70, 8391-8401. 
221. Tobler, K.; Kelly, M.L.; Pinto, L.H.; Lamb, R.A. Effect of cytoplasmic tail truncations on 
the activity of the M(2) ion channel of influenza A virus. J Virol 1999, 73, 9695-9701. 
222. Park, E.K.; Castrucci, M.R.; Portner, A.; Kawaoka, Y. The M2 ectodomain is important 
for its incorporation into influenza A virions. J Virol 1998, 72, 2449-2455. 
223. Takeuchi, K.; Lamb, R.A. Influenza virus M2 protein ion channel activity stabilizes the 
native form of fowl plague virus hemagglutinin during intracellular transport. J Virol 
1994, 68, 911-919. 
224. Ciampor, F.; Bayley, P.M.; Nermut, M.V.; Hirst, E.M.; Sugrue, R.J.; Hay, A.J. Evidence 
that the amantadine-induced, M2-mediated conversion of influenza A virus 
hemagglutinin to the low pH conformation occurs in an acidic trans Golgi compartment. 
Virology 1992, 188, 14-24. 
225. Madsen, J.J.; Grime, J.M.A.; Rossman, J.S.; Voth, G.A. Entropic forces drive clustering 
and spatial localization of influenza A M2 during viral budding. Proc Natl Acad Sci U S 
A 2018, 115, E8595-E8603, doi:10.1073/pnas.1805443115. 
226. Martyna, A.; Gómez-Llobregat, J.; Lindén, M.; Rossman, J.S. Curvature Sensing by a 
Viral Scission Protein. Biochemistry 2016, 55, 3493-3496, 
doi:10.1021/acs.biochem.6b00539. 
227. Schroeder, C.; Heider, H.; Möncke-Buchner, E.; Lin, T.I. The influenza virus ion channel 
and maturation cofactor M2 is a cholesterol-binding protein. Eur Biophys J 2005, 34, 52-
66, doi:10.1007/s00249-004-0424-1. 
228. Thaa, B.; Siche, S.; Herrmann, A.; Veit, M. Acylation and cholesterol binding are not 
required for targeting of influenza A virus M2 protein to the hemagglutinin-defined 
budozone. FEBS Lett 2014, 588, 1031-1036, doi:10.1016/j.febslet.2014.02.014. 
229. Castrucci, M.R.; Hughes, M.; Calzoletti, L.; Donatelli, I.; Wells, K.; Takada, A.; 
Kawaoka, Y. The cysteine residues of the M2 protein are not required for influenza A 
virus replication. Virology 1997, 238, 128-134, doi:10.1006/viro.1997.8809. 
230. Grantham, M.L.; Wu, W.H.; Lalime, E.N.; Lorenzo, M.E.; Klein, S.L.; Pekosz, A. 
Palmitoylation of the influenza A virus M2 protein is not required for virus replication in 
vitro but contributes to virus virulence. J Virol 2009, 83, 8655-8661, 
doi:10.1128/JVI.01129-09. 
231. Stewart, S.M.; Wu, W.H.; Lalime, E.N.; Pekosz, A. The cholesterol 
recognition/interaction amino acid consensus motif of the influenza A virus M2 protein is 
not required for virus replication but contributes to virulence. Virology 2010, 405, 530-
538, doi:10.1016/j.virol.2010.06.035. 
232. Honigmann, A.; Sadeghi, S.; Keller, J.; Hell, S.W.; Eggeling, C.; Vink, R. A lipid bound 
actin meshwork organizes liquid phase separation in model membranes. Elife 2014, 3, 
e01671, doi:10.7554/eLife.01671. 
233. Vogel, S.K.; Greiss, F.; Khmelinskaia, A.; Schwille, P. Control of lipid domain 
organization by a biomimetic contractile actomyosin cortex. Elife 2017, 6, 
doi:10.7554/eLife.24350. 
234. Haggie, P.M.; Kim, J.K.; Lukacs, G.L.; Verkman, A.S. Tracking of quantum dot-labeled 
CFTR shows near immobilization by C-terminal PDZ interactions. Mol Biol Cell 2006, 
17, 4937-4945, doi:10.1091/mbc.e06-08-0670. 
121	
235. Chen, Y.; Veracini, L.; Benistant, C.; Jacobson, K. The transmembrane protein CBP 
plays a role in transiently anchoring small clusters of Thy-1, a GPI-anchored protein, to 
the cytoskeleton. J Cell Sci 2009, 122, 3966-3972, doi:10.1242/jcs.049346. 
236. Tinevez, J.Y.; Schulze, U.; Salbreux, G.; Roensch, J.; Joanny, J.F.; Paluch, E. Role of 
cortical tension in bleb growth. Proc Natl Acad Sci U S A 2009, 106, 18581-18586, 
doi:10.1073/pnas.0903353106. 
237. Smith, A.S.; Nowak, R.B.; Zhou, S.; Giannetto, M.; Gokhin, D.S.; Papoin, J.; Ghiran, 
I.C.; Blanc, L.; Wan, J.; Fowler, V.M. Myosin IIA interacts with the spectrin-actin 
membrane skeleton to control red blood cell membrane curvature and deformability. Proc 
Natl Acad Sci U S A 2018, 115, E4377-E4385, doi:10.1073/pnas.1718285115. 
238. Giner, D.; Neco, P.; Francés, M.e.M.; López, I.; Viniegra, S.; Gutiérrez, L.M. Real-time 
dynamics of the F-actin cytoskeleton during secretion from chromaffin cells. J Cell Sci 
2005, 118, 2871-2880, doi:10.1242/jcs.02419. 
239. Giner, D.; López, I.; Villanueva, J.; Torres, V.; Viniegra, S.; Gutiérrez, L.M. Vesicle 
movements are governed by the size and dynamics of F-actin cytoskeletal structures in 
bovine chromaffin cells. Neuroscience 2007, 146, 659-669, 
doi:10.1016/j.neuroscience.2007.02.039. 
240. Jackson, D.; Lamb, R.A. The influenza A virus spliced messenger RNA M mRNA3 is 
not required for viral replication in tissue culture. J Gen Virol 2008, 89, 3097-3101, 
doi:10.1099/vir.0.2008/004739-0. 
241. Nolen, B.J.; Tomasevic, N.; Russell, A.; Pierce, D.W.; Jia, Z.; McCormick, C.D.; 
Hartman, J.; Sakowicz, R.; Pollard, T.D. Characterization of two classes of small 
molecule inhibitors of Arp2/3 complex. Nature 2009, 460, 1031-1034, 
doi:10.1038/nature08231. 
242. Isogai, T.; van der Kammen, R.; Innocenti, M. SMIFH2 has effects on Formins and p53 
that perturb the cell cytoskeleton. Sci Rep 2015, 5, 9802, doi:10.1038/srep09802. 
243. Yang, Q.; Zhang, X.F.; Pollard, T.D.; Forscher, P. Arp2/3 complex-dependent actin 
networks constrain myosin II function in driving retrograde actin flow. J Cell Biol 2012, 
197, 939-956, doi:10.1083/jcb.201111052. 
244. Bovellan, M.; Romeo, Y.; Biro, M.; Boden, A.; Chugh, P.; Yonis, A.; Vaghela, M.; 
Fritzsche, M.; Moulding, D.; Thorogate, R., et al. Cellular control of cortical actin 
nucleation. Curr Biol 2014, 24, 1628-1635, doi:10.1016/j.cub.2014.05.069. 
245. Köster, D.V.; Mayor, S. Cortical actin and the plasma membrane: inextricably 
intertwined. Curr Opin Cell Biol 2016, 38, 81-89, doi:10.1016/j.ceb.2016.02.021. 
246. Fujiwara, T.K.; Iwasawa, K.; Kalay, Z.; Tsunoyama, T.A.; Watanabe, Y.; Umemura, 
Y.M.; Murakoshi, H.; Suzuki, K.G.; Nemoto, Y.L.; Morone, N., et al. Confined diffusion 
of transmembrane proteins and lipids induced by the same actin meshwork lining the 
plasma membrane. Mol Biol Cell 2016, 27, 1101-1119, doi:10.1091/mbc.E15-04-0186. 
247. Hiramoto-Yamaki, N.; Tanaka, K.A.; Suzuki, K.G.; Hirosawa, K.M.; Miyahara, M.S.; 
Kalay, Z.; Tanaka, K.; Kasai, R.S.; Kusumi, A.; Fujiwara, T.K. Ultrafast diffusion of a 
fluorescent cholesterol analog in compartmentalized plasma membranes. Traffic 2014, 
15, 583-612, doi:10.1111/tra.12163. 
248. Suzuki, K.; Ritchie, K.; Kajikawa, E.; Fujiwara, T.; Kusumi, A. Rapid hop diffusion of a 
G-protein-coupled receptor in the plasma membrane as revealed by single-molecule 
techniques. Biophys J 2005, 88, 3659-3680, doi:10.1529/biophysj.104.048538. 
122	
249. Rodgers, B.; Mims, C.A. Interaction of influenza virus with mouse macrophages. Infect 
Immun 1981, 31, 751-757. 
250. Nicholls, J.M.; Chan, M.C.; Chan, W.Y.; Wong, H.K.; Cheung, C.Y.; Kwong, D.L.; 
Wong, M.P.; Chui, W.H.; Poon, L.L.; Tsao, S.W., et al. Tropism of avian influenza A 
(H5N1) in the upper and lower respiratory tract. Nat Med 2007, 13, 147-149, 
doi:10.1038/nm1529. 
251. Landsman, L.; Jung, S. Lung macrophages serve as obligatory intermediate between 
blood monocytes and alveolar macrophages. J Immunol 2007, 179, 3488-3494. 
252. Misharin, A.V.; Morales-Nebreda, L.; Reyfman, P.A.; Cuda, C.M.; Walter, J.M.; 
McQuattie-Pimentel, A.C.; Chen, C.I.; Anekalla, K.R.; Joshi, N.; Williams, K.J.N., et al. 
Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over 
the life span. J Exp Med 2017, 214, 2387-2404, doi:10.1084/jem.20162152. 
253. Simons, K.; Sampaio, J.L. Membrane organization and lipid rafts. Cold Spring Harb 
Perspect Biol 2011, 3, a004697, doi:10.1101/cshperspect.a004697. 
254. Sezgin, E.; Levental, I.; Mayor, S.; Eggeling, C. The mystery of membrane organization: 
composition, regulation and roles of lipid rafts. Nat Rev Mol Cell Biol 2017, 18, 361-374, 
doi:10.1038/nrm.2017.16. 
255. Chichili, G.R.; Rodgers, W. Cytoskeleton-membrane interactions in membrane raft 
structure. Cell Mol Life Sci 2009, 66, 2319-2328, doi:10.1007/s00018-009-0022-6. 
256. Winter, P.W.; Van Orden, A.K.; Roess, D.A.; Barisas, B.G. Actin-dependent clustering 
of insulin receptors in membrane microdomains. Biochim Biophys Acta 2012, 1818, 467-
473, doi:10.1016/j.bbamem.2011.10.006. 
257. Goswami, D.; Gowrishankar, K.; Bilgrami, S.; Ghosh, S.; Raghupathy, R.; Chadda, R.; 
Vishwakarma, R.; Rao, M.; Mayor, S. Nanoclusters of GPI-anchored proteins are formed 
by cortical actin-driven activity. Cell 2008, 135, 1085-1097, 
doi:10.1016/j.cell.2008.11.032. 
258. Lillemeier, B.F.; Pfeiffer, J.R.; Surviladze, Z.; Wilson, B.S.; Davis, M.M. Plasma 
membrane-associated proteins are clustered into islands attached to the cytoskeleton. 
Proc Natl Acad Sci U S A 2006, 103, 18992-18997, doi:10.1073/pnas.0609009103. 
259. Fontana, J.; Steven, A.C. At low pH, influenza virus matrix protein M1 undergoes a 
conformational change prior to dissociating from the membrane. J Virol 2013, 87, 5621-
5628, doi:10.1128/JVI.00276-13. 
260. Zhirnov, O.P. Isolation of matrix protein M1 from influenza viruses by acid-dependent 
extraction with nonionic detergent. Virology 1992, 186, 324-330. 
261. Bruce, E.A.; Abbink, T.E.; Wise, H.M.; Rollason, R.; Galao, R.P.; Banting, G.; Neil, S.J.; 
Digard, P. Release of filamentous and spherical influenza A virus is not restricted by 
tetherin. J Gen Virol 2012, 93, 963-969, doi:10.1099/vir.0.038778-0. 
262. Watanabe, R.; Leser, G.P.; Lamb, R.A. Influenza virus is not restricted by tetherin 
whereas influenza VLP production is restricted by tetherin. Virology 2011, 417, 50-56, 
doi:10.1016/j.virol.2011.05.006. 
263. Agosto, L.M.; Zhong, P.; Munro, J.; Mothes, W. Highly active antiretroviral therapies are 
effective against HIV-1 cell-to-cell transmission. PLoS Pathog 2014, 10, e1003982, 
doi:10.1371/journal.ppat.1003982. 
264. Jolly, C. Cell-to-cell transmission of retroviruses: Innate immunity and interferon-
induced restriction factors. Virology 2011, 411, 251-259, 
doi:10.1016/j.virol.2010.12.031. 
123	
265. Sigal, A.; Kim, J.T.; Balazs, A.B.; Dekel, E.; Mayo, A.; Milo, R.; Baltimore, D. Cell-to-
cell spread of HIV permits ongoing replication despite antiretroviral therapy. Nature 
2011, 477, 95-98, doi:10.1038/nature10347. 
266. Mori, K.; Haruyama, T.; Nagata, K. Tamiflu-resistant but HA-mediated cell-to-cell 
transmission through apical membranes of cell-associated influenza viruses. PLoS One 
2011, 6, e28178, doi:10.1371/journal.pone.0028178. 
267. Roberts, K.L.; Manicassamy, B.; Lamb, R.A. Influenza A virus uses intercellular 
connections to spread to neighboring cells. J Virol 2015, 89, 1537-1549, 
doi:10.1128/JVI.03306-14. 
268. Kumar, A.; Kim, J.H.; Ranjan, P.; Metcalfe, M.G.; Cao, W.; Mishina, M.; Gangappa, S.; 
Guo, Z.; Boyden, E.S.; Zaki, S., et al. Influenza virus exploits tunneling nanotubes for 
cell-to-cell spread. Sci Rep 2017, 7, 40360, doi:10.1038/srep40360. 
269. Bennett, A.E.; Narayan, K.; Shi, D.; Hartnell, L.M.; Gousset, K.; He, H.; Lowekamp, 
B.C.; Yoo, T.S.; Bliss, D.; Freed, E.O., et al. Ion-abrasion scanning electron microscopy 
reveals surface-connected tubular conduits in HIV-infected macrophages. PLoS Pathog 
2009, 5, e1000591, doi:10.1371/journal.ppat.1000591. 
270. Schneider, C.; Nobs, S.P.; Heer, A.K.; Kurrer, M.; Klinke, G.; van Rooijen, N.; Vogel, J.; 
Kopf, M. Alveolar macrophages are essential for protection from respiratory failure and 
associated morbidity following influenza virus infection. PLoS Pathog 2014, 10, 
e1004053, doi:10.1371/journal.ppat.1004053. 
271. Tumpey, T.M.; García-Sastre, A.; Taubenberger, J.K.; Palese, P.; Swayne, D.E.; Pantin-
Jackwood, M.J.; Schultz-Cherry, S.; Solórzano, A.; Van Rooijen, N.; Katz, J.M., et al. 
Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional 
roles of alveolar macrophages and neutrophils in limiting virus replication and mortality 
in mice. J Virol 2005, 79, 14933-14944, doi:10.1128/JVI.79.23.14933-14944.2005. 
272. Tate, M.D.; Pickett, D.L.; van Rooijen, N.; Brooks, A.G.; Reading, P.C. Critical role of 
airway macrophages in modulating disease severity during influenza virus infection of 
mice. J Virol 2010, 84, 7569-7580, doi:10.1128/JVI.00291-10. 
273. Purnama, C.; Ng, S.L.; Tetlak, P.; Setiagani, Y.A.; Kandasamy, M.; Baalasubramanian, 
S.; Karjalainen, K.; Ruedl, C. Transient ablation of alveolar macrophages leads to 
massive pathology of influenza infection without affecting cellular adaptive immunity. 
Eur J Immunol 2014, 44, 2003-2012, doi:10.1002/eji.201344359. 
274. Kopf, M.; Schneider, C.; Nobs, S.P. The development and function of lung-resident 
macrophages and dendritic cells. Nat Immunol 2015, 16, 36-44, doi:10.1038/ni.3052. 
275. Morales-Nebreda, L.; Misharin, A.V.; Perlman, H.; Budinger, G.R. The heterogeneity of 
lung macrophages in the susceptibility to disease. Eur Respir Rev 2015, 24, 505-509, 
doi:10.1183/16000617.0031-2015. 
276. Ettensohn, D.B.; Frampton, M.W.; Nichols, J.E.; Roberts, N.J. Human Alveolar 
Macrophages May Not Be Susceptible to Direct Infection by a Human Influenza Virus. J 
Infect Dis 2016, 214, 1658-1665, doi:10.1093/infdis/jiw413. 
277. Pulendran, B.; Maddur, M.S. Innate immune sensing and response to influenza. Curr Top 
Microbiol Immunol 2015, 386, 23-71, doi:10.1007/82_2014_405. 
278. Pang, I.K.; Iwasaki, A. Inflammasomes as mediators of immunity against influenza virus. 
Trends Immunol 2011, 32, 34-41, doi:10.1016/j.it.2010.11.004. 
124	
279. Kato, H.; Takeuchi, O.; Sato, S.; Yoneyama, M.; Yamamoto, M.; Matsui, K.; Uematsu, 
S.; Jung, A.; Kawai, T.; Ishii, K.J., et al. Differential roles of MDA5 and RIG-I helicases 
in the recognition of RNA viruses. Nature 2006, 441, 101-105, doi:10.1038/nature04734. 
280. Pichlmair, A.; Schulz, O.; Tan, C.P.; Näslund, T.I.; Liljeström, P.; Weber, F.; Reis e 
Sousa, C. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-
phosphates. Science 2006, 314, 997-1001, doi:10.1126/science.1132998. 
281. Rehwinkel, J.; Tan, C.P.; Goubau, D.; Schulz, O.; Pichlmair, A.; Bier, K.; Robb, N.; 
Vreede, F.; Barclay, W.; Fodor, E., et al. RIG-I detects viral genomic RNA during 
negative-strand RNA virus infection. Cell 2010, 140, 397-408, 
doi:10.1016/j.cell.2010.01.020. 
282. Baum, A.; Sachidanandam, R.; García-Sastre, A. Preference of RIG-I for short viral RNA 
molecules in infected cells revealed by next-generation sequencing. Proc Natl Acad Sci U 
S A 2010, 107, 16303-16308, doi:10.1073/pnas.1005077107. 
283. Te Velthuis, A.J.W.; Long, J.C.; Bauer, D.L.V.; Fan, R.L.Y.; Yen, H.L.; Sharps, J.; 
Siegers, J.Y.; Killip, M.J.; French, H.; Oliva-Martín, M.J., et al. Mini viral RNAs act as 
innate immune agonists during influenza virus infection. Nat Microbiol 2018, 3, 1234-
1242, doi:10.1038/s41564-018-0240-5. 
284. Vasilijevic, J.; Zamarreño, N.; Oliveros, J.C.; Rodriguez-Frandsen, A.; Gómez, G.; 
Rodriguez, G.; Pérez-Ruiz, M.; Rey, S.; Barba, I.; Pozo, F., et al. Reduced accumulation 
of defective viral genomes contributes to severe outcome in influenza virus infected 
patients. PLoS Pathog 2017, 13, e1006650, doi:10.1371/journal.ppat.1006650. 
285. Vale-Costa, S.; Amorim, M.J. Clustering of Rab11 vesicles in influenza A virus infected 
cells creates hotspots containing the 8 viral ribonucleoproteins. Small GTPases 2016, 1-7, 
doi:10.1080/21541248.2016.1199190. 
286. Genoyer, E.; López, C.B. Defective viral genomes alter how Sendai virus interacts with 
cellular trafficking machinery leading to heterogeneity in the production of viral particles 
among infected cells. J Virol 2018, doi:10.1128/JVI.01579-18. 
287. Zebedee, S.L.; Lamb, R.A. Growth restriction of influenza A virus by M2 protein 
antibody is genetically linked to the M1 protein. Proc Natl Acad Sci U S A 1989, 86, 
1061-1065. 
288. Hirao, M.; Sato, N.; Kondo, T.; Yonemura, S.; Monden, M.; Sasaki, T.; Takai, Y.; 
Tsukita, S. Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma 
membrane association: possible involvement of phosphatidylinositol turnover and Rho-
dependent signaling pathway. J Cell Biol 1996, 135, 37-51. 
289. Heiska, L.; Alfthan, K.; Grönholm, M.; Vilja, P.; Vaheri, A.; Carpén, O. Association of 
ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2). Regulation 
by phosphatidylinositol 4, 5-bisphosphate. J Biol Chem 1998, 273, 21893-21900. 
290. Zhang, M.; Bohlson, S.S.; Dy, M.; Tenner, A.J. Modulated interaction of the ERM 
protein, moesin, with CD93. Immunology 2005, 115, 63-73, doi:10.1111/j.1365-
2567.2005.02120.x. 
291. Kaufmann, S.; Käs, J.; Goldmann, W.H.; Sackmann, E.; Isenberg, G. Talin anchors and 
nucleates actin filaments at lipid membranes. A direct demonstration. FEBS Lett 1992, 
314, 203-205. 
292. Martel, V.; Racaud-Sultan, C.; Dupe, S.; Marie, C.; Paulhe, F.; Galmiche, A.; Block, 
M.R.; Albiges-Rizo, C. Conformation, localization, and integrin binding of talin depend 
125	
on its interaction with phosphoinositides. J Biol Chem 2001, 276, 21217-21227, 
doi:10.1074/jbc.M102373200. 
293. Watson, M.J.; Lee, S.L.; Marklew, A.J.; Gilmore, R.C.; Gentzsch, M.; Sassano, M.F.; 
Gray, M.A.; Tarran, R. The Cystic Fibrosis Transmembrane Conductance Regulator 
(CFTR) Uses its C-Terminus to Regulate the A2B Adenosine Receptor. Sci Rep 2016, 6, 
27390, doi:10.1038/srep27390. 
294. Delaney, M.K.; Malikov, V.; Chai, Q.; Zhao, G.; Naghavi, M.H. Distinct functions of 
diaphanous-related formins regulate HIV-1 uncoating and transport. Proc Natl Acad Sci 
U S A 2017, 114, E6932-E6941, doi:10.1073/pnas.1700247114. 
295. Dotson, D.; Woodruff, E.A.; Villalta, F.; Dong, X. Filamin A Is Involved in HIV-1 Vpu-
mediated Evasion of Host Restriction by Modulating Tetherin Expression. J Biol Chem 
2016, 291, 4236-4246, doi:10.1074/jbc.M115.708123. 
296. Ménager, M.M. TSPAN7, effector of actin nucleation required for dendritic cell-
mediated transfer of HIV-1 to T cells. Biochem Soc Trans 2017, 45, 703-708, 
doi:10.1042/BST20160439. 
297. Usmani, S.M.; Murooka, T.T.; Deruaz, M.; Koh, W.H.; Sharaf, R.R.; Di Pilato, M.; 
Power, K.A.; Lopez, P.; Hnatiuk, R.; Vrbanac, V.D., et al. HIV-1 Balances the Fitness 
Costs and Benefits of Disrupting the Host Cell Actin Cytoskeleton Early after Mucosal 
Transmission. Cell Host Microbe 2019, 25, 73-86.e75, doi:10.1016/j.chom.2018.12.008. 
298. Banerjee, I.; Miyake, Y.; Nobs, S.P.; Schneider, C.; Horvath, P.; Kopf, M.; Matthias, P.; 
Helenius, A.; Yamauchi, Y. Influenza A virus uses the aggresome processing machinery 
for host cell entry. Science 2014, 346, 473-477, doi:10.1126/science.1257037. 
299. De Conto, F.; Fazzi, A.; Razin, S.V.; Arcangeletti, M.C.; Medici, M.C.; Belletti, S.; 
Chezzi, C.; Calderaro, A. Mammalian Diaphanous-related formin-1 restricts early phases 
of influenza A/NWS/33 virus (H1N1) infection in LLC-MK2 cells by affecting 
cytoskeleton dynamics. Mol Cell Biochem 2018, 437, 185-201, doi:10.1007/s11010-017-
3107-9. 
300. Delpeut, S.; Sisson, G.; Black, K.M.; Richardson, C.D. Measles Virus Enters Breast and 
Colon Cancer Cell Lines through a PVRL4-Mediated Macropinocytosis Pathway. J Virol 
2017, 91, doi:10.1128/JVI.02191-16. 
301. Dietzel, E.; Kolesnikova, L.; Maisner, A. Actin filaments disruption and stabilization 
affect measles virus maturation by different mechanisms. Virol J 2013, 10, 249, 
doi:10.1186/1743-422X-10-249. 
302. Koga, R.; Sugita, Y.; Noda, T.; Yanagi, Y.; Ohno, S. Actin-Modulating Protein Cofilin Is 
Involved in the Formation of Measles Virus Ribonucleoprotein Complex at the 
Perinuclear Region. J Virol 2015, 89, 10524-10531, doi:10.1128/JVI.01819-15. 
303. Wakimoto, H.; Shimodo, M.; Satoh, Y.; Kitagawa, Y.; Takeuchi, K.; Gotoh, B.; Itoh, M. 
F-actin modulates measles virus cell-cell fusion and assembly by altering the interaction 
between the matrix protein and the cytoplasmic tail of hemagglutinin. J Virol 2013, 87, 
1974-1984, doi:10.1128/JVI.02371-12. 
304. Aleksandrowicz, P.; Marzi, A.; Biedenkopf, N.; Beimforde, N.; Becker, S.; Hoenen, T.; 
Feldmann, H.; Schnittler, H.J. Ebola virus enters host cells by macropinocytosis and 
clathrin-mediated endocytosis. J Infect Dis 2011, 204 Suppl 3, S957-967, 
doi:10.1093/infdis/jir326. 
305. Schudt, G.; Dolnik, O.; Kolesnikova, L.; Biedenkopf, N.; Herwig, A.; Becker, S. 
Transport of Ebolavirus Nucleocapsids Is Dependent on Actin Polymerization: Live-Cell 
126	
Imaging Analysis of Ebolavirus-Infected Cells. J Infect Dis 2015, 212 Suppl 2, S160-166, 
doi:10.1093/infdis/jiv083. 
 
